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Background: Globally, 80% of children with cancer live in low- and middle-income 
countries (LMIC) and 20% or less are expected to survive.  Research 
demonstrates a gap on recording experiences of planners who have successfully 
established a pediatric cancer unit (PCU), lack of studies on systematic, evidence-
based planning of a PCU, and absence of an actionable, practical framework that 
guides planners. 
Objectives: This qualitative study used a case study approach to examine the key 
elements in the planning process of effectively establishing a new PCU and identify 
the challenges that need to be addressed.  
Methods: Porter’s Value Chain Model served as the theoretical framework to 
guide the research agenda. Semi-structured in-depth interviews were conducted 
in 2017 with a purposive sample of 35 key informants reflecting experiences from 
30 countries. An interview guide was developed and recruitment continued until 
 
 vi 
saturation. Participants included physicians, nurses, architects, administrators, 
consultants, and academicians. Data were also employed from three other 
sources: document review, observation, and pre-dissertation findings.  Interviews 
were recorded, transcribed using REV, and analyzed using NVIVO. Data were 
analyzed using a thematic analysis and principles of grounded theory method were 
applied in the interview guide design and analysis.  
Results: Respondents reported nine strategic elements essential in the process: 
leadership, mission, planning principles, organizational structure, situation 
analysis, medical model, financing, stakeholders, and international partnerships. 
Corruption, distrustful culture, ineffective communication, and lack of data were 
cited as key barriers.  
Discussion: Documenting best practices and implementing a data-driven, 
systems-based planning is essential in advancing local PCU management know-
how in LMIC. The modified Porter’s Value Model showed promise as a 
generalizable model for future public health practitioners and created a framework 
for systems-based, multidisciplinary approach in strategic planning.  
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AYUVI Fundación Ayúdame a Vivir 
CCHE Children’s Cancer Hospital Egypt 57357 
HIC High-Income Countries 
HITO Hospital Infantil Teletón de Oncología 
KI Key informant(s) 
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LMIC Low- and Middle-Income Countries 
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Medical entrepreneurs, leaders, and/or their teams who are in the 
process of establishing a new pediatric oncology unit in a low-
resource setting. 
Process The procedure and collection of steps involved in the planning of 
a new pediatric oncology unit in a low-resource setting. 
Project The set of activities and tasks undertaken by the hospital planners 
with the goal to develop a pediatric oncology unit in a low-resource 
setting. 
Unit Any type of pediatric oncology facility in a low-resource setting 
which is in the process of being planned whether within a general 
hospital, within a children’s hospital, or a free-standing children’s 
cancer hospital. The acronym PCU (Pediatric Cancer Unit) will be 
used in the study. 
Element Key strategic considerations in the process of planning a new 
PCU in a low-resource setting. This includes critical elements and 
resources in the process, and reflects the horizontal and vertical 
cells in Porter’s Value Chain Model. An element may have more 
than one activity in it and the term reflects the group of planning 












Addressing global health challenges requires context-specific health 
system strengthening that takes into consideration national priorities and political 
willingness to implement change. In January 2016, the United Nations presented 
the 17 Sustainable Development Goals (SDG) that countries agreed to reach as 
part of the 2030 agenda.1 Although awareness about the SDGs has increased and 
interest in reducing health inequities is growing, the burden of diseases still 
disproportionally affects populations in Low- and Middle-Income Countries (LMIC) 
where health, social, political, and economic systems may already be fragmented, 
immature, and weak.  
Non-Communicable Diseases as Priority 
Experts emphasize the need for a comprehensive action plan to tackle the 
growing burden of non-communicable diseases (NCD) which kill 36 million people 
annually.2 The World Health Organization (WHO) and World Economic Forum 
point out in their joint report that the invisible NCD crisis is “an under-appreciated 
cause of poverty and hinders the economic development of many countries.”3  A 
2005 WHO report on chronic diseases underlined the large economic impact NCD 
have on a country-level due to the large-scale productivity loss, debilitating 
physical and mental impact, and financial devastation families often go through 





due to high costs of treatment and out of pocket expenses. The report’s key 
message underscored the need to invest in sustainable healthcare services and 
highlights the link between chronic disease and poverty in LMIC.4  
Pediatric Oncology in Low-Resource Settings 
A series in the Lancet Oncology in 2013 highlighted the increasing 
proportion of childhood mortality due to NCD, including childhood cancer.1,5,6 The 
series emphasized the necessity for pediatric oncology services prepared and 
equipped to provide adequate, safe, and long-term care to children with cancer. 
Approximately 200,000 children and adolescents are diagnosed with cancer 
every year around the world; of those, 80% live in LMIC.2  LMIC are not only 
burdened with most of childhood cancer cases but also account for more than 90% 
of cancer-related deaths globally. Health systems in LMIC are already ill-prepared 
to meet the challenge of treating NCD, in general, and childhood cancer, in 
particular.2 Weak systems to address a high burden of disease exacerbates the 
global health inequities and limit equal access to care for all children no matter 
where they live.   
Even though cancer is the second leading cause of death in children in the 
USA, Canada and other High-Income Countries (HIC) after accidents, the 
epidemiology of pediatric cancer is still not fully known.2,7,8 The types of cancers 
occurring during childhood are substantially different from those arising in adults, 
and while epidemiological studies are scarce, some data suggest socioeconomic, 





cancer, prevention, screening, or population-based campaigns are not applicable 
strategies to affect pediatric cancer mortality or decrease incidence as pediatric 
malignancies are not caused by known modifiable environmental risk factors.10,11  
Outcomes for children with cancer in developing and underdeveloped 
countries are negatively influenced by several factors including: late presentation, 
misdiagnosis, under diagnosis, lack of awareness of the signs and symptoms of 
cancer, high treatment abandonment rates, high prevalence of complicating 
factors such as malnutrition, lack of palliative care, other comorbidities, and limited 
access to curative therapies.2 
Despite the pressing need, public health agendas do not prioritize pediatric 
cancer in most LMIC; instead governments prioritize communicable diseases, 
nutrition, and other health concerns.3 As health systems improve in LMIC and 
fewer children die under five years of age, the proportion of NCD and, 
subsequently, the number of children with cancer is estimated to increase by 30% 
by 2020.4,5 This increase is due to the reduction of other diseases that kill children 
and the enhanced ability of LMIC health systems to identify pediatric cancer.  
Planning Capacity in LIMC 
 Studies demonstrate the insufficient public health systems in developing 
countries, lack of trained healthcare leaders, and haphazard planning of new 
children’s services, including pediatric cancer units (PCU).12,13 Sullivan and 
colleagues proposed the strengthening of international professional networks and 





planning of oncology services.6 Filerman drew attention to the shortage of 
competent managers, management skills, and adequate management 
infrastructure to allow hospital planners to effectively organize the development of 
health services, including oncology.14 
A 2016 report by the United States Agency for International Development 
(USAID) stated that “good leadership, management and governance are the key 
enabling factors to achieve sustainable health outcomes.”13  A subsequent USAID 
publication highlighted the fact that health leaders in developing countries are not 
adequately prepared to succeed in leadership roles and challenges.15 They 
pointed out the environmental challenges that health leaders in LMIC face 
(decentralization of healthcare system, irregular medical supply, unstable work 
conditions, and such) which further impact leadership decisions and 
implementation. Frenk and colleagues underlined the persistent and systemic 
problem with professional development and education of health leaders both in 
HIC and LMIC, and called for an educational reform so that doctors and other 
healthcare professionals would be able to cope with the rapid changes in global 
health.16 Horton added that the current delivery, content, and organization of the 
education of healthcare professionals have thus far failed to address the needs 
and interests of patients and populations.17  
As a result of the shortage of trained hospital leaders, planning for new 
healthcare facilities in LMIC also suffers.18  A 2005 study of hospitals in Tanzania 





importantly, the almost nonexistent strategic and long-term management.19 
Planners and executives have emphasized the need for systematic 
healthcare strategic planning and the role of an efficient planning process in the 
effective delivery of care and value for patients.20,21 Furthermore, studies have 
shown that the lack of documented planning guidelines means that feedback, 
lessons learned, and errors in planning are not shared and future hospital planners 
cannot learn from others’ past experiences.22 The lack of a systematic, evidence-
based approach to planning may lead to ineffective use of already limited 
resources which eventually result in inadequate treatment and further outcome 
disparities between developed and developing countries. 
Therefore, given the rise in NCD in LMIC, frail healthcare systems in LMIC, 
growth of pediatric oncology cases in the future, and lack of trained hospital 
planners, there is a need for methodical planning for new PCU to effectively treat 
children with cancer and decrease health inequities globally.   
 
 
This document is intended for individuals at public or nonprofit organizations 
in LMIC who may have little business experience, yet are motivated to turn their 
ideas into a concrete, actionable plan to establish a new PCU.  The target audience 
is medical entrepreneurs and their teams who want to start discussing the idea of 
a new facility and would like to know the preliminary stages and key factors 






stage. This study will enable hospital planners to go through the initial steps to plan 
their PCU in a cost-effective, evidence-based manner and assist leadership teams 
to move quickly and efficiently from an idea into a concrete, actionable plan. 
  
The scope of this research starts with the moment when the hospital 
planners conceive the idea of developing a new PCU in their country and ends at 
the point where they are ready to materialize the actual development of the PCU. 
The starting point of the scope answers the question “What do I need to know to 
start planning a new PCU?” and ends with the question “What do I do next now 
that I know what the key elements in planning for a PCU are?” 
The scope excludes operational and logistical issues which will depend on 
the key initial strategic considerations and would be the next steps after the key 
elements are identified. For example, decisions and topics excluded from the 
scope of this dissertation are the type of PCU (ex. stand-alone, within a children’s 
hospital, within a general hospital), patient referral mechanisms (ex. public and 
physician awareness, referral chains, patient origin), facilities and design (ex. 
space and floor plans), procurement (ex. equipment list, supplier contracts), 
financing models (ex. cost per treatment, insurance coverage, government 
reimbursement), health policy initiatives (ex. lobbying efforts to achieve universal 
health coverage), and staffing calculations (ex. how many full-time nurses must be 






basis to proceed to operational and logistical questions in the next phase.  
The scope lies in the broad, introductory stage of the process when leaders 
need to strategize about the vital elements that need to be in place acknowledging 
that decisions on these elements and navigation through challenges related to 




Documenting Best Practices 
This study will explore and document the experiences of hospital planners 
in more than ten countries who have already successfully established a PCU and 
describe the key strategic elements in the process. This study is unique in that it 
leverages perspectives of leaders who are currently in the process of planning a 
PCU to highlight what is important for them and what pieces of information are 
essential to them. Furthermore, it records the perspective of international 
collaborators, consultants, and other professionals who have assisted hospital 
planners to establish a PCU in the past.  
This is the first time that all accounts are collected in one complete 
document and lessons from pitfalls are discussed, which may not otherwise be 
disclosed in a scientific paper or conference presentation. An inclusive, systems 
approach to planning facilitates open communication and encourages dialogue 
among medical, public health, and management professionals that often tend to 
operate in silos but which is essential so that they work together to provide 





multidisciplinary care to children with cancer and foster the establishment of 
sustainable pediatric oncology services. 
Learning from Best Practices  
The end product of this study reflects the learning from extensive qualitative 
research in developing and running pediatric cancer programs, and includes 
advice for future planners and a quantitative model for sizing PCU. The availability 
of a comprehensive guidebook that examines real-life cases, documents practices, 
and records knowledge of past examples may equip planning teams to take data-
driven decisions, maximize the use of existing resources, and prioritize needs. A 
practical guide on the key strategic considerations, barriers, and facilitators in the 
process provides realistic tools to plan sustainable facilities and decrease the time 
spent on the learning process, thus, adding value for patients, overall healthcare 
system, and society at large. 
Platform for Knowledge Transfer 
Reliable data on planning for the establishment of specialized, high-quality, 
comprehensive facilities in LMIC are severely lacking and, to my knowledge, no 
platform exists for international leaders to network and learn from each other for 
the purpose of planning a PCU. Knowledge translation and transfer are essential 
for hospital planners as the documented and transmitted knowledge allows them 
to explore the essential considerations when planning for a new PCU.23,24,25 This 
study will be relevant to hospital planners, even outside pediatric oncology, who 





successfully built a PCU and ask them questions about the process and key 
elements.  This knowledge can help those currently in the process avoid repeating 
the same mistakes, replicate practices that have proven to work, expedite 
progression, and create units that appropriately meet the needs of children with 
cancer in terms of capacity and sustainability.  
Bridging Global Health Inequities 
 Through this work, personal and institutional knowledge is publicly 
registered and can be transferable to other disciplines or medical diseases. 
Comprehensive and evidence-based planning for a PCU builds local PCU 
management know-how and increases the number of PCUs that are effectively 
planned and executed. This advanced local know-how expands access to care for 
children who would not have a place to be diagnosed or would not have received 
adequate and quality treatment, thus, promoting their fundamental human right to 
care. It also raises public’s awareness about cancer and dismisses misconceptions 
that pediatric cancer equals a death sentence. Ultimately, this means that 
sustainable pediatric oncology facilities are established to maximize the potential 
to improve survival for children with cancer and contribute to the advancement of 











 The approach documented in this study can be scaled up and generalized 
to include medical specialties that are usually treated together with oncology (such 
as blood disorders), other specialized care (such as rare diseases), and any LMIC 
where facilities and specialized pediatric oncology care just start to emerge outside 
the private sector (such as in Georgia). The scope can be expanded to private 
facilities as the principal framework is applicable to any facility no matter its 
financial or legal status. Hospital planners in other LMIC may use the generalizable 
lessons learned as narrated by key informants, and replicate the model by using 
chapters independently or as a complete set of guidelines from start to finish.  
advance local PCU management know-how in 
LMIC
increase number of well-planned PCU in LMIC
expand access to pediatric cancer care in LMIC
improve pediatric cancer survival rates in LMIC
improve global health equity





Findings from the case studies, templates, and concrete advice from professionals 
in the field can serve as a guide to expand existing oncology facilities or add a 
satellite clinic by replicating some or all the planning steps.  
Findings will advance the three core public health functions (assessment, 
policy development, and assurance) as follows:26 
1. Assessment: Assists planners to enhance the effectiveness of population-
based health services in pediatric oncology 
2. Policy Development: Presents a plan that supports community health efforts 
to improve outcomes for children with cancer and investigates innovative 
solutions to the problem of childhood cancer by bridging science, 
management, and global health 
3. Assurance: Helps planners to ensure oncology services meet personal 
health needs of children and families, and educates hospital planners on 
how to establish effective PCU  
Lastly, by incorporating a systems-perspective and bringing 
multidisciplinary teams together from the inception phase, the results of the study 
may be more valid and feasible, and the planning guide is more likely to be 
relevant.  The study may serve as a platform to promote a team-based approach 
by involving pediatric oncologists, nurses, epidemiologists, architects, 
accountants, and parents to tackle a global health issue and close the health 






CHAPTER 2. BACKGROUND 
 
 
An extensive systematic literature search was conducted from September 
2016 to January 2018.  The principal objectives of the review were to catalogue 
existing studies on the establishment of PCU in LMIC and strategic plans for PCU 
in LMIC, to examine the essential elements in the process, and to evaluate the 
published literature on past experiences. The Boston Children’s Hospital Medical 
Librarian assisted with search strategies and engines. Appendix 1 includes the list 
of resources that were included in the electronic search (bibliographic databases, 
specific journals, and grey literature).  
Search Terms 
The following categories of search terms and combinations of MeSH terms were 
used to guide the literature review strategy: 
Table 1. Literature Review Search Terms by Category 
Category Search Terms 
Type of 
organization 
Healthcare OR hospital OR health facility OR health unit OR 
clinic OR ward OR department OR health services 
Disease category Pediatric oncology OR oncology OR cancer OR childhood 
cancer 
Planning  Hospital development OR hospital planning OR business 
plan OR strategic plan OR decision-making OR hospital 
governance OR hospital administration OR intervention OR 
process  
Individuals Administrator OR leader OR manager OR decision-maker 
OR planner OR champion OR stakeholder 





Guidelines Guidelines OR steps OR how-to OR manual OR tool-kit OR 
roadmap OR advice OR best practices OR standards OR 
Elements OR elements 
Lessons learned Lessons learned OR perspectives OR success factors OR 
challenges OR thoughts OR advice  
Countries Countries OR nations OR settings OR context 
Developed OR developing OR underdeveloped OR less 
developed OR low-resource OR low-income OR lower-
income OR high-income OR middle-income OR third-world  
Porter’s Model 
Elements 
Mission OR values OR goals OR leader OR twinning OR 
partnership OR collaboration OR needs assessment OR 
feasibility OR financing OR communication OR foundation 
OR NGO OR alliance OR network 
 
Inclusion Criteria 
The following inclusion criteria were used in the literature review: 
• Hospital planning process 
• Published in English, Spanish, Italian or French 
• Published between 1990 and 2018 
Although the primary interest was results in the developing and 
underdeveloped countries, I wanted to explore the depth and quantity of available 
articles for developed countries as well to use as reference, and highlight the lack 
of literature for the developing and underdeveloped countries. Sources referring to 
other clinical disciplines beyond medical oncology or pediatric oncology were still 
included as I wanted to use concepts and guidelines that can be applicable to 
pediatric oncology.  
Exclusion Criteria 
Studies and sources were excluded from the review if they did not meet the 





• Were within healthcare but outside a hospital setting, ex. pharmaceuticals, 
insurance companies, medical supply retailers 
• Used the search terms (planning, standards, guidelines, etc.) to refer only 
to the clinical and disease-related treatment rather than to the 
organizational unit or system in which such treatment was delivered 
• Included only training curriculum for leaders, managers, etc.  
• Focused only on operational aspects of hospital planning such as 
scheduling, discharges, intakes, hospitalization criteria, workflow, as 
opposed to a systems aspect of the PCU 
A diagram of the literature results, based on the PRISMA Statement, is 
found in Figure 2 below.31 I conducted a full text review of 915 articles and selected 
869 articles relevant to be included in the literature review, either as a direct 
reference in the Bibliography (289 references) or to serve as background 































































B. Specific Journals 
Eur J of Oper Res: 1,148 
Int J Equity Health:745 
Int J Health Plan Manage: 
1,366 
Int J Pro Manag: 552  
Harvard Bus Rev: 1,689 
Health Policy & Plan: 
1,367 
J Cancer Policy: 49 
J Chang Manag: 102 
J Glob Oncol: 833 
Lancet Global Health: 
458 
Lancet Onc: 2,897 
Total=11,206 
Removal of 13,735 duplicates 
A=10,910; B=2,820; C=5 
Records screened (titles, abstracts) 
= 29,951 
Records excluded  
= 28,916 
 
Full-text articles assessed for 




relevance = 120 
 
Full-text review = 915 
Total articles included in the 




















Hospital Strategic Planning and Change 
 I examined studies conducted on the strategic planning process and change 
management for hospitals as the creation of a new (or first, in many countries) 
PCU marks a noteworthy transformation in the healthcare system and hospital.  
In his book Leading Change, Kotter explores case studies from diverse 
organizations to apply his eight-stage process of creating major change. The eight 
stages include: 1. Establishing a sense of urgency; 2. Creating the guiding 
coalition; 3. Developing a vision and strategy; 4. Communicating the change vision; 
5. Empowering broad-based action; 6. Generating short-term wines; 7. 
Consolidating gains and producing more change; 8. Anchoring new approaches in 
the culture.32 These steps, although not specific to new hospitals, can be useful for 
hospital planners to realize the considerations associated with changing the status 
quo, barriers, and how to address them. Kotter also talks about errors common to 
organization change efforts and their consequences that can help hospital 
planners avoid mistakes that others have committed and accelerate change. The 
author documents examples of 100 companies and explains that the change 
process needs to go through a series of phases in the right order.33  
Saleh and colleagues examined 79 hospitals in Lebanon 79% of which have 
strategic plans. The authors identified six domains of the strategic planning 
process: having a plan, plan development, plan implementation, responsibility for 





planning activities, governing board involvement, and physicians’ involvement.34 
They concluded that in a LMIC setting, flexible plans allow hospitals to adjust to 
changes in the environment and better promote financial performance.  
The Facility Guidelines Institute, a nonprofit organization that works to 
develop guidelines for designing and building hospitals and other health care 
facilities, in their 2014 guidelines outline the minimum design standards and 
describe the process.35 The guide is available for sale by the American Society for 
Healthcare Engineering of the American Hospital Association and is available in 
an electronic version under a fee.36 Similarly, the Joint Commission International 
sells their manuals on international accreditation standards for academic medical 
hospitals.37 The manual lists the standards and operating procedures that need to 
be in place to become accredited, along with the measurable elements and intent 
of the guideline. It covers a wide range of standards from patient safety, access to 
care, patient and family education, facility management, governance, and 
management of information.  
The American Academy of Pediatrics issued an updated policy statement 
in 2014 on the agreed-upon guidelines for pediatric cancer centers which directs 
that PCU should  have specific personnel, facilities, and capabilities in order to 
provide oncologic care to children.38 The policy statement lists requirements for 
these three areas and draws attention to the role of multi-disciplinary care 






Some PCU are designed as a public-private partnership (PPP), therefore 
development bank guidelines (planning, financial, legal, etc.) on how to implement 
PPP are relevant. The World Bank published a guide in 2015 to support and 
document lessons learned in client countries where PPP in healthcare were built. 
They describe the strategic framework applied, explore drivers of success and 
failure, and highlight the importance of country maturity and infrastructure in the 
development of PPP.39 The Asian Development Bank (ADB) also published a 
handbook on PPP that added details on contract negotiations and addresses “pro-
poor interventions” when PPP are developed.40 The handbook presents key 
implementation issues such as stakeholder management and the requirement for 
technical and managerial skills for the teams involved. A second publication by 
ADB is a guidebook on PPP hospital management and includes six steps in the 
development of a PPP for hospital management highlighting the social marketing 
and promotion plan, and procurement details.41 It includes a list of tasks for the 
business plan, sample implementation plan and sample monitoring and evaluation 
forms. 
A 2007 publication by the World Bank Institute (WBI) gives an extensive 
guide for medical entrepreneurs that provides tools, examples, and a wide-range 
of analyses to ensure financial sustainability of a private health care facility in a 
developing country.42 The guide walks readers through project concept, feasibility 
analysis, financing, facility planning, construction, equipment, and facility opening, 





The U.S. Department of Health and Human Services Human Resources 
and Services Administration (HRSA) introduced a How-To Manual on starting a 
rural health clinic which provides useful information on cost, billing, and coding 
issues, along with sample policies and procedures.43 HRSA has posted a technical 
assistance series on their website which offers resources that can be transferable 
in a low-resource setting.  
Hoey and Myers from USAID gave a presentation on hospital space 
planning and utilization in 2012 where they identified key operational elements 
needed to build a functional program, highlighted how the design of a facility 
impacts other operational aspects, and defined the necessary elements in the first 
steps in hospital planning.44 Their presentation included floor plans and hands-on 
templates on how to estimate size and space. USAID and Management Sciences 
for Health created an eHandbook for leaders and managers which incorporates a 
health systems approach.45 The eHandbook outlines critical competencies for 
leaders, highlights the importance of civil society engagement, describes proven 
practices, and links planning to leading and managing for results. The authors 
discuss pitfalls in planning and present a graph that summarizes what tasks need 
to be planned and how, for example, to analyze the environment by conducting a 
SWOT analysis.  
Partners Healthcare International summarize the four phases in hospital 
planning and development as: 1. Strategic planning and assessment; 2. Project 





based technical advice is to explore local culture, political, and historical 
complexities which may impact the development of a new facility outside the U.S.  
Business Plans for New Hospitals 
Business plans and resources on business plan development for new 
hospitals were examined. Massachusetts General Hospital issued a prototype 
business plan including mission statement, organizational structure, demand 
estimation, equipment, pricing, and competitive analysis.47 World Bank Institute 
also offers a sample business plan outline for the establishment of private health 
facilities in developing countries.48 The 10-page sample business plan describes 
the project concept and external environment analysis, medical operations and 
financial aspects.  
Pediatric Oncology Unit Planning  
The literature review included strategic plans of major professional pediatric 
oncology associations such as the American Society of Pediatric 
Hematology/Oncology (ASPHO) and the European Society for Paediatric 
Oncology (SIOPE).49,50,51 SIOPE underlines the commitment of all stakeholders 
(parents, patients, survivors, policy makers, industry, and others) as a key success 
factor. The strategic plan from the Oncology Nursing Society underlines the 
importance of a comprehensive model of leadership development for nurses and 





Consulting firms offer advice on essential elements in the strategic planning 
process of a new healthcare facility. Hayes Management Consulting presents a 
guide with seven steps to strategic planning which include: 1. Develop mission and 
vision; 2. Conduct business and operational analysis, 3. Develop and select 
strategic options; 4. Establish strategic objectives; 5. Draft strategy executing plan; 
6. Establish appropriate budget and resource allocation; and 7. Review execution 
on a constant basis.53 The Advisory Board Company prepared a Power Point 
Presentation on a strategic plan template for oncology which can serve as an 
active document across the life of the strategic plan and applies to an individual 
hospital or service line.54 It delineates four crucial elements: 1. Current 
performance analysis; 2. Future market assessment; 3. Plan design; and 4. Plan 
summary.    
The Asian Development Bank drafted a business plan and financial 
feasibility analysis for proposed facilities in the Philippines. The resources outlined 
how to conduct a bed-to-population ratios for a particular catchment area, and 
presented tables with forecasted cash flow statements with line item detail (such 
as expense allocation for housekeeping night shifts, ambulances service, and 
rent).55 The plans were for a general hospital, a birthing facility and a pharmacy 
management facility. 
Motivated to integrate the voice of the end user, Warkentin and Frewen urge 
planners to involve input from children and actively engage pediatric stakeholders 





potential consequences when input from children and child health experts are 
ignored when sizing and scoping a new pediatric unit. They recommend working 
to align different stakeholders’ visions for the PCU and suggest that planners 
effectively communicate decisions and their rationale to all stakeholders, including 
the public.   
Review of the experience of building a national pediatric cancer center and 
network in Paraguay highlights the importance of forming international 
partnerships, engaging active non-profit organization (NGO) participation, and 
creating synergies among the healthcare, educational, and judicial national system 
players during the development of the new pediatric cancer center.57 The study 
documents subsequent success in increasing survival and improving overall 
outcomes of childhood cancer. 
Clinical Outcomes for Pediatric Oncology Units in LMIC 
In addition to the aforementioned studies, a number of peer-reviewed 
articles are published on global oncology in LMIC with a focus on the planning for 
a new clinical program or description of the clinical management of a specific 
pediatric cancer type, or adult cancers. 
Four studies by researchers at Butaro Cancer Center of Excellence in 
Rwanda review program-level experience implementing the new adult and 
pediatric cancer center and challenges in the delivery of care.58,59,60 Tapela 





interventions and generate evidence that allows for effective replication and scale-
up.61 
Additional studies describe the development of clinical programs and 
medical guidelines to treat specific childhood cancer types in LMIC such as 
nephroblastoma in Rwanda, retinoblastoma and neuroblastoma in Central 
America, Burkitt lymphoma in Uganda, or brain tumors in India.62,63,64,65,66   
 
 
Search findings highlighted the lack of publications, reports, conference 
proceedings, and guidelines on how to develop a strategic plan specifically for a 
new PCU in a LMIC or HIC. The literature lacks adequately detailed description of 
the key strategic elements, barriers and facilitators in the process. 
While several publications mentioned successful cases of new PCU in LMIC 
improving outcomes for children with cancer or increasing survival, they did not 
provide practical information on how to start the PCU in the first place.67,68,69 These 
articles focused instead on how medical treatment plans were developed at a new 
PCU in a LMIC for a specific type of pediatric cancer or how the use of specific 
treatment protocols was instrumental in decreasing mortality. Several articles 
presented overviews of planning for new cancer facilities for adults but, again, 
findings or advice emphasized the clinical treatment of breast, prostate, lung or 
other types of adult cancer. These studies offered insight on the screening, 
incidence comparisons, effectiveness of treatment plans or cancer burden in a 





LMIC or region but not data on planning the cancer unit.70,71,72,73,74 In the case of 
studies which discussed the challenges and experiences of PCU in LMIC, these 
barriers were described from a clinical perspective without reviewing managerial 
or administrative aspects of planning for a new PCU or operating an existing 
PCU.75,76,65,77,78,79 
In the few cases that guidelines, lessons learned, or recommendations were 
mentioned, their broad perspective and generalizability were limited as there was 
lack of tangible recommendations on how to materialize the steps in the process. 
For example, the need to have a strong mission statement from the beginning was 
mentioned but no advice was given on how to formulate one. Or, in the case of the 
American Academy of Pediatrics, the guidelines were detailed but there was no 
connection with the specific context or practical course of action on how to comply 
with these guidelines. 
Applicability to the specific target audience and user was also limited as 
results did not take into consideration the hospital planners’ lack of prior 
experience or training in similar strategic endeavors. Findings failed to relate to the 
ultimate target population for whom the PCU is developed (i.e. children with 
cancer), nor did they reflect the requirements for specialized pediatric oncology 
care, inclusion of parents, and the necessity to operate within the national health 
system. 
Further examination of conference proceedings and agendas of 





reports on how PCU have been established, their success factors and 
management. Although the International Society for Pediatric Oncology (SIOP) 
does have a working group dedicated to pediatric oncology in developing countries 
called SIOP PODC, its working areas are clinical and do not include the 
management, administration, or strategic operation of the PCU nor do they invite 
a dialogue for PCU leaders to share experiences on strategic decisions and 
challenges with developing their PCU.80 Even in the case of Children’s Cancer 
Hospital Egypt 57357 (CCHE 57357) which was established in 2007 and 
completed 10 years of continuous operation in July 2017, there are no 
assessments, reflections, or case studies documenting their example, sharing their 
experience, or measuring and evaluating programmatic outcomes.81 Likewise, 
there are numerous videos, references, and posts in social and online media about 
both CCHE 57357 in Egypt and Unidad Nacional de Oncología Pediátrica (UNOP) 
in Guatemala but no documented report in academic literature on how the team 
did it and what the key elements in the process were. 
Resources that referred to setting up infrastructure and capacity-building 
did not include a systems approach and looked at each factor independently 
without linking business concepts and public health tools. For example, reports did 
not connect the market demand and bed size with the epidemiology and need 
assessment. The studies often omitted reference to strategic plans or a validated 
business planning methodology, or assumed strategic planning was already a 





In summary, the literature review showed a paucity of resources that would 
be useful to hospital planners, and limited value of the available information for the 
following reasons:  
• Assumption that an already developed level of country infrastructure exists 
• Not relevant to the audience of the dissertation: 
o Not applicable to a LMIC and a public or non-profit setting 
o Aimed at teams who can afford to pay consulting fees 
• Not relevant to the scope of the dissertation: 
o Too narrowly focused in terms of clinical, disease type, or operational 
area 
o Too general without actionable steps or how-to advice on how to move 
through the steps and secure the key elements 
o Too broad in scope or appropriate for a national cancer control plan 
o Too technical in terms of construction or facilities planning or business 
concepts 
o Not incorporating a systems-perspective 







CHAPTER 3. CONCEPTUAL FRAMEWORK 
Gaps in the literature underscore the need to define the set of strategic 
elements that are essential in the process of planning a new PCU and constraints 
around navigating through them to create a facility that brings value to society. 
There is also limited evidence on how key strategic elements are linked to each 
other or accounts of hospital planners who were directly responsible for carrying 
out these key elements. Recurring themes in the literature review discuss barriers 
in the process either internally in the organization (e.g. uncommitted people, 
mission misalignment) or externally (e.g. ineffective engagement of stakeholders, 
disregard for feasibility analysis).  
 
 
In choosing a theoretical framework to guide my analysis, I considered the 
gaps identified in the literature review and discussed in detail in Chapter 2. Porter’s 
Value Chain Model is an appropriate framework for this research as it is depicts 
the strategic alignment of various key elements that need to support the 
development of an organization or a process. 82,83  In this chapter, I describe 
Porter’s Value Chain Model and how it might be adapted to structure the strategic 
planning process for a PCU. 
Porter’s Value Chain Model was chosen for its power to graphically illustrate 
a complex process and reflect the hierarchical relationship between support and 
primary activities, and their interconnectedness and dynamic nature (Figure 3).  






Figure 3. Porter’s Value Chain Model. Reprinted from Porter’s book Competitive 
Advantage: Creating and Sustaining Superior Performance84 
 
Porter’s Model is based on the process view of an organization and can 
depict elements required in a planning process. The Model starts with the 
understanding that a set of nine value-adding activities (rather than one single 
activity) involved in a process. It distinguishes activities as either primary (five 
activities) and or support (four activities).  
All the activities work together synergistically to increase the “margin” or 
profitability of the organization. Christensen and Methlie clarify that customers of 
service firms buy a result of the process, not a product.85  Normann and Ramirez 
have stated that strategy can be defined as “the art of creating value.”86  Therefore, 
the concept of value creation is essential in the process of establishing a new PCU 





Porter integrates a systems-approach to the process and decomposes 
elements of a firm into strategically important activities.87 Porter explains that the 
generic categories of activities can be valid in various industries and it depends on 
each industry to determine which activities are vital.87 The underlying assumption 
is that disaggregated activities are the building blocks based on which a product 
or a service creates value.  
The overall logic of the Value Chain Model is that if all nine primary and 
support elements work synergistically, they will bring value to the customers.88 In 
applying Porter’s Value Chain Model to the planning of PCU, I consider the process 
of developing the PCU as involving subsystems (or activities) that use inputs, apply 
processes, and result in outputs.  In this case, the service value chain structures 
the value processes of a service organization such as the PCU.  
Primary and Support Activities 
Porter’s Model separates activities into primary and support, and assesses 
the internal and external elements necessary for the effective development of the 
organization and, ultimately, delivery of benefit to the customer.84 
Primary activities are directly related to the product or service provided to the 
customer, and take place across organizations. These are: 
1. Inbound Logistics: Activities required to receive, store, and 
disseminate inputs; and relationships with suppliers 
2. Operations: Activities required to transform inputs into outputs 







Activities required to collect, store, and distribute 
the output 
4. Marketing and 
Sales: 
Activities to inform buyers about products and 
services, induce buyers to purchase them, and 
facilitate their purchase 
5. Service: Activities required to keep the product or service 
working effectively for the buyer after it is sold and 
delivered 
Support (secondary) activities are internal within the organization and provide the 
assistance necessary for primary activities. They include: 
1. Firm 
Infrastructure: 
Activities and functions that allows the company to 
maintain daily operations (legal, accounting, 
administrative, general management, planning, 




Activities involved in all human resources 
management (hiring, recruitment, retention, 
training, motivation, etc.) 
3. Technology 
Development: 
Equipment, hardware, software, procedures; and 
management of information and protection of 
knowledge base 
4. Procurement: Activities related to acquisition of inputs or 






A firm’s value chain is a system of interdependent activities, which are 
connected by linkages. These activities and linkages can be analyzed to determine 
a firm’s strengths and weakness.89 The series of activities brings value to 
customers in the form of product or service.90  Value chain analysis is used to 
measure the activities within the value chain, and identify interdependencies.90  
Trade-offs may exist when certain activities need to be optimized, according to the 
organization’s overall strategy, to ensure competitive advantage.  
Linkages 
Linkages are relationships between value activities and can lead to 
competitive advantage.91 A linkage is created when the performance of one activity 
affects the other, in terms of cost, effectiveness, or other type of impact. Linkages 
are crucial for the success of the organization and, when coordinated effectively, 
reflect seamless cooperation and flow of information between the activities.92 
Careful management of linkages is key to smooth functioning and effective delivery 
of the end goal of the process and a powerful advantage to manage obstacles that 
emerge. 
 
Porter’s Value Chain Model was originally used in corporate for-profit 
industries, mainly in manufacturing. A range of industries in various countries have 
applied and built upon this framework ranging from beverage manufacturing 





industry in South Africa93, natural gas in Europe94, and exporting in Ghana95 to 
major global multinational corporations such as Walmart96, IKEA86 and 
Starbucks.97 
 Researchers and strategists have modified this Model to adapt it to the 
service and nonprofit industry, for example the Knowledge Chain Model. The 
Knowledge Chain Model builds upon Porter’s Model to illustrate the fact that when 
key interrelated activities are orchestrated and organized they can enhance the 
organization’s performance and add value (Figure 4).98 This modified model is 
analogous to Porter’s Model, recognizes and translates the primary and support 
activities into knowledge management process and infrastructure respectively.99 It 
includes concepts such as mission, vision, and values and uses Porter’s model as 
a framework to identify activities and challenges in the process of managing 






Figure 4. Knowledge Value Chain. Reprinted from Lee and Yang to show 
Porter’s Model Modifications100 
 
 
Preece introduced the performing arts value chain as a decision-making 
tool for performing arts organizations to address intensive challenges and decide 
on partnerships.101 The author modified the nine activities to adjust them to the 
needs and circumstances of an arts organization (Figure 5). Instead of margin he 
used “viability” to capture the notion of success or profit and to underline that all 







Figure 5. Theatre/Social Service/Corporate/School Partnership Value Chain 
Model. Reprinted from Preece to show Porter’s Model Modifications101 
 
Several studies in education have reconfigured Porter’s Model and explored 
the set of activities that need to be in place to bring value to customers. A 2012 
study from Iran revisited the Model to explain the curriculum delivery process and 
ways to deal with challenges in academia. Their goal was to improve the quality of 
higher education by explaining that knowing these important factors can enhance 
management methods and boost the institution’s competitive advantage.102  A 
study of 807 Scholars from 35 Canadian business schools used a revised model 
to gain a deeper understanding of how individual academic activities improve 





Another report on 
case studies in higher 
education in India and 
Tanzania built upon 
Porter’s Model to 
trace challenges in 
the curriculum 
development process 
and examine threats 





Figure 6. Modified Value Chain for Higher Education 




Their modified value chain explains that not all components of Porter’s 
Model can be directly applied to the service industry, and applies an inside-out and 
outside-in approach to analyze the higher education system. The authors translate 
primary activities into primary attributes and support activities into support 
attributes to adjust the model to the higher education industry. 
In the case of a value chain for British universities, researchers kept the 
idea of splitting activities into primary and secondary, and added intermediary 
activities (teaching consultancy, research consultancy, and research and 
development).105 They also replaced the concept of margin as the end result of the 





objectives, universities are contributing to the greater community. In addition, they 
explain which activities are not appropriate in the case of higher education and 
remodeled them to fit the activities that are valid for a university.  
In healthcare, there has been extensive use and modification of the Model, 
even by Porter himself.  Based on their book Redefining Health Care published in 
2006, Porter and Teisberg, give examples of the model adaption for specific 
medical conditions in primary, specialized, and preventive care. In a presentation 
they gave they explained their adaptation in different medical specialties (including 
cancer care) in the US, Germany, Sweden.106,107  
Porter along with his colleagues published the Care Delivery Value Chain 
(CDVC) in 2009, which examines care as an overall system and encourages 
government agencies, philanthropic organizations, and NGO to use this framework 
for HIV/AIDS capacity improvement.108 The CDVC framework maps activities in 
resource-poor settings, analyzes the process of delivering HIV/AIDS care, and 
synthesizes knowledge about the entire system of subsystems.  The authors 
illustrate that value for patients is measured as a product of the entire care cycle 
and explore barriers and facilitators within the process.  
During a seminar Porter gave in 2014, he showed an example of the CDVC 
for specialized care delivery (acute knee-osteoarthritis replacement) where value 
activities included three support activities (informing and engaging, measuring, 
accessing), and six primary activities (monitoring/preventing, diagnosing, 





care (Figure 7).109 A case study for a clinic in Kazakhstan in 2016 added on the 
CDVC adaptation and used it for individual practice units such as surgery.110 
 
Figure 7. Care Delivery Value Chain for Acute Knee-Osteoarthritis Requiring 
Replacement.  Reprinted from Porter show Porter’s Model modifications109 
 
Other studies have used the Model to schematically represent the entire 
healthcare system as in the case of healthcare systems in Malta, Brazil, and 
Philippines and adjusted it to their local context to gain a deeper understanding of 
their public health systems and provide recommendations on maximizing strengths 
and minimizing challenges.111,112,113  A group of researchers from Wharton School 
of Business based their research on Porter’s Model to identify major segments in 





operate, and analyze the key strategic issues.114,115  Their book has been widely 
used and referenced since its publication in 2002. They emphasized the important 
role of collaborative partnerships and knowledge management as key ingredients 
in the process.  
In addition to Porter’s Model adaptations, studies have analyzed the Model 
to explore its advantages and disadvantages. Although analyses highlight the 
Model’s contribution to modern day strategy, some researchers question the 
Model’s relevance to today’s social media, digital era, and globalized economy, 
point out the difficulty in identifying the discrete individual activities, and are 
concerned with quantifying the link between the nine activities and competitive 
advantage.116,117,118,119   
In all the described adaptations, the underlying idea is to use Porter’s Value 
Chain Model as the theoretical framework to identify primary and support activities, 
illustrate interdependency among activities, and examine as a set of activities that 
bring value to the customer. Value activities are depicted as building blocks and 
are flexible in their interpretation based on the industry environment where the 
organization operates. The analysis of the model reflects challenges, facilitators, 
or other key elements essential in the process or organization depicted.   
Similarly, I will build on this conceptual framework to guide the research 
plan of the dissertation and, in the end, present a modified model that shows the 
primary and support activities in the process of developing a PCU that brings value 







For the PCU case, the concepts of customer and margin are replaced as 
follows:  
Customer: The primary customer is the pediatric oncology patient as end 
user of the set of activities in the planning process. The secondary user benefiting 
from this planning process is the community. Community may include parents, 
healthcare personnel, and individuals involved in the process (such as suppliers, 
policy makers, etc.). In Preece’s modified Value Chain Model mentioned earlier, 
he highlights that in the case of NGO and service institutions, the value they create 
is their contribution to the community and the impact on people beyond the artists 
and performance arts audiences.  
Customer’s Context: This dissertation will explore experiences in low-
resource settings from public or non-profit PCUs. In the countries examined, 
patients may not be expected or required to pay for access to care and do not 
regularly hold private health insurance (although they may incur some out-of-
pocket expenses). Costs for pediatric oncology care are generally covered by the 
government or charitable donations, therefore, pediatric oncology patients are not 
the typical customer buying a service or negotiating prices or shopping around for 
the best treatment. However, given the fact that the PCU is usually the only 
available facility in the country providing cancer treatment, its sustainability is 
crucial to patients’ survival and improvement of patient outcomes. 





Margin: As in the case of higher education or performing arts, the value for 
the patient and broader community is the successful planning of an adequate PCU. 
When all known value activities work synergistically, they will create a PCU that 
effectively addresses current and future oncological care needs, is financially 
sustainable and operationally viable, and is relevant to the local context.  
Thinking about the alternative 
Applying Porter’s Value Chain Model to PCU development presents an 
opportunity to think about the alternative scenario where primary and support 
activities are not effectively identified and assessed, and thus, lead into inefficient 
planning of a new PCU.120,121,122 An Ishikawa (fishbone) diagram depicts the 
potential root causes when key elements are not properly considered early on, 
leading to poor planning and unsuccessful development of a PCU (Figure 8). For 
example, not performing a demand forecast in the early stages of planning, may 
result in a PCU with too few or too many beds that cannot meet the needs of its 
population. This means that the new PCU will not bring value to patients, will not 
address the needs of patients with cancer, and could be an ineffective use of 






Figure 8. Fishbone Diagram for Unsuccessful Development of a PCU in a LMIC 
 
 A real-case highlighting the implications on decision-making about bed 
capacity is CCHE 57357 in Cairo which in 2017 remains the largest children’s 
cancer hospital in the world with 365 beds. Leaders recognized within the first 
years of operations that their bed capacity could only serve 50% of the demand. 
This forced the Board of Directors to change their strategic plan and intensify their 





bed capacity and address other patients’ needs such as guest house for families, 
research capacity, and outpatient clinics which were not included in the initial 
strategic plan.  
 
 
Given the established relevance and applicable adaptation of Porter’s Value 
Chain in strategic planning, healthcare, service and nonprofit industry, Porter’s 
Model is used as the theoretical framework for this study. The goal is to base the 
research agenda of the dissertation on Porter’s Value Chain Model and create a 
modified version. The adapted model will include new model elements that need 
to be in place when planning a new PCU and, after identifying these integral 
components, explore the facilitators that need to be considered and challenges 
that need to be tackled to successfully plan a PCU.  
Identifying the primary and support elements depicted in Porter’s Model 
helps move the process forward and assess how elements correlate with each 
other. Figure 9 (below) graphically summarizes the rationale for Porter’s Model 
relevance to the planning process of a new PCU. 
 
Figure 9. Rationale for Porter's Model Relevance to PCU Planning 
Identify primary and 
support Elements
Identify challenges 





effectively plan the 
PCU





Porter’s Model served as the primary theory to structure the research 
methodology. This enabled me to describe the strategic framework of steps, 
considerations, and obstacles, and devise a modified Porter’s Model for the case 






CHAPTER 4. STUDY METHODOLOGY 
The study documents the technical understanding of hospital planners by 
inviting them to reflect on their own experience during the initial strategic planning 
steps. This experience stimulated discussions on lessons learned, allowing me to 
extract valuable advice for future hospital planners. Themes that emerged through 
the various methods provided detailed perspectives and captured the voice of the 
participants, allowed for experiences to be explained within their respective social, 
cultural, political and organizational context, and identified factors contributing to 
the success or failure of specific steps within the process.  
 
 
The objectives of the study, qualitative data collection from the interviews, 
and the data analysis methodology were developed based on Porter’s Value Chain 
Model. Questions and probes in the interview guides and additional data examined 
and identified the key elements (support and primary) that have led to successful 
planning for a new PCU. The interviews were flexible enough to allow key 
informants to expand on their experience and elaborate on other critical insights, 
which are also explained. 
 
 
This dissertation sought to address two key questions related to the process 
of planning of a new pediatric oncology unit in a low-resource setting based on 
4.1 Application of Theoretical Framework 





Porter’s Value Chain Model and gaps in the literature review. The specific 
objectives of the dissertation were as follows:  
Objective 1: Identify the key initial strategic elements that need to be 
considered for the effective planning of a new pediatric oncology unit in a 
low-resource setting.  
The study examined the primary and support components in successfully starting 
to plan for a PCU by documenting the experience of hospital planners and other 
professionals involved in the process.  
• What was the experience like? 
• What and who were involved in the process? 
• What are the essential elements within the team and in the environment? 
• What has worked well? 
• What advice do hospital planners have to share with future planners? 
Objective 2: Identify the key barriers and facilitators that need to be 
considered during the planning of a new pediatric oncology unit in a low-
resource setting. 
Objective 2 aimed to develop an understanding of emerging themes related to 
challenges and lessons learned during the process, obstacles associated with 
each key element, and outline concrete advice for future strategists and 
implementers.  






• What are the challenges and constraints within each element? 
• What are the pitfalls to avoid when replicating the process? 
• What are the concerns that current planners face and can benefit from 
others’ experience?  
• Where were the bottlenecks and waste in the process? 
As explained in Chapter 3, Porter’s Value Chain Model was a suitable 
theoretical framework to address the two research questions as it defines each 
individual activity, groups activities in either support or primary, and showcases 
their linkage. Porter’s Model allowed to determine the nine elements, indicate 
which ones are support or primary, and explain how they relate to each other.  
 
 
4.3.1 Study Design 
This study used a qualitative research case study approach with a multiple 
context studies type. The case study approach was appropriate for the purpose of 
this research as it aimed to develop an understanding of individuals’ experience 
around the elements involved in the process of establishing a new PCU within their 
multiple contexts in their respective countries123,124,125. Using multiple context 
studies enabled me to explore individual narratives and document multiple hospital 
cases showing how participants moved through the process.  





4.3.2 Data Collection 
Four data gathering methods were used to strengthen the understanding of 
the context and create a more robust study:126,127,128 1. Key informant interviews; 
2. Observation during site visits; 3. Document review; and 4. Pre-Dissertation 
informal interviews and site visits.  Table 2 describes data collection methods and 
type, and number of participants/documents. I collected all data and a research 
assistant from Boston University School of Public Health was hired to assist with 
the data analysis during the fall of 2017.   
Table 2. Summary of Data Collection Methods & Collection 
# Method Rationale Data Type # of 
Participants/ 
Documents 
1 Key Informant 
Interviews  
Identify and explore key 
elements; document 
barriers and facilitators 
 
Qualitative 35 
     
2 Document 
Review 
Examine history and 


















During Site Visits 
 
Study structure of PCU; 







1. Key informant Interviews and Oral Histories 
Semi-structured interviews using an interview guide were conducted with 
key informants from three groups as follows: 
• Group I: Participants located and practicing at existing PCU in LMIC, 
i.e. individuals with past, successful experience in planning 
and implementing a new PCU in a LMIC 
• Group II: Participants located and practicing at facilities in the process 
of developing ideas or plans for a new PCU in a LMIC  
• Group III: Participants from diverse types of institutions who were either 
experts or had already provided technical advice on PCU 
development, design, and planning, such as architects, 
financial planners, project managers, etc. Participants in this 
Group might or might not be located in a LMIC at the time of 
the study. The majority of Group III participants have 
collaborated with participants in Group I & II during the process 
of planning at PCU in the past and were still (in 2018) involved 
with them after the establishment of the new PCU. 
I created a list of Key Informants (KI) in Excel including the KI’s name, 
position, background, name of institution, location (city and country) of institution, 
group number, rationale for interviewing the KI, and information on the interview 
(date an email was sent, date of interview, location of interview). Table 3 below 





Table 3. Key Informants (n=35) 
Key Informant Group I: Interviewees at existing PCU with prior experience in 
planning a new PCU (n=12) 
KI # Position Discipline/Background Country/Region* 
1 General Director  Pediatric Oncologist Mexico 
2 Medical Director  Pediatric Oncologist Mexico 
3 Director, Pediatric Oncology Pediatric Oncologist Mexico 
4 Director  Pediatric Oncologist Philippines 
5 Director  Pediatric Oncologist Myanmar 
6 Director  Pediatric Oncologist Myanmar 
7 CEO Pediatric Oncologist Egypt 
8 Director Pediatric Oncologist Egypt 
9 Vice President & Managing Director 
Project Management, 
Consultant  Egypt 
10 Director Pediatric Oncologist Guatemala 
11 Director Pediatric Oncologist Tanzania 
Key Informant Group II: Interviewees currently planning a new PCU (n=7) 
KII # Position Discipline/Background Country/Region* 
12 Coordinator, Member of Planning Team Pediatric Oncologist Armenia 
13 Member of Planning Team Medical Oncologist Armenia 
14 President, Member of Planning Team Social Worker Armenia 
15 PCU Faculty, Member of Planning Team Pediatric Oncologist Bulgaria 
16 PCU Director, Member of Planning Team Pediatric Oncologist 
Georgia 
 
17 PCU Fellow, Member of Planning Team Pediatric Oncologist Kenya 
18 PCU Faculty, Member of Planning Team Pediatric Oncologist Laos 
Key Informant Group III: Interviewees from diverse institutions with prior 
experience in providing technical advice on PCU planning (n=17) 
KII # Position Discipline/Background Country/Region* 
19 Director 








20 Medical Director, Global Health 
Pediatric Oncologist, 
global pediatric oncology 
capacity building 
Armenia, Egypt, 
Haiti, Mexico, Saudi 
Arabia 
21 Deputy Chief Medical Director Pediatric Oncologist Haiti, Rwanda 
22 Professor, Global Health 
Former Healthcare 




various in the 
Middle East 
23 Senior Project Manager 









25 Nursing Director, Global Health 
Global pediatric oncology 






26 Director of Programmes Global pediatric oncology capacity building 
Malawi, Myanmar, 
Uganda 






28 Director of Project Management 
Project Management, 
children’s hospital (BSEE) USA 
29 Nursing Director, Global Health 




30 PCU Faculty 
Pediatric Hematologist, 








global pediatric oncology 





32 Founder & Director 
International consulting, 






Director of Global Health 
Systems Cluster, 
Professor of Global Health 
Systems 










Director of Innovation and 
Entrepreneurship, Lecturer 
on Health Care 
Management 
International consulting USA 
35 Dean, School of Public Health  
Member, Armenian 
National Cancer Control 
Plan Committee  
Armenia 
*: Country/Region denotes geographic area where KI reported their experience, 
not country origin of KI. 
 
Interview Guide 
Three separate interview guides were developed for each key informant 
group category and are listed in Appendix 2.  The questions were developed based 
on Grounded Theory to identify the key elements, barriers, and facilitators in the 
process of establishing a new PCU, as well as the literature review findings and 
pre-dissertation discussions and observations.  Grounded Theory was an 
applicable approach for this study because knowledge existed on PCU in LMIC 
but there was lack of knowledge about the people, steps, elements, challenges, 
and overall experiences involved in the process of planning for the PCU.129,130 
Grounded Theory is used when there is need to develop an explanation of a 
process that is not understood, involves a number of individuals, and is grounded 
in the views and experiences of participants.131,132 The interview guide served as 
a roadmap to direct the topics to be covered and specific questions to be asked, 
covered areas to probe, and gave a broad sense of timing.  
Interview Procedure  





acknowledged the fact that I needed to apply attentiveness and active listening to 
engage the participants. I began each in-depth interview with an explanation and 
rationale of the study, confirmed that the participants had received the Institutional 
Review Board approval documents (presented later), asked if the participants had 
any questions, and asked for permission to record the session. During the 
interview, I took personal notes and asked the participants to elaborate on a 
question using the probes in the interview guide. I made preliminary notes on 
words, phrases, and concepts that may be a compelling quote in the data analysis. 
I closed the interview session by asking participants if they had anything to add 
that was not included in the interview guide but they found important to share and 
document. In the end, I thanked the participants for their time and input in the study, 
and offered to be available for any follow-up questions or clarifications. Interviews 
lasted 60-90 minutes. 
Interviews were recorded on an Apple i-phone using the free phone 
application Rode Rec and a purchased Rode Rec microphone.133 A fee-based 
transcription service, www.rev.com, was used to professionally transcribe all 
transcripts.134  Online interviews were conducted via Skype, and telephone 
interviews via regular landline or WhatsApp.  
2. Document Review 
I conducted a detailed review of 65 types of materials in various formats 
such as print (hard copy) documents, electronic documents, social media, video, 





analyses, financial reports, Board meeting minutes, staff minutes, brochures, 
information sheets, posters, executive summaries, floor plans, photos from 
construction sites, news articles, and other materials. I tried to collect as many of 
these documents I could from each site but, in some cases, only some types of 
materials were available or could be shared with me. I also reviewed organizational 
content from facilities’ corporate websites, videos, and social media accounts 
(Facebook, Twitter, YouTube).  
These materials were either publicly available or voluntarily shared with me 
in confidence for the purposes of this study. The retrospective document review 
lasted three months and no identifying information was recorded. The table below 
lists the documents that were reviewed and later used to supplement the 
identification of the key elements and modification of Porter’s Value Model.  
Table 4. List of Documents Reviewed in the Study 
# Type of Document Institution Country Topics Explored 
Websites 
1.  Hospital Website UNOP Guatemala General information; history; structure 








Georgia  General information; history; structure 




Bulgaria General information; history; structure 













USA Advice; best practices; templates 
7.  Organization Website 
Ansara Family 
Fund USA 
Advice; best practices; 
templates 
Reports 







CCHE 5357 Egypt  Milestones; history;  
10.  Feasibility Analysis Report CCHE 5357 Egypt  
Demand and growth 
projections 
11.  Annual Report UNOP / AYUVI Guatemala Patient data; milestones; goals; finances 
12.  Annual Report HITO Mexico Patient data; milestones; goals; finances 
13.  Annual Report KOICA Korea / Laos 
Goals; priorities; 
successes 













USA Goals; priorities; successes  
16.  Annual Report Dana-Farber Cancer Institute USA 
Goals; priorities; 
successes  
17.  Strategic Plan Dana-Farber Cancer Institute USA 
Goals; priorities; 
successes; mission 
Notes from Meetings, Workshops, Training Sessions 





19.  Meeting Minutes UNOP Guatemala Structure; leadership; challenges; teamwork 
20.  Meeting Minutes HITO Mexico Structure; leadership; challenges; teamwork 
21.  




Cancer Institute USA 
Requirements; steps; key 
elements; tools 
22.  Workshop Notes - Determining 
Dana-Farber 





















USA Process; tools; templates; best practices 
25.  





School of Public 
Health  
USA 
Demand and workload 
projections; budget; 
principles; best practices; 
resources 
26.  Town Hall Meeting Notes 
Dana-Farber 




27.  Construction Cost & Budget UNOP Guatemala 
Demand projections; cost 
categories; expenses 
28.  Budget Request Proposal UNOP Guatemala 
Expenses; cost categories; 
financing; templates 
29.  Financial Statement HITO Mexico 
Expenses; cost categories; 
financing; templates 
30.  Financial Statement Teletón  Mexico 
Expenses; cost categories; 
financing; templates 














Expenses; cost categories; 
financing; templates 





USA Expenses; cost categories; financing; templates 
34.  Capital Budget Worksheet 
Dana-Farber 
Cancer Institute USA 
Cost categories; 
assumptions 
35.  Financial Statement 
Dana-Farber 
Cancer Institute USA 





& Budget Updates 
Dana-Farber 
Cancer Institute USA 







Cancer Institute USA 











Goals; templates; policies 
39.  Gantt Chart CCHE 57357 Egypt Process; steps; timeline; dependencies 
40.  Master Plan CCHE 57357 Egypt Conceptual design, construction, and layout 
41.  Expansion Plan CCHE 57357 Egypt Demand projections; timeline; priorities 
42.  Floor plans CCHE 57357 Egypt Layout; needed space 
43.  Floor plans UNOP Guatemala Layout; needed space 
44.  Building & Growth Projections UNOP Guatemala 
Demand and projections; 
assumptions 














Priorities; best practices; 
templates; policies 
47.  
Jimmy Fund Clinic 
Schedule 
Overview & Gantt 
Chart 
Dana-Farber 
Cancer Institute USA 
Process; steps; timeline; 
dependencies 
48.  Jimmy Fund Clinic Programming 
Dana-Farber 








Cancer Institute USA Layout; needed space 
50.  Rwanda Hospital Design Standards 
Mass Design 






Group USA Guidelines; layout 
Videos 
52.  Interview CCHE 57357 Egypt History; milestones; challenges; facilitators 
53.  Leadership Workshop CCHE 57357 Egypt Leadership; teamwork 
54.  Interview UNOP Guatemala History; milestones; challenges; facilitators 














Myanmar History; milestones; challenges; facilitators 







on pediatric oncology 
PowerPoint Presentations 








59.  Presentation Slides 
Kenyatta 






















62.  Facebook CCHE 57357 Egypt Foundation; fundraising 










UNOP / AYUVI Guatemala Key elements; themes; implications 
 
3. Pre-Dissertation and Informal Interviews and Site-Visits 
Before the official start of the research and formal in-depth interviews, I 
conducted informal discussions, site visits, and pilot interviews with key informants 
from each of the three groups. This allowed me to gain a preliminary understanding 
of the process of planning a new PCU, and develop the interview guide. The pre-





guides and testing the time allocated for each in-depth interview. These interviews 
allowed for calibration of the interview guides, identification of preliminary themes, 
assistance with personal notes, and design of the quantitative model (discussed 
later).  Remarks, documents collected, and information from these discussions 
provided additional context to the in-depth interviews and exploration of case 
studies. I conducted a total of 20 pre-dissertation interviews and site visits. Table 
5 lists the pre-study interviewee’s organization, location/venue, country, and date.  
4. Direct Observation 
Before and during the study, I conducted multiple site visits to facilities in 
Group I, II & II to directly observe study participants and non-participants in their 
natural settings. Direct, non-participant observation helped develop a rapport, 
fostered a rich understanding of the process from the participants’ perspective, and 
contributed to development and application of Porter’s Value Chain theory used in 
the study.135,136,137  
During observations, I examined several organizational and administrative 
aspects of the PCUs to gain exposure to their operations, as follows: 
• Decision-making process by attending Board, senior leadership and staff 
meetings 
• Organizational culture 
• Physical layout 





• Other structural elements of the pediatric oncology facilities 
I observed at least three business days at each site and took personal notes on 
findings. Table 5 lists the organization, location/venue, country, and date where 






Table 5. Pre-Dissertation Visits & Interviews, and Direct Observation 
# Hospital / 
Conference 




1.  Yangon Children’s 
Hospital Myanmar June 2015 ü ü 
2.  Bugando Medical 
Centre Tanzania October 2015 ü  
3.  Muratsan 
Chemotherapy Clinic Armenia 
January & May 
2016 ü ü 
4.  Asociación de 
Hemato-Oncología 
Pediátrica de Centro 
América (AHOPCA) 
Nicaragua February 2016 ü  
5.  Hospital Nacional de 
Niños Benjamín 
Bloom 
El Salvador April 2016 ü ü 
6.  Tata Memorial 
Hospital India June 2016 ü  
7.  Obafemi Awolowo 
University Hospital Nigeria June 2016 ü  
8.  Ayder 
Comprehensive 
Specialized Hospital 
Ethiopia July 2016 ü  
9.  Belgrade University 
Children’s Hospital Serbia October 2016 ü  




Ireland October 2016 ü  
11.  Iashvili Children’s 
Hospital & Jo Ann 
Medical Center 
Georgia January 2017 ü ü 
12.  Children’s Cancer 
Hospital Egypt 
(CCHE) 57357 
Egypt January & November 2017 ü ü 




Oman January 2017 ü  
14.  Beijing Children’s 
Hospital China February 2017 ü  
15.  UNOP Guatemala March 2017 ü ü 
16.  International Society 







17.  HITO Mexico March 2017 & January 2018 ü ü 
18.  Butaro Cancer 
Center of Excellence Rwanda November 2017 ü ü 
19.  Asociación de 
Hemato-Oncología 
Pediátrica de Centro 
América (AHOPCA) 
Panama February 2018 ü  
20.  Dana-Farber/Boston 









4.3.3 Sampling & Recruitment 
Recruitment 
KI were recruited by purposive sampling. Purposive sampling allowed for 
illustration of the range of information-rich experiences and reflected the diversity  
within the sample population, rather than statistical representation.138,139 
Participant recruitment was achieved by contacting KI directly via email or asking 
them in-person to participate in the study. My 5-year experience working in global 
pediatric oncology allowed me to already be familiar with most of the PCU or be 
able to contact individuals who could introduce me to KI to request an interview. 
Participants were given the option to participate or opt-out of the study, and remain 
anonymous.  
Sampling 





rigor of the study and answer the research questions.138, 140, 141,142 
a. Criterion sampling: Cases were selected that meet and share common 
criteria i.e. participants in all three KII groups with experience in planning a 
new PCU or are currently in the process of planning a new PCU.138,140 
b. Critical case sampling: Specific individual cases were selected to allow for 
logical generalization because if it is true for this case, it is possible to be 
true in similar cases (which further allows for replicability). Critical case 
sampling also allowed me to select individuals to further learn about how 
they are experiencing the development of a new PCU and their involvement 
in this process.138,140 
c. Intensity case sampling: Cases were selected to provide rich information 
from a few selected cases that highlight both the unusual and the typical 
experiences.138,140 
Inclusion criteria 
• Expertise-specific criteria: 
o Group Il: Clinician (physician, nurse) or individual with demonstrated 
past experience in planning for the establishment of a new PCU in a 
LMIC. 
o Group II: Clinician (physician, nurse) or individual currently in the 





o Group III: Clinician (physician, nurse), strategic planning expert, 
global health expert, healthcare management expert, facilities 
expert, clinical operations expert, policy expert or individual with 
demonstrated experience in planning for the establishment of a new 
PCU in a LMIC, or having collaborated with participants in Group I or 
II, or currently collaborating with a PCU, or with demonstrated 
experience in planning healthcare facilities in LMIC or HIC. 
• English or Spanish speaker 
• Willing to participate and list their institution affiliation and position 
• Ability to be interviewed online, via phone, or in-person 
• Working at an existing or planned public or nonprofit PCU 
• Geographic/regional expertise: Experience in or practicing at LMIC 
Exclusion Criteria 
• Not able to speak either English or Spanish 
• Working at a private, for-profit PCU 
• Not willing to disclose name or location of organization 
Sample size 
Thirty-five KI were interviewed representing experiences from 30 countries 
(Table 3).  Three additional KI were approached to be interviewed but I was not 
able to recruit them: one of the KI did not respond to the email, and the other two 





• Group I: 11 key informants   
• Group II: 7 key informants   
• Group III: 17 key informants   
Thematic and theoretical saturation was considered as a tool to ensure that 
enough data was collected from the interviews and to ensure that no new themes 
are emerging and that value activities from Porter’s Value Chain Model are fully 
accounted for.143,144,145 
4.3.4 Study sites 
In-depth interviews (in-person, phone, or online) were conducted in several 
settings and geographic locations as follows:  
• My private office located at Dana-Farber Cancer Institute in Boston, MA. 
• During the International Society for Pediatric Oncology Asia annual 
conference in Bangkok, Thailand in May 2017.146 
• During my site visits to hospitals (see Table 5). 
4.3.5 Language  
Data collection was conducted in English and Spanish. No translators 
during interviews or translation of any material (transcripts or other print material) 
were needed. Transcripts in Spanish were not translated into English. I took notes 
from transcripts during the data analysis (coding) and from the literature review in 
English only and I translated transcripts or other pieces of materials included in the 





4.3.6 Data Storage & Management 
Data (audio recordings, transcripts, materials, notes, photos, etc.) were 
stored in a secure, private laptop that required a two-step password process and 
had an encryption software installed. Data was backed-up on a password-
protected cloud storage. I was responsible for the data management and no data 
was transmitted or shared with third parties, except sharing the audio recordings 
with the transcription service (www.rev.com) and the transcripts with the research 
assistant.  
4.3.7 Qualitative Data Analysis 
Key Informant Interviews  
First, I listened to the audio recordings from each key informant and, after 
confirming that the recording was audible, I uploaded the audio file to 
www.rev.com.  I received the transcript in Word back from www.rev.com via email 
within 24 hours and read each transcript. I edited the transcripts for accuracy of 
names, use of acronyms, addition of KI names, and further formatting purposes. 
Where needed, I made corrections and edits to the content. I then uploaded the 
transcripts to NVIVO for analysis.  
The in-depth interviews reflected experiences from 30 countries and 24 
existing or planned PCU in the world. Figure 10 includes a map illustrating the 
countries where KI narrated their experience and provided oral histories (the map 
was created using https://mapchart.net/). Most of the participants were female 





at or associated with an NGO (69%). Table 6 includes a summary of the 
characteristics of the study participants.  
 
Figure 10. Map of Countries Reflected in the In-Depth Interviews 













1  I Y F Nonprofit PCU Mexico In-Person 
2  I Y F Nonprofit PCU Mexico In-Person 
3  I Y F Nonprofit PCU Mexico In-Person 
4  III N M Nonprofit PCU USA In-Person 










7  III Y F Nonprofit NGO Haiti, Rwanda Phone 
8  III N F Nonprofit PCU USA In-Person 














PCU Georgia Skype 
12  III N F Nonprofit Architect Firm USA Skype 




PCU Armenia Skype 
14  III N F Private, 
Nonprofit 
PCU USA, China, 
Saudi Arabia 
In-Person 
15  I Y F Public PCU Myanmar In-Person 
16  I Y F Public PCU Myanmar In-Person 
17  I Y F Public PCU Philippines In-Person 




PCU Armenia Skype 
19  II N F Nonprofit NGO Armenia Skype 
20  II Y F Public PCU Bulgaria In-Person 
21  II Y F Public PCU Laos Skype 
22  III Y F Nonprofit PCU Liberia Skype 
23  II Y F Public PCU Kenya In-Person 











various in the 
Middle East 
In-Person 














28  III N M Nonprofit PCU Egypt Skype 





30  I Y F Nonprofit PCU Egypt Skype 




32  I Y F Public PCU Tanzania WhatsApp 













35  I Y M Nonprofit PCU Egypt In-Person 
 *Explanation of Terms in Table 6 
Group:  KI Group (see Chapter 4, Data Collection)  
Clinician:  Clinician or Medical Doctor or Nurse = Yes (Y) 
Non-clinician = No (N) 
Gender:  F = Female; M = Male 
Institution Status:  Institution classification status: Private, Public, Nonprofit 
Institution Type:  Type of organization ex. Consulting Firm, NGO, 
Academia 
Country or Region:  Country or geographic region where the PCU planning 
experience took place or where the KI demonstrated 
related expertise, not the KI’s country of origin or 
nationality 
 
At the end of each interview, I dedicated one hour to take personal notes in 
journal style to distance myself from the KI, as in the majority of the cases I 





the interview, the respondent’s nonverbal communication, impressions on how the 
flow of the discussion went, points that were unexpected, and concepts that have 
emerged.  
At the end of the interview, I updated the Key Informant Excel file to note 
the number of the interview, mark the interview as completed, and indicate the 
date and location of the interview.  
Document Review, Observations, and Pre-Dissertation Notes 
As indicated in Table 4, I reviewed several documents to identify key 
elements, barriers, and facilitators in the process of establishing a PCU. Field 
notes from observations during site visits were stored and saved individually for 
each site indicating the site name and observation date. A separate data form per 
site was used to document key elements identified, concepts that related to the 
two research questions, and impressions of facilitators and challenges 
encountered during observations. The form included notes on important themes 
as they emerged and were observed, for example, leadership, financial 
information, stakeholders, barriers, resistance, etc. Notes from informal 
discussions and pre-dissertation notes were reviewed to identify themes and 
recurring elements. 
4.3.8 Data Coding 
I used NVivo 11 Software by QSR International for thematic analysis of data 





pre-dissertation notes.147 This diverse data assisted in triangulating themes found 
in the in-depth interviews and helped reinforce the rigor of the qualitative 
data.148,149,150  As mentioned earlier in this chapter, Grounded Theory was used to 
identify themes in data that address the two research questions.151,152,153 Data from 
in-depth interviews was coded by the research assistant and me, and we 
discussed discrepancies and major findings. A summary of the steps in data 
coding is found in Figure 11. 
 
Figure 11. Steps in Data Coding 
First, analysis began by initial reading of all notes and memos to gain an 
understanding of the predominant concepts, ideas, and themes. The research 
questions set the context for the Level 1 coding, as well as Porter’s Value Chain 
Model.  Pre-specified (a priori) codes were identified from the two research 
questions, interview guides, literature review, and theoretical framework. The a 
priori codes addressed four focus areas for the KI interviews as follows: key 
elements, challenges, lessons learned, and advice. New codes, such as “tools” 
and “people”, were created during the process using open coding.154 An example 















Table 7. Example of Open Codes for Research Question #1 
Open Code Properties Examples or quotes 
Leadership - Medical expertise 
- Vision, charisma 
- Change agent 
- Passion is a deal-breaker 
- If no oncologists, it's a non-
starter 
 
 During the second reading, the parent, child and grandchild nodes that the 
research assistant created in NVIVO were reviewed. I looked for meaning beyond 
the actual words that the KI used, as participants may use different phrases or 
terms, or paraphrase to describe steps or activities in the process.155,156 Children 
and grandchildren coding helped to break the parent themes into sub-topics. For 
example, the parent code “leadership” had children themes: leader, planner, 
champion, team, and visionary.  
Secondly, in Level 2 coding, data was coded to identify themes and 
patterns.157,158 The analysis aimed to capture meaning beyond the descriptive, re-
examine codes from Level 1, identify how codes are related in broader patterns, 
and document themes of the key elements.159,160 Common threads among 
participants were recorded and included strategies, key elements, steps, 
perceived values, priorities, challenges, facilitators, lessons learned, and 
advice.123,161 I noted recurring themes (ex. KI categorized facilitators and barriers 
into internal, external, and people-related types), emerging themes (ex. resistance 
from physicians), overlapping themes (ex. need for strong leadership), interrelating 
themes (ex. how mission relates to planning principles), relationships (ex. 





planning process of a new PCU.  
The third step in analysis entailed the development of a code book to 
summarize findings from the 35 in-depth interviews. Findings were depicted in a 
code book which included details on key elements in the process, people involved 
in the process, stakeholders, challenges, successes/facilitators, lessons learned, 
country context (an example is found in Table 8).   


























people in a 











The final step of the analysis linked the coding outcome table and nodes 
with Porter’s Value Chain Model. I triangulated data from all four qualitative data 
sources to identify and list the nine key elements in the process, and group them 
into support or primary. For example, leadership was identified as a key element 
and I decided to categorize it as a “support” element as it is an essential starting 
element within the organizational structure. In the summary of nodes, I added 
qualities of good leadership, advice related to leadership, obstacles in securing a 
good leadership team, etc.  I used the nine key elements identified in the data 
analysis to adjust Porter’s Model and present the key strategic elements as part of 





PCU. The modified Porter’s Model is illustrated in the Study Results Chapter. 
An analytical tool applied to the interviews was a word search. I conducted 
word frequency queries to identify the 100 most frequent words of 5 characters or 
more. Frequency and terms used assisted with highlighting the most important 
themes in the data. I performed text search queries for each of the nine elements 
in the modified Porter’s Model. For example, I looked for “stakeholders” throughout 
NVIVO to identify who the stakeholders were. Once a few stakeholders were 
named, I applied iterative method to look for these stakeholders as KI may not 
have used the term “stakeholder” but they may have paraphrased and indicated 
which individuals or organizations were instrumental in the process such as 
Minister of Health, First Lady, NGOs, media, parents, and medical schools. 
Moreover, when a new concept was repeated in the data, such as corruption or 
transparency, I performed a search query to specifically look for this node. A 
summary of qualitative analysis categories and themes, along with the key 






Table 9. Qualitative Analysis Categories and Themes  
Category Themes Question 
Key Elements • Key elements related to the internal 
structure 
• Key elements related to pediatric oncology 
services 
• Essential elements within the organization 
• Essential elements across organizations 
What are the 
critical 
elements? 
Facilitators • Internally within organization/team 
• Externally within environment/system 
• People-related 
• Success factors 





• Internally within organization/team 
• Externally within environment/system 
• People-related 
• Mistakes, resistance, delays, constraints 
• Lessons learned 
What went 
wrong? What 
can go wrong? 
Advice • Key messages 
• Suggestions 
• Lessons learned  





The importance of being reflexive in qualitative research and putting aside 
assumptions so that the true experiences of interviewees are properly accounted 
for has been widely documented.162,163,164  In an effort to enhance the validity of 
the study, I sought to maintain reflexivity by identifying and accepting knowledge 
that I intuitively possessed prior to starting this study from my personal and 
professional background. By systematically building reflexivity into the research 
methodology of the study, I tried to recognize that my academic, professional, 





findings and contain potential preconceptions and biases so that their effect on the 
research process is minimal.165,166 
Acknowledging preconceptions brought into the dissertation and beliefs 
about what questions to ask was essential to the objective data analysis and 
interpretation, and every step of the research process. I examined the data for 
competing conclusions or opposing assumptions or new patterns which I was not 
familiar with or perspectives beyond my professional interest area.  
 
The pre-dissertation interviews, findings from the literature review, and 
subsequent qualitative data analysis agreed that the size of the new PCU was an 
important element in the process of establishing a new PCU. During a Directed 
Study at Boston University School of Public Health, I had created a simple Excel-
based computer Capacity Model to collect and analyze relevant quantitative data, 
and during the dissertation research I conducted a pilot exercise to calibrate the 
model based on the findings from the in-depth interviews and KI from Group II who 
were in the process of examining the possibility of a new, nonprofit PCU in 
Armenia.  
The goal of the Capacity Model was to be simple, user-friendly, and easy to 
complete within an hour without any expertise in Excel, epidemiology, forecasting, 
modeling, or other areas. A primary purpose of the Model was to serve as a 
discussion platform for planning teams to start looking into concepts that they may 





not be familiar with or not typically part of their daily tasks. For example, it is helpful 
for teams to think about market share and population growth, and how these data 
impact the number of beds, occupancy rate, etc. Users may repeat the calculations 
in different spreadsheets (i.e. Spreadsheet 1 for Year 2, Spreadsheet 2 for Year 
10, Spreadsheet 3 for Year 15) or use the high scenario to incorporate growth 
projections. In places where enough valid data exists about prevalence, users may 
also use prevalence data in addition to incidence. Calculating a very small or a 
very high number of beds, provides an instant idea of the feasibility and scale of 
the planned PCU, and helps guide the discussion during the preliminary steps. For 
example, a conclusion of 4 beds or 500 beds opens the door to starting different 
discussions and considering different implications.  
The Capacity Model illustrates multiple parameters from four different data 
sets, a mathematical formula, a list of considerations that may influence capacity 
calculations, a list of changeable assumptions (constant Elements), and a list of 
questions to assist users input data. Quantitative data is derived from the following 
types of data sets: 
1. Population Science and Demographics  
2. Epidemiology of Pediatric Oncology 
3. Hospital Utilization 
4. Market/Demand 
The model includes a two-part calculation scheme and a sensitivity analysis 





independently depending on the needs of future planners and data already 
available in their countries.  
• Part A: Projected number of new pediatric oncology cases per year in the 
country and at the PCU  
• Part B: Subsequent number of beds required to treat these new cases   
The quantitative data are further analyzed in the Study Results Chapter 
where the need to estimate the burden of disease and expected patient volume 
(Element 5. Situation Analysis) and number of beds (Element 6. Medical Model, 
Scale of PCU) are discussed by the KI. A full description and pilot exercise of the 
Capacity Model is in Appendix 3.  
The results from the quantitative data in the model may complement the 
findings from the qualitative data, and can be useful to hospital leaders, 
international and local foundations which provide funding for hospital development, 
government officials who are planning a national oncology facility, and academic 
or healthcare institutions which develop capacity-building programs in low-
resource countries.  An evidence-based, data-driven analysis of current and future 
market situation will assist hospital planners in developing a realistic timeline of the 
steps they need to take and aligning all planning activities with expected patient 
volumes.  
Financial Planning Tool 





a template for users to input projected expenses and income to form a preliminary 
idea of the financial feasibility of the project. The quantitative tool is described in 
the Study Results Chapter (Element 7. Financial Planning), and the quantitative 
instrument is found in Appendix 11.  
 
The study was submitted to Boston University School of Public Health Office 
of the Institutional Review Board (IRB) and was qualified for an exemption 
determination under the policies and procedures of the Human Research 
Protection Program on March 3, 2017 (IRB Number: H-36146). The IRB exemption 
document and the research information sheet were emailed to all KII prior to data 
collection and for in-person KII, a copy of the two documents was provided before 
the start of the interview (Appendix 4 includes both IRB documents).  
As described in the research information sheet, participants were informed 
prior to data collection that the interviews will be recorded and transcribed, and are 
not anonymous or confidential. Participants were asked for verbal consent before 
the beginning of the interview and were given the option to refuse to be recorded, 
and still be included in the study. All participation was voluntary. The contents of 
this dissertation are the sole responsibility of the author. 
 
 
Readers of this document are urged to take into consideration that the 






dissertation does not reflect all the experiences from PCU developed in all LMIC 
but just a few, representing different countries, infrastructure (tier) levels, patient 
volume, and leadership structure. Other limitations include: 
• Investigator bias167,168: During my work at Dana-Farber/Boston Children’s, I 
have met some of the key informants, have visited their hospitals, and have 
read about their hospital stories prior to the start of this study. This prior 
interaction and familiarity with me as the interviewer may have interfered with 
their responses.   
• Selection bias169,170: The key informants  were nonrandomly selected as I 
wanted to elicit responses and reflect experiences from specific sits. 
• Recall bias171,172,173: Participants may have difficulty recalling specific details 
or may remember incidents more vividly than others. Participants may 
demonstrate wishful thinking resulting in a systematic error in the differences 






CHAPTER 5. STUDY RESULTS 
 
5.1.1 Porter’s Value Chain Model Adaptation 
As discussed in earlier chapters, Porter’s Value Chain Model was used to 
structure the research plan and analyze findings.  The literature review showed 
that the Model has been effectively modified and applied to a number of industries 
to explain the attributes and elements necessary in a process. It provided a way to 
look at cross cutting, horizontal elements that interact with the vertical elements at 
a PCU in maximizing value for childhood cancer patients. Based on the findings of 
the 35 in-depth interviews, I created a modified Porter’s Value Chain Model where 
certain key functions are analogous to the original Porter’s Model (Figure 12).  
 
Figure 12. Modified Porter’s Value Chain Model 





Similar to other adaptations of the Model, I adapted the three main terms of the 
Model as follows to create a modified version: 
Adaptation of Terms 
 
Figure 13. Adaptation of Terms 
 
Element  
As explained in the Glossary, an element is a critical strategic consideration 
in the process of planning a new PCU. The term depicts a step or activity, or set 
of steps or activities, and reflects the horizontal and vertical cells in Porter’s Value 
Chain Model. An element may have more than one task or activity within it as, for 
example, Element 7 Financing, includes the sub-steps of assessing current 
funding, estimating cost of care, calculating reimbursement rates, etc. (discussed 
in 5.2 Summary of Results). 
  
• ElementActivity
• Structure ElementsSupport Activities





Structure and Execution Elements 
As depicted in the modified Porter’s Model above, the results indicated nine 
essential elements in the strategic planning process for a new, successful PCU 
which can be grouped in two main sets of elements as follows: 
Structure Elements Execution Elements 
1. Leadership  
2. Mission, Vision, & Values 
3. Planning Principles 
4. Organizational Platform (NGO) 
5. Situation Analysis 
6. Medical Model 
7. Financing 
8. Stakeholders 
9. International Partnerships 
 
Table 10 summarizes the rationale behind the classification and definition of 
elements as “structure” or “execution”, and their interaction.  
 Structure Elements Execution Elements 
Element Property   
Outlook Internal External 
Time Sequence First Second 
Independence Cut-across Parallel 
Nature Fundamental Operational 
Function Reinforce Implement 
Relationship to Plan 
Development 
Indirect Direct 
Perspective Conceptual Practical 
Focus Within organization Across organizations 
 







Structure Elements: Leadership, mission, planning principles, and organizational 
platform were the four elements categorized as “Structure Elements” because KI 
explained that they were viewed as integral and principal when building the internal 
working structure of their PCU. Findings related to these four, horizontal elements 
were grouped together and deemed “structure” because they were indispensable 
preconditions in the process, needed to happen first, and served as the 
foundational basis for hospital leaders before they develop and execute the other 
five elements. These four elements also cut across the five execution elements 
and are internal within the organization.  
Execution Elements: The five elements that were considered “Execution 
Elements” reflected operational considerations supported by the four horizontal 
elements and related directly to the PCU functions and delivery of pediatric 
oncology care in the KI’s local setting. These five, vertical elements (situation 
analysis, medical model, financing, stakeholders, and international partnerships) 
were organized together as “execution” because they depended on the way that 
structure activities have been previously developed, happen after the structure 
activities, and related to logistical, action-oriented and practical tasks that need to 
be performed in the planning process. Executive elements involve external 
interactions with outside organizations, for example Ministry of Health 
(stakeholder). 
These nine elements are presented in this order in the Summary of Results 





elements (Research Question #1), and barriers and facilitators (Research 
Question #2) in the process.  
Resources for future planners 
Appendix 5 includes a summary of questions to facilitate identification of 
each element which planners may use during their strategic planning process.  
5.1.2 Structure of the Summary of Results 
The Summary of Results is organized in a way that tracks the interrelated 
nine elements in the adapted Porter’s Model and is divided in structure (horizontal) 
and execution (vertical) elements. The Summary presents findings related to each 
of the nine elements individually and is organized as follows: 
• Element identification (ex. Element 1: Leadership)  
• Questions related to the identification and relevance of the Element 
o Main question in the form of Who, What, Why, How Much, etc.? 
o Sub-questions 
• Summary table of results related to the Element 
• Examples and quotes reported verbatim from KI, indicating the KI coding 
number (ex. KI 5) and country/ies where the specific KI’s experience took 
place (ex. Egypt, Myanmar). When more than one country is listed next to 
the KI number, it means that this KI narrated his or her experience from 





• Analysis of results, including description of the Element, challenges and 
facilitating factors. Challenges refer to difficult conditions in the internal or 
external environment, and facilitators to enabling contextual factors 
• Advice for future planners related to the Element  
• Resources and tools related to the Element 
  
The analysis of the qualitative data provided rich information on the 
experiences of the planners and collaborators, as well as areas of assistance that 
future planners need during the strategic process of planning a new PCU. It 
allowed for a deeper understanding of the context and nuances involved in the 
process, and identification of nine elements (support and primary activities) in the 
process, along with key barriers and facilitators that need to be considered. Table 
10 includes a summary of the qualitative results.  
Table 11. Summary of Qualitative Themes by Study Outcome 
Outcome Themes 
Key Elements Structure Elements: 
1. Leadership  
2. Mission, Vision, Values 
3. Planning Principles 
4. Organizational Platform  
Execution Elements: 
5. Situation Analysis 
6. Medical Model 
7. Financing 
8. Stakeholders 
9. International Partners 
Facilitators • Internal: Collaboration and teamwork, culture, passion, 
communication, mission-related, planning  





• External: Culture, trust, transparency, national guidelines 
• People-related: Leadership, support from Foundation/NGO 
from the beginning  
Challenges / 
Barriers 
• Internal: Culture, financial, communication, mission-related 
• External: Culture, corruption, financial 
• People-related: Leadership, shortage, resistance  




Structure Elements (Elements 1-4) 







• Who is the champion? 
• Who is leading this effort? 
• Who are the leadership team members? 
• What makes a good leadership team? 
• What qualities characterize a good leader? 
• Why is effective leadership important? 
 
Table 12. Summary of Results for Key Element 1: Leadership 
Outcome Themes 
Key Element: Leadership  
 
Team Composition: • Leaders, members, Board  
 
Qualities of Good 
Leadership: 
• Medical/Clinical Expertise 
• Passion & Perseverance 
• Champion for the cause 
• Vision & Charisma 
• Change Agent 
• Management & Communications Skills 
 
Challenges: • Internal: Culture, team composition 
• External: Lack of trained leaders, culture, corruption 





Respondents agreed that assembling a strong and effective leadership 
team is one of the most essential elements in the planning process of a PCU 
(Figure 13). They explained that, first, the leader needs to acknowledge that 
planning for a new PCU is a team-led effort and, then, look for qualities that make 
this team successful in planning for a new PCU.  
KI expressed the need for a small and flexible planning team to lead the 
process. They stated that this first step is fundamental in the process and serves 
as the foundation for all planning elements in the future because this team will stay 
together to spearhead the initiative, coordinate initial planning efforts, and 
delineate the long-term vision of the PCU. They referred to cases where not having 
a pediatric oncologist or pediatrician championing the cause from the start; or 
beginning with only one person without a team; or convening an ineffective 
leadership team; or assembling a large (more than 15 people) team or Board 
resulted in plans never being materialized or PCU inefficiently planned.   
Participants described their initial planning leadership team as small (ranging 
from 3-10 people) and consisting of a combination of the following individuals and 
roles: 
1. Leader: The pediatric oncologist or clinician who champions the cause.  
2. Planning Team: The small number of individuals who work closely with the 
leader during the planning phase.  
3. Board of Directors: The members of the Board of the non-profit organization 





when discussing Element 4. Organizational Platform). 
 
Figure 14. Element 1: Leadership 
Leadership Theme. Expertise in Pediatric Oncology 
The KI from Mexico underlined that because she and her team had more 
than 20 years of experience practicing in pediatric oncology, they had a deep 
understanding of the needs of children with cancer and appropriate care delivery 
method. This allowed them to be focused on the goals of the project and have a 
strong content (medical) knowledge to guide their actions. The two additional 
participants from the same hospital agreed that having extensive experience in 
pediatric oncology helped them in the process of developing a comprehensive plan 
because they were already aware of disease-related issues from building facilities 





strategic considerations such as the mission and core values where the hospital 
based its plan.  Other respondents added that expertise in pediatrics (either a 
pediatrician or nurse specialized in pediatric oncology) is essential both for the 
operational issues but also to assist with fundraising and advocacy by presenting 
a solid, strong argument about the clinical needs of the patients. The pediatric 
oncologist leader was usually the main decision-maker responsible for final 
decisions with input from their team and Board. KI from Group III cited examples 
where planning for PCU started without a pediatric oncologist onboard and 
resulted in unsuccessful units which did not meet the patients’ needs, could not 
secure external funding, and ran into several inefficiencies and waste of resources.  
Examples/Quotes: Medical/Clinical Expertise KI#, Country 
“If somebody needs to do this, it has to be a pediatric oncologist. 
Similarly, to building an orthopedic hospital, it has to be an 
orthopedic surgeon” 
3 Mexico 
“If you have no oncologists, it's a non-starter” 7 Rwanda 
“Need to work with somebody who understands the patient flow” 12 Rwanda 
“Our Chief had years of experience [in pediatric oncology] and 
knew how to start” 
18 Armenia  
“We knew what is needed to care for children with cancer from 




Leadership Theme. Passion & Perseverance 
 KI underlined that passion and perseverance were instrumental in the 
planning process. Respondents from Group I and II described the emotional toll 
they underwent choosing pediatric oncology as a career in a low-resource setting 
and planning for a new PCU in a LMIC where the public policy agenda and 





They explained that they had to 
continuously possess and 
demonstrate ongoing passion 
and perseverance to challenge 
the status quo, dispel myths 
about cancer, maintain their 
enthusiasm, and disprove those 




Figure 15. Emotions Reported by KI 
KI mentioned instances where colleagues, family members, or others 
thought they were “crazy” for wanting to embark on such an ambitious endeavor.  
The KI from Egypt mentioned that people considered him crazy for spending a 
large amount of money on a feasibility analysis for the new PCU and resources on 
defining the new hospital’s mission and vision. Key informants from Group III also 
highlighted that passion is a necessary element to start this process and a deal-
breaker when it is absent. Respondents indicated that despite their emotional 
experiences in the process, they were determined to change the situation in their 
countries and improve outcomes for children with cancer. 
Examples/Quotes: Passion & Perseverance  KI#, Country 
“A good leader will find the right people who will have the same 
passion” 
5 Various 
“Give your soul” 19 Armenia 
“I'm not going to take no for an answer” 7 Rwanda 
“Lack of passion is almost a deal-breaker” 27 Various 
“You really have to at least be extremely passionate” 28 Egypt 
 
overwhelmed suffering




a lot of 
sacrifices






Leadership Theme. Champion for the Cause  
 Respondents mentioned that the entire leadership team needs to be an 
active advocate for the cause and have a strong voice to promote the mission. 
They underlined that the “urgency to change” drove them to start planning for a 
new PCU and described their determination to send a message to their country 
that this change is possible. They defined as “urgency” the drastic need to stop 
seeing their pediatric patients die from cancer and demand a radical change. They 
fought for the idea of a place for children with cancer to get treatment, and KI 
reported navigating through bureaucracy, taking tough decisions, and being 
assertive about what needed to be done. Participants said that they took the matter 
into their hands, wrote proposals, contacted the highest political officials (President 
or Prime Minister), talked to wealthy citizens, openly talked about stigma, and 
urged the community to share their belief that children of their country deserve 
better care.  
Examples/Quotes: Champion  KI#, Country 




“If there's not a strong leader or a real strong champion who's 
willing to cut through the bureaucracy, make decisions, and 
stand up for his or her idea, it's not going to happen” 
25 Various 
“You have to fight for it” 32 Tanzania  
  
Leadership Theme. Visionary and Charismatic 
 Respondents discussed that when leaders had a clear vision in their minds 
about the overall project and were able to articulate this to their stakeholders, this 





in. They mentioned that being charismatic is valuable, but not always a 
requirement, as long as the leader is visionary, passionate, transparent, and a 
good communicator. Key informants from Group III indicated that when there was 
a visionary leader from the beginning, the project progressed more efficiently 
because the leaders planned for the long-term future, ensured sustainability, and 
encouraged others to follow them towards a new status-quo where children with 
cancer in LMIC have equal chance of surviving as compared with children in HIC.  
Moreover, they stated that visionary leadership can be a catalyst of change for the 
entire country and serve as an example for other hospitals in the country or region.  
Examples/Quotes: Visionary & Charismatic  KI#, Country 
“Somebody who can inspire the right people to join the team” 5 Various 
“You need to engage the mind and the emotions” 25 Various 
“Passion is almost a deal-breaker and charisma is like nice 
little icing on the cake” / “It's so helpful when the leader has 
some amount of charisma that can fire up” 
27 Various 
“Can be an inspiration for other hospitals in the nation” 28 Egypt 
“And sometimes you have to be like a salesperson. You have 
to sell your dream. And make people dream and become part 
of the dream” 
29 Guatemala 
“Having a clear vision from the start is a key success factor” 30 Egypt 
 
Leadership Theme. Change Agent 
 The interviews revealed an emphasis on urgency and willingness to 
change. Key informants with past experiences mentioned that they looked for team 
members who embraced change, perceived change as a positive element, were 
open to learning, and wanted to continuously learn new ways. They discussed how 





an argument to stakeholders required that they acknowledge the need to change. 
The KI from Mexico described her experience when visiting a hospital in USA 
during the planning phase: “[I was told] ‘Mexico cannot do it.’  [That’s] like telling 
us that we need to continue with the same” which is something that she did not 
accept. She then moved forward with changing the current situation. Respondents 
from Group III emphasized that power to change was a key consideration when 
collaborating with leaders and creating space for people to innovate is vital when 
planning a new PCU. They also noted that having a leadership team that is willing 
to change may help when there is a rigid hierarchical organizational structure that 
needs to be overcome to promote open dialogue and collaboration.  
Examples/Quotes: Change Agent  KI#, Country 
“You need people who want to change. They need to change. 
Both themselves and the environment around them”  
13 Armenia 
“I would like to organize something that we don’t’ have here”  20 Bulgaria 
“Power of having a cohort of people who see things differently 
that will be the seeds for organizational change” 
27 Egypt 
 
“Our former Chief, he wasn’t afraid to start every time something 
new” 
18 Armenia 
“You've gotta try to move a culture. You gotta try to get over the 
inertia that exists”  
31 Various 
 
“Have to have enough power to be able to actualize change 27 Various 
 “It helped that hospital leadership is open to change and take 




Leadership Theme 6. Commitment 
 A common element in recruiting team members and a facilitator in building 
a strong leadership team was to select individuals who are committed and focused 





in the beginning but were not fully dedicated to the cause or lost focus and 
enthusiasm early in the planning process or were impatient to see rapid results. In 
some cases, lack of commitment led to low morale, loss of donor funding, delays, 
or it meant that plans for a new PCU never materialized. 
Examples/Quotes: Commitment   KI#, Country 
“You are in it for the long haul. You need to be motivated and 
stick with it”  
5 Various 
 
“You need to find the balance between patience and 
excitement” 
21 Laos 
“The challenge is finding partners who have the time. There's 
a lot of people who were super interested, super willing and 
kind-hearted, but just can't commit the time to do it” 
22 Liberia 
“They need to be committed and focused” 25 Various  
  
Leadership Theme. Management Skills 
 Participants explained that in the beginning the leader or small leadership 
team needed to dedicate their time on every single aspect of strategizing about the 
new PCU, while at the same time continuing to treat patients. KI in Group I and II 
stated that although they did not have any formal training in management, strategic 
planning, or public health, they still needed to map the key steps in the process. 
They all talked about the multi-tasking nature of their role during the planning 
process that extended beyond being a good pediatric oncologist. The respondent 
from Guatemala was the only leader who had an administrative manager to work 
closely with him and the team from Egypt hired consultants for the feasibility 
analysis and a project manager to head the development of the hospital. When KI 
reflected back on their experiences, they indicated that assigning a person to lead 





Group III agreed that projects moved smoothly when a person with organizational, 
communications, and management skills was part of the team. Respondents 
underlined the importance of a project leader who not have competing demands 
and serves as the main contact person.  
Examples/Quotes: Management Skills KI#, Country 
“It's the project manager that has to keep everybody 
together, make sure they're all heading in the right direction” 
4 USA 
 
“Somebody with the right skills and experience to run a 
project, that's where it comes to the project coordinators” / 
“useful to have somebody who has some knowledge in 
public health” 
6 Various 
“Project manager becomes the primary guy… the executor”  8, 9 USA 
“Having organizational skills is essential”      10 Haiti, 
Rwanda          
“The challenge is not finding partners who are interested, it's 
finding partners who have the management skillset to 
actually enact a solution” 
22 Liberia 
 
“If you have a medical degree, that's not enough. We need 
the administrative side and the leadership side” 
25 Various 
“Project management can happen at the construction level, 
it can happen at the planning level, it can happen at the 
operational level. So, project management has so many 
layers” 
28 Egypt 
“Otherwise, you are diluted in things that you are not good at 
doing. Which is perhaps a recipe for failure. It's very 
important to have a very strong administrative person since 
the beginning” / “The administration has to be involved at the 
beginning, because a doctor cannot fundraise, administrate 
and see the patients at the same time” 
29 Guatemala 
 
“We were physicians. It was not part of our job description to 
work to raise money to build a hospital, to deal with 
engineers, to do the strategy planning, to do the pre-
designing, and feasibility. All these stuff is not part of our job 
description, but we grew up that we need to do everything”  
30 Egypt 
“The ideal is to get a physician who understands 
management.  Nurses can also be excellent leaders of 
organizations because they bring the clinical and the 







Leadership Theme. Diversity 
 KI expressed consensus that a key element in the planning process is 
assembling a diverse team. They explained how having a diverse team facilitated 
the planning process and helped them better understand the elements in the 
process because they had different voices and experts to guide them.  Findings 
defined diversity in terms of technical expertise, culture, religious affiliation, 
geography, academic background, and personalities. For example, KI from Egypt 
proudly indicated that having Muslim and Christian employees was considered a 
competitive advantage, and allowed them to create a welcoming and friendly 
environment both for patients and employees. Moreover, one KI from Guatemala 
(physician-leader) explained that having a colleague with administrative expertise 
from the beginning, helped the team avoid mistakes and make better informed 
decisions. A KI reported that when a flexible and inclusive hierarchy existed within 
the organization, diverse voices were more likely to be heard and, thus, space for 
new ideas and approaches was created.  
Examples/Quotes: Diversity KI#, Country 
“Diversity in the group is very, very useful… specially in the 
initial planning stage to appreciate the thoughtful, systematic, 
scientific, and long process of planning” 
28 Egypt 
“You need to have in your team all type of personalities. Some 
people want action fast, other people are more laid back, they 
need to go slow” / “It needs to be a diverse team. The last thing 
you want is everybody who just says ‘Yes’. You want some 
naysayers who are going to identify the issues that people 
haven't thought about” 
29 Guatemala 
 
“The diversity was one of the strength points of our five board 
members.” 
30 Egypt 





“[Board Members who are] Problem-solvers. Super-committed. 
Someone to be wealthy. Someone to be influential” 
32 Tanzania 




Other qualities of good leadership that KI felt were important when planning 
a new PCU were leaders who delegate and empower others, have small ego, are 
respectful, are diplomatic, lead by example, empower others, are self-aware, 
promote an open hierarchical structure, and know their limitations.  
Summary of perceived facilitators 
ü Willingness to change and learn 
ü Open and transparent communication 
ü Empowering leadership style 
ü Sense of community  
ü Enthusiasm  
ü Shared values 
ü No-blame culture 
ü Flexible institutional hierarchy 
Summary of challenges and perceived barriers 
• Not having one single person assuming the leadership and decision-
making (i.e. no assigned responsible individual who owns the project) 
• Having only one person involved in all aspects of the planning (i.e. one 
leader micromanaging all steps in the process) 





o Not having a leader expert in pediatric oncology 
o Poor and dishonest communication within the team 
o Having leaders who are not passionate, fully committed, and ready 
to take risks 
o Having leaders who do not get buy-in from team or higher-ups or 
do not have power to impact change 
o Not having a designated project manager 
• External constraints: 
o Shortage of trained professionals with management, public health, 
communications, and strategic planning skills 
o Rigid hierarchical structure 
o Corruption 
Advice for future planners  
ü Assemble your team carefully, in terms of training, leadership qualities, 
and shared mission 
ü Choose leadership team that shares same values and is diverse 
ü A clinician in pediatric oncology needs to lead the planning effort 
ü Strong, focused leader is needed 
ü Qualified project manager is needed 
ü Passion is required 













• Why are we doing this? 
• What goal will this new PCU serve? 
• Where do we want to be in 5, 10, 20 years from now? 
• On what values our project should be built? 
• What are we trying to achieve? 
 
Table 13. Summary of Results for Key Element 2: Mission, Vision & Values 
Outcome Themes 
Key Element: Mission, Vision, and Values  
 
Mission Formulation: • Health equity as guiding principle 
• Fundamental planning element 
• Future implications  
• Tool to build consensus 
• Moral compass 
• The “big why” 
 
Facilitators: • Clarity and cohesiveness 
• Transparency 
• Alignment 
• Strong leaders 
 
Challenges: • Internal: Culture, lack of past experience, lack of 
team diversity 
• External: Lack of trained leaders, culture, corruption 
• People-related: Inefficient leadership style 
 
The second element that KI described as key in their strategic planning 
process was formulating their mission, vision, and values (Figure 15). 
Respondents felt that being guided by these three concepts from the beginning 





goals, and communicate their message more productively.  
 
Figure 16. Element 2: Mission, Vision, Values 
 
Although not all KI had explicitly written down their mission and vision 
statement and values from the start, they all explained that their determination was 
to improve the lives of children with cancer in their country. They added that having 
a set of guiding principles served as a moral compass in the decision-making 
process and a tool to build consensus and align stakeholders under a common 
purpose. All KII agreed that being able to refer back to the “big why” was 
instrumental in maintaining enthusiasm, increasing morale, and providing rationale 
for major decisions.  
For example, CCHE 57357 started with the vision of a cancer free childhood 





formulated eight strategic goals which built upon their clearly articulated vision and 
mission. These concepts determined all their future plans and steps from 
fundraising, purchasing, financing, operations, etc. and defined their brand.  The 
KI from Egypt mentioned that formally articulating a mission and vision was an 
innovative idea in his country back in early 2000’s but the team appreciated the 
need for this step early on. The KI from HITO explained that their goal was to 
provide comprehensive care to patients and prioritize quality of life based on five 
strategic principles. This goal was the basis for subsequent decisions such as the 
creation of “Casa Teletón” (Teletón House provides accommodations for the 
patients and their families adjacent to the hospital) and inclusion of palliative care, 
psycho-oncology, nutrition, and pain medicine from the start. The KI from Tanzania 
stated that her firm belief in all children with cancer having access to free care 
drove her to develop innovative fundraising models and formulate strong bonds 
with the local and international community.  
Participants reflected on cases where similar efforts started but because the 
mission was not clear, members not aligned under the same vision and values, or 
leaders and stakeholders were motivated by personal and self-serving motives, 
projects were unsuccessful or halted early on. They mentioned examples of 
projects starting because a funding opportunity from a major international 
organization was available, a First Lady wanting to associate her legacy with 
children with cancer, planners seeking political power through a leadership position 





centers in the US as a gateway to gaining local academic recognition.  
Two recurring themes related to mission, vision, and values during the in-
depth interviews were a) the idea of health equity and health as a human right, and 
b) transparency/corruption.  
Participants described how they would not accept that children with cancer 
die because of lack of access to care or because they were born in a LMIC. Their 
drive to close the global health inequity gap and reduce the stigma associated with 
cancer was the foundation where they based the model and planning process and, 
thus, guided the definition of their mission, vision, and values.  
Examples/Quotes: Health Equity KI#, Country 
“The kids deserve this. The children of Mexico deserve less 
than any other place, the United States or England only 
because the government thinks otherwise? This was all we 
could do? Enough” 
2 Mexico 
“We relied on a human rights and social justice model” 7 Rwanda 
“My first question would be why they need this center. What's 
the reason, what's the main goal?” 
11 Georgia 
“The kids kept coming and I just felt like it was the right thing to 
do” 
17 Philippines  
“Just get chemo drugs, should not be the first steps. Need to 
see the big picture” 
21 Laos 
“The case for Boston Children's Hospital, and most 
organizations that are doing this, there is a big mission 





“Because at some fundamental level, it bothers you that the 
world is an unequal place That basic inequity just seems 
insane. And think that's probably why we all do it 
fundamentally” 
27 Various 
“The kids. I mean, they can be cured, why not?” 29 Guatemala  
“We wanted to bridge the gap between what we have in our 
country, which is a low- income country, and what we see in 
Europe and USA” 






“I'm going to find a way to try and treat them and give them the 
care they deserve, because they're human beings. And not 
losing sight of that is important” 
“Care for children with cancer should be free” 
32 Tanzania  
“Our big why is our children” 35 Egypt  
 
Furthermore, KI recognized that corruption was an everyday reality in many 
LMIC and emphasized that transparency was a guiding principle in all the elements 
related to planning the new PCU from compiling a team to forming international 
collaborations. KI reported that recruiting a leadership team based on a 
transparent and traceable process, as well as selecting leaders who agree to 
promote principles of transparency in the way they explain decisions and share 
data contributed to the success of the project and safeguarded the PCU from 
external instances of corruption. Honesty was highlighted as a strong value to 
govern communication and interactions with the community and stakeholders, 
along with the risk of losing trust and reputation among the donor community when 
transparency is not promoted and equally shared by all. The KI from Guatemala 
explained that “you need to be honest with the use of the resources so there has 
to be transparency. Anybody can see the books. Anybody can see the results. 
Anybody can come to the hospital and talk to the families.”  
A KI from Group II expressed his concern about corruption in his country 
and mentioned the case when an intergovernmental, economic organization based 
in Europe donated a six-figure US dollar amount to the existing, public PCU, but 
the public hospital’s administration never actually allocated the funds to the PCU. 





procurement process of major diagnostic equipment which was not based on need 
but on kickbacks from the equipment manufacturer to the individual leading the 
negotiations. Another common example of corruption was the instances when 
government officials required informal cash payments to facilitate a transaction or 
process paperwork, such as a license application. Participants also mentioned the 
cases of local foundations misappropriating funds donated by individual or 
corporate donors that led to the public losing confidence to the cause and the PCU 
risking its credibility and reputation.  
Other themes reflected the KI’s thoughts on: 
• Uniting for the same goal no matter the political, social or other differences, 
as in the case of the KI from Georgia inviting colleagues from Armenia, 
Azerbaijan, and other neighboring countries to collaborate on the common 
mission of saving children with cancer 
• Underlining that transparency, honesty and open communication are vital 
in the mission, vision and values formulation 
• Having clear mission, vision, and values that can be easily communicated 
• Striving for excellence and following the highest standards when preparing 
the mission, vision, and values 
Benefits from establishing clear mission, vision and values: 
ü Guide decision-making 
ü Hire people with aligned mindset 





ü Resist political and donor pressures 
Advice for future planners  
ü Define your mission, vision, and values early on  
ü Have a clear mission, vision and set of values 
ü Include the team when drafting your mission, vision and values 
ü Actively adopt value of transparency 
ü Refer to your mission, vision, and values for future decisions 
ü Stay true to your mission, vision, and values  
 
Resources for future planners 
Examples of mission statements from selective KI’s organizations are found 
in Appendix 6 to assist future planners when brainstorming with their teams and 
developing their own mission, vision, and values. 







• How are we going to plan for this effort? 
• How do I start? 
• Where will we base our decisions? 
• What is the risk of starting without a plan? 
• Why is a plan important? 
• Why are planning principles important? 
 
While only one of the KI in Group I and II had a written strategic/business 





of having a plan to guide the process and illustrated important planning principles 
for future users (Figure 16).  The KI from Group II indicated that although they may 
not be familiar with drafting a strategic plan, they would find any guidance on the 
steps in the process particularly helpful. 
Table 14. Summary of Results for Key Element 3: Planning Principles 
Outcome Themes 
Key Element: Planning Principles  
 






• Step-by-step  
 
Challenges: • Internal: Culture, lack of diversity and teamwork 
• External: Shortage of trained planners, lack of planning 
culture and value, corruption, donor and political pressure 
• People-related: Impatience, resistance, ineffective 







Figure 17. Element 3: Planning Principles 
 
Need for a plan 
 Participants indicated that the first important notion is to realize that a plan 
is needed and that a set of organized planning steps need to happen to effectively 
plan a new PCU. They pointed out that just wanting to create a new PCU is not 
enough; the leadership team needs to understand that a roadmap is needed and 
measurable progress within the various planning elements needs to be achieved 
as time passes by. 
Examples/Quotes: Need for a Plan KI#, Country 
“The planning is more important than anything” 4 USA 
“You really need a road map. You need a plan, a logical plan 
with a timeline and with a budget and with people who are 
responsible in there” 
6 Various  
“What I learned since two years ago: planning is very important. 






“You have to know where you're going before you can do 
anything. If you don't have that clear sense of strategy, you're 
just not going to succeed. It's just going to fall apart” / “So, you 
want to have a strategy that's good enough to get going, and 
then you can build on that” 
25 Various 
“It has to be, to the extent possible, driven by a process, a plan 




“I followed the 8 steps of change according to Kotter” 35 Egypt 
  
Mission-based 
Respondents described their experience in planning a new PCU facilitated 
by a strong sense of serving patients and contributing to society. They insisted that 
the mission should drive the development of the facility, not the other way around. 
Avoid focusing too early on the construction of a building was common advice 
among KI and a shared lesson learned. Participants emphasized that people and 
patients were at the center of their planning considerations. They urged future 
planners to resist the temptation to please donors who seek naming opportunities 
for buildings or funders who feel more confident having a building as part of their 
funding, and encourage them to defer decisions about the physical building until 
later in the planning process. KI cautioned against the idea that the only approach 
is to construct a new building or think about the building before other tasks are 
completed (e.g. medical services, staffing, equipment, etc.) which will influence the 
decision about the potential construction of a building or design of the facility. 
KI recommended that planners concentrate on formulating and 
implementing their mission, first, rather than starting with a building without 





planning principles with the importance of having a clear and unifying mission and 
vision, which gave them a platform to take decisions on all planning and execution 
steps.  
Examples/Quotes: Mission-based planning KI#, Country 
“The building is the easy part it's all the other stuff that goes 
with it” 
9 USA 
“Like Boston Children’s Hospital, we are the best hospital with 
the worst building” 
14 China, 
Saudi Arabia 
“Functionality is more important than fancy buildings” 22 Liberia 
“I've always found it ironic that as well-revered as the U.S. 
healthcare system is, it's not because of the buildings. The 
buildings are not that nice actually, but the wonderful things that 




“This project has a special nature. You're not building a mall, or 
an office building” 
28 Egypt 
“Think about the patient experience. It's not what place had the 
nicest, newest building. It was the interaction between the 
doctors and the nurses and the patients. People and 
communication. That's what you should be focusing your 
attention on” 
31 Various 
“Everyone thinks of construction and philanthropy focuses on 
buildings. None of them focus on processes and quality of care 
…they want naming opportunities, and you cannot name 




In an effort to emphasize the need for people-centric approach to planning, 
KI indicated that keeping children in mind in all elements of the planning enabled 
them to move quickly and effectively through the process.  Respondents felt that 
considering what the end-users (patients and families) need was a vital step in the 
process and guided their decisions about space, financing, resources, etc. Key 
respondents 4, 8, and 9 also gave importance to the needs of the healthcare staff 





Examples/Quotes: Child-centered Planning KI#, Country 
“Keep children in mind in all elements of planning” 3 Mexico 
“Plan with children in mind” 4 USA 
“Need to look at the programmatic needs through their eyes” 7 Rwanda 
“We have a real mission to make the families happy and we 
involve them” 
8, 9 USA 
“The family members and parents should be part in whole 
process” 
11 Georgia 
“The goals that we defined for the project were … that it was 
going to be patient centric” 
12 Rwanda 
“Something that is useful for the people that are on the ground. 
There's a lot of cool projects and a lot of interesting projects, 
but if they don't quickly make the lives of people who are on the 
ground better, and that's the patients and the providers, then 
it's not going to win traction or keep attention” 
22 Liberia 
“You can get stuck in the process and forget it’s about the kids. 
You get lost and you forget why you're doing it. It's for the kids, 
right? You forget that these are real living human beings who 
want to color, and want to play” 
23 Kenya 
“How do you involve the families in the process? How do you 
support the families?” 
24 Liberia, 
Brazil  
“People often forget the people side of it. They just want to build 
the building, put a name on it, and then assume it's going to 
work” 
25 Various 
“The whole is about people. Remember at the end, we're doing 
it for the people, by the people. Of course, it's about people” 
28 Egypt 
“Everybody gets motivated by the patients and families. It's to 
be centered on the patient and their needs” 
29 Guatemala 
“If you put the patients and the community the center of 





Respondents added that in order to promote this patient-centered planning 
element, a multidisciplinary and systems-wide approach was required. They 
discussed how planning was a collaborative team effort between everyone from 





depth interviews with administrators at Dana-Farber Cancer Institute also 
emphasized that during the 2016 renovation of the Jimmy Fund Clinic 
administration, operations, nursing, psychosocial, pharmacy, radiology, and other 
disciplines were heavily involved in the planning.  
As mentioned earlier, developing a new PCU in a LMIC is usually a novel 
initiative that changes the current status-quo. Therefore, KI thought that the 
overarching planning principle was to change the entire system not just plan a new 
clinical unit. Moreover, they explained that providing safe and quality pediatric 
oncology entails investment in many components of the care delivery system 
internally (blood banks, pathology labs, operating rooms, etc.) and externally 
(housing for the patients and families, continuing efforts for the children to stay in 
school, awareness to decrease stigma, etc.).  
Examples/Quotes: Systems-based Planning KI#, Country 
“We need to put systems in place” 10 Rwanda 
“Everybody must work together from quality to surgeons” 11 Georgia 
“Understanding the subsequent ripple effects there are with building 
a facility… understanding how all of these are linked together” 
12 Rwanda 
“We have to change the system. We need a systems-wide and 
public health-approach to create change”  
20 Bulgaria 
“Understand what the big picture is and how to manage it” 25 Various 
“Pediatric oncology is not like HIV. That's the beautiful argument for 
setting up a pediatric oncology unit; that I can't help these kids 
unless the surgeons have what they need, unless the lab has what 
it needs, unless radiology has what it needs. You lift it, it's ‘the rising 
tide lifts all boats’. That's what pediatric oncology is” 
32 Tanzania  
  
Benchmarking  





was cited as a key element for effective planning. Although one single manual on 
how to plan for a PCU in a low-resource setting does not currently exist, KI felt that 
looking at the leading pediatric oncology hospitals globally was a productive 
starting point. Respondents in Group I talked about using clinical treatment 
protocols for pediatric oncology endorsed by US and European medical and 
nursing associations. Participants in Group III emphasized that use of standards 
in individual steps in the planning process (fundraising, governance, facilities 
planning, etc.) is an actionable piece of advice for future planners. Respondents 
also indicated that hiring an architecture firm that specializes in hospital design 
would be helpful as they will likely be familiar with international standards and 
provide technical expertise on building requirements.  
Some KI from LMIC had the opportunity to spend time at St. Jude Children’s 
Research Hospital in Memphis, TN and Dana-Farber/Boston Children’s Hospital 
Boston, MA, or regionals centers of excellence in Singapore and El Salvador 
where they were exposed to evidence-based care and clinical and business 
operations governed by numerous policies. Planners at Dana-Farber/Boston 
Children’s Hospital Boston, MA also looked at other PCU in the US when planning 
for the renovation of the facilities to incorporate best practices and avoid mistakes 
that others have experienced.  
Key informants agreed that conforming or aiming at the highest possible 
standards was an important element in planning the PCU which enabled them to 





confidence, enhanced morale, and minimized instances of corruption. 
Furthermore, they felt that it served as a catalyst to strive for excellence and inspire 
their constituents. A few KI mentioned occasions when planning was done 
haphazardly and based on outdated or not validated guidelines or compiled via a 
simple Google search. They cited leaders, who despite their strong medical 
training and clinical expertise, did not appreciate the value of following 
internationally approved standards and the need for adjusting guidelines to the 
local context. For example, international guidelines may indicate a specific bed to 
nurse ratio, but given the lack of nurses in the country, complete adherence to this 
standard may not be possible.   
Examples/Quotes: Benchmarking KI#, Country 
“Get the golden standards and follow the best example” 1 Mexico 
“If we do not think about making the best possible hospital, we 
will be stuck in the middle. Being the best implies many things. 
It implies excellence, quality, etc.” 
2 Mexico 
“For a new program, we start with the nursing baseline 
standards” 
5 Various 
“We started by getting the first clinical protocols in place” 7 Rwanda 
“We usually pick the strictest and we apply to that” 8 USA 
“We look to see what's required by the latest guidelines, the 
latest thinking in healthcare design”  
9 USA 
“Need to select and follow the treatment protocols from the 
beginning” 
11 Georgia 
“Our advantage when we first opened was that we used USA 
treatment protocols. This helped us build trust among the public, 
even though we were young doctors” 
18 Armenia 
“We were looking for best practices. We were looking for cases 
that sometimes people also would worry a lot if you tell them to 
do something that never existed before. So, we were trying to 
look for assurance that others have done it, so why can't we do 
it?” 
28 Egypt 





“We wanted to learn from the best and follow the best. We 
wanted to have the most up-to-date science that’s why we 
visited St. Jude and Dana-Farber and Boston Children’s” 
30 Egypt 
“Need to use international standards and advice from experts, 




 Participants emphasized another important element when planning for a 
new PCU: the need for a long-term planning. Participants in Group I indicated that 
even though some of them may have started with a small scale and without having 
formal statistics about cancer incidence, they still wanted to ensure that the PCU 
is sustainable in the future and meets the needs of the patients in the long-run. As 
mentioned earlier, in many cases the establishment of a PCU is a new initiative in 
the country or the only referring hospital where children with cancer can get 
treatment. Therefore, once a center is built, the diagnostic capacity in the country 
increases and a higher number of new cases will require treatment.  
Participants in Group III agreed that planning with a long-term horizon is 
essential. KI referred to cases when leaders insisted on rapid construction or 
donors pressured for immediate results or teams based their decisions only on 
current trends which led to facilities too small to serve the rising numbers of 
children with cancer, among other inefficiencies and wasted resources. Experts in 
Group III mentioned a time horizon of at least 15 years when planning a new 
pediatric oncology unit or even renovating existing facilities. They explained that 





operational considerations (budget, space, procurement, staffing, etc.) are linked 
to each other.  
Step-by-step planning  
 Another key planning principle was the idea of step-by-step planning. While 
KI in Group I were passionate about materializing their dream and wanted to 
actively change the treatment available in their countries, they all mentioned that 
the process requires patience and that planning in phases was essential. They 
underlined that in the beginning their team had to make decisions on all aspects 
of the planning (which could be overwhelming and distracting) so keeping in mind 
that all elements in the process are linked and that taking incremental steps in the 
planning process is wise. Respecting the incremental nature of the process helped 
them ensure sustainability, minimize risks, maintain confidence, and make 
continuous adjustments to the plan as they go. Participants referred to the 
pressure that donors or politicians may add to the planning approach but advised 
for cautious, controlled, and systematic planning in phases.  
KI in Group II, while eager to implement changes, appreciated the need for 
pacing their tasks and the linkages between each planning task. Respondents in 
Group III illustrated examples where planners were impatient to build a PCU or 
perceived the process as based on one single main element (usually securing 
funding or land for the building) or regarded the individual steps as unrelated to 
each other, which resulted in projects never actualized, waste of resources, loss 





example, a KI cited the example of a hospital leader who prioritized the preparation 
of floor plans without first assessing if, indeed, a new building is needed. 
Examples/Quotes: Step-by-step Planning KI#, Country 
“Start small and move in phases” 1,2,3 Mexico 
“Start small and move gradually” 6 Various 
“You can't wait 10 years when the kids are dying. You can't do 
everything now, but you can do some things now. And I think 
that's a really important lesson” 
7 Rwanda 
“Planning is like Maslow's hierarchy of needs…You have to 
have the foundation pieces in place. Then you march up the 
pyramid and there's lots of stuff in between” 
10 Haiti, 
Rwanda 
“I started with 6 beds in a room that used to be a storage. We 
now have 74 beds” 
15 Myanmar 
“You start with just one step at a time” 17 Philippines 
“Step by step. Maybe it would have to be something little in the 
beginning. We first need to create the alphabet” 
20 Bulgaria 
“Start small and accept that.  Accept the fact that you can't solve 
the problem in one stroke” 
22 Liberia 
So, once you start it's better to go slow, and in a pacing manner. 
Start building slowly and every time there's more need, you 
continue on the building. Grow on an orderly manner” 
29 Guatemala 
“It’s an iterative process. You say: Let's try this. Let's try that. 
Let's recalibrate.” 
31 Various  
“You need to do it step by step. As you grow your service, more 
and more kids will come. We've gone from 100 kids to like last 




In summary, challenges in gaining an appreciation that planning principles 
need to be incorporated in the planning process of a new PCU or barriers in 
effective implementation of planning principles include: 
• Internally: 





o Team undervaluing the usefulness of planning and linkage among 
steps 
o Lack of diversity and teamwork 
• Externally: 
o Lack of planning culture 
o Shortage of strategic planners or resources 
o Donor motivations  
o Political pressure 
o Donors and funders not pushing for strategic planning  
• People-related:  
o Ineffective leadership team (impatient, close-minded)  
o Hidden, self-serving agendas 
o Resistance to change 
Advice for future planners  
ü Invest in early planning  
ü Define the planning principles with the leadership team 
ü Look at best practices and standards regionally and internationally 
ü Plan with the patient in mind 
 
Resources for future planners 
Appendix 7 indicates sources where future planners may find planning 





Element 4. Organizational Platform   
Key Question 
 




• What structural platform is needed? 
• What is the organizational structure needed? 
• Why is it important to form or work closely with a 
Foundation/NGO? 
• What is important when forming or working closely with 
a Foundation/NGO 
 
Table 15. Summary of Results for Key Element 4: Organizational Platform 
Outcome Themes 
Key Element: Organizational Platform (Foundation/NGO) 
 
Themes: • Philanthropic culture 
• Financial sustainability 
• Transparency and trust 
• Leadership (Board) 




• Past experience with foundations and NGO 
• Trustworthy, diverse, connected Board Members 
• Mission-alignment 
 
Challenges: • Internal: Culture, lack of transparency 
• External: Communication, corruption, lack of 
regulations around NGO, mistrust of NGO 
• People-related: Ineffective leadership, self-serving 
motives 
 
Participants discussed the importance of designing their organizational 
platform as a foundation/NGO or working closely with a trustworthy NGO partner 






Figure 18. Element 4: Organizational Platform 
 
Key informants indicated that no matter the governance status of the PCU 
(non-profit or public) or financing mechanisms in the country (universal health 
coverage, insurance plans, reimbursement rates, etc.), envisioning the internal 
organizational platform of the PCU within an NGO or having an NGO as the 
fundraising partner was a key to successful planning. They explained that even in 
the most supportive government environment, it is probably not possible for the 
government to provide all the resources the PCU needs to effectively deliver 
comprehensive pediatric oncology care.  
Benefits of an NGO Organizational Platform 
Respondents felt that creating a foundation/NGO or closely aligning with one was 





• Assumes the responsibility of carrying out various administrative tasks that 
are not handled by the Ministry of Health or hospital administration such as 
fundraising, volunteers, facilities planning, marketing, communications, 
procurement, etc. 
• Adds accountability and transparency in financial governance and 
fundraising process 
• Creates a stronger voice to advocate and raise awareness for childhood 
cancer 
• Serves as the liaison with parents, other NGO, community, donors, 
international partners, and other stakeholders 
The table below summarizes the foundations/NGOs associated with the key 
informants to illustrate that the majority of them are part of an NGO (additional the 
information about KI characteristics is found earlier in the Study Methodology 
Chapter).  
Table 16. Foundations/NGOs related to Key Informants 
KII # Country Nonprofit 
PCU/Hospital* 
Name of Foundation/NGO 
1, 2, 3 Mexico Y Teletón Foundation 
4 USA Y Jimmy Fund  
7, 10, 12 Rwanda Y Mass Design  
Partners-in-Health 
13, 18 Armenia N - Public Currently at public hospital 
Planned PCU will be a nonprofit 
facility supported by City of Smile 
Foundation 
19 Armenia Y Bridges of Health 
8, 9, 14 USA Y Boston Children’s Hospital  
Boston Children’s Foundation 





Planned PCU will be at existing 
nonprofit hospital called Jo Ann 
Medical Center 
15, 16 Myanmar N - Public City Love & Hope Foundation 
Amelia Project 
17 Philippines N - Public PGH Medical Foundation 




N - Public Sickle Cell Foundation of Ghana 
 
29 Guatemala N - Public AYUVI 
30 Egypt Y CCHE  
Egypt Cancer Network (ECN) 
Association of Friends of the 
National Cancer-free Initiative 
(AFNCI) 
32 Tanzania N - Public Their Lives Matter Foundation  
*Indicates whether the KI’s PCU or Hospital is itself is a nonprofit institution 
 
 Three recurring themes emerged regarding the steps and need to design 
the PCU organizational platform as an NGO: a) changing the local philanthropy 
culture, b) transparency and trust, and c) role of Board Members. Respondents 
highlighted how these concepts are interconnected and depend on the key 
elements in the process, for example having leaders willing to change is 
instrumental in changing the local giving culture or consciously applying 
transparency in all operations will impact the relationships with international 
partners and stakeholders.  
a. Changing the local philanthropy culture 
Respondents in Group I highlighted that they were the pioneers to create a 
giving culture in their countries and that their foundations acted as catalysts to 





foundation (AYUVI) started with a small number of volunteers buying medications 
for the children and that there was no similar organization in the country.  One KI 
from Egypt stated that “not only didn’t we have the money and the land, but we 
also needed to change the mindset of Egyptians to give to a non-governmental 
organization.” The KI from Myanmar noted that it was one of the first times when 
large for-profit companies embarked on systematic support of healthcare services 
and pediatric oncology in particular (City Love & Hope Foundation is the 
philanthropic arm of City Mart, the leading supermarket chain in Myanmar). 
Participants in Group II were aware of the fundraising efforts led by ECN to 
support CCHE 57357 and mentioned that they would like to replicate this in their 
future plans for the new PCU. The KI in Group III agreed that a PCU in a LMIC 
may face difficulties carrying out all administrative tasks and securing a sustainable 
funding source. Therefore, the model of having an NGO partner is important and 
enables planners to move smoothly through the planning process.  
Examples/Quotes: Philanthropy Culture KI#, Country 
“Teletón Foundation gave us the resources and confidence to 
include in the project all the elements that we considered 
essential for the treatment of children with cancer” 
1 Mexico 
“The Ministry of Health respects the support and expertise that 
Partners in Health brought to the country” 
10 Rwanda 
“The help from World Child Cancer Foundation and small local 
NGOs was key” 
15 Myanmar 
“Foundation support has been a success factor” 17 Philippines 
“The pediatric oncology unit was made possible by having a 
Korean Foundation supporting the training and drug supply” 
21 Laos 
“The first step was to start the process to form a foundation. 
That was the starting point” 
29 Guatemala 
“We first started a non-governmental organization which was 






“Having an NGO gives us more flexibility in doing tenders, in 
hiring employees, financing” 
“We realized actually we needed to be our own independent 
NGO, so that we could manage the money ourselves and we 
could employ people directly and we could pitch to bigger 
donors” 
32 Tanzania 
“During my visits to major oncology hospitals in the United 
States, I realized that the best universities and hospitals are 
NGOs. So, I decided to initiate our own foundation” 
35 Egypt 
 
b. Transparency and Trust 
Respondents found that having an NGO structure that sensibly raises and 
manages funds for the PCU contributes to the PCU’s credibility and trust in the 
community. Respondents emphasized that the NGO needs to exhibit 
transparency, honesty, and openness in all its functions as the reputation of the 
PCU will depend on the responsible use of funds.  
c. Board Members 
In terms of recruiting Board Members to set up an NGO, KI felt that a diverse 
board with strong, well-connected people, committed to the mission, and willing to 
implement change is recommended. Alignment with the mission, vision, and 
values was reported to be essential when nominating Board Members as they will 
determine the future direction and strategic planning of the PCU.  
Facilitators 
Respondents mentioned that if team members are already part of a 
foundation/NGO and the NGO enjoys a positive reputation, then forming the 
organizational platform around a foundation may be easier. Selection of effective 





(financial, connections, buy-in, recognition, etc.) to the PCU, facilitated the process 
of creating a productive and long-term foundation.  
Challenges 
Challenges in associating the PCU with a foundation/NGO or effectively 
establishing a foundation/NGO usually resulted from an overall lack of planning or 
overestimating the possibility that the projected PCU can be completely 
independent. A culture of mistrust towards NGOs and lack of diverse team 
members who can offer different perspectives on the organizational platform were 
identified as barriers in appreciating the need to partner with a foundation.  
Advice for future planners  
ü Set up or partner with a foundation/NGO  
ü Select NGO Board Members in a systematic and transparent way 
ü Prioritize mission, vision, and values-alignment when selecting Board 
Members and forming the foundation/NGO 
ü Recruit a diverse NGO Board 
 
Execution Elements (Elements 5-9) 
Element 5. Situation Analysis  
Key Question 
 




• What is the problem? 
• How big is the problem? 
• Why is it a (public health) problem? 
• Who is currently addressing the problem and how? 







Table 17. Summary of Results for Key Element 5: Situation Analysis 
Outcome Themes 
Key Element: Situation Analysis 
 
Themes: • Size the problem and need 
• Data as part of the argument and assessment 
• Assess the care delivery context 
• Internal and external environment 
• Needs-based and long-term planning 
 
Facilitators • Data availability and past experience 
• Data-driven planning mentality 
• Team diversity 
 
Challenges: • Internal: Lack of experts in the team 
• External: Lack of reliable data, retrospective data 









Respondents indicated that performing a situation analysis was a vital 
element in the process (Figure 18). They agreed that having a comprehensive 
understanding of the current and future need based on a data-driven assessment 
was important for planning purposes, building an argument, engaging 
stakeholders, and assessing the feasibility of the PCU. Concrete data on the size 
of the pediatric oncology problem and overall healthcare system in the country, as 
related to pediatric oncology, was essential and allowed planners to make 
evidence-based decisions. 
Examples/Quotes: Situation Analysis KI#, Country 
“Define assumptions in your data” / “Your biggest selling point 
is the need” 
4 USA  
“What's the need? What's already here? What's the funding? 
How sustainable is this? All that homework has to done” 
5 Various 
“A detailed needs assessment on cancer burden is essential” 6 Various 
“What are the gaps? Where is it that we can add value?” 7 Rwanda 
“We looked at the population in Massachusetts, our local 
growth here, we looked at our international business to see 
where that was coming from” 
8 USA 
“We do a feasibility analysis” 9 USA 
“Start by assessing the current situation” 11 Georgia 
“First, we wanted to understand the need” 12 Rwanda 
“It helped that I compared data with neighboring countries in 
South-East Asia” 
15 Myanmar 
“It's the numbers, it's the data – what opened the eyes of 
administrators and decision-makers” / “My advice is to 
understand the current situation and the problems” 
17 Philippines 
“Know what is feasible in the local setting” 22 Liberia 
“Planning needs to be as needs-based as much as possible” 26 Malawi, 
Myanmar, 
Uganda 
“Need to know the org chart for the country; who's doing the 
asking and what power do they have personally, institutionally, 
and governmentally; permanence of people; funding and 
financing” 





“We got an idea of what was needed and that was the starting 
point” 
29 Guatemala 
“We thought that to start in a right way we need to know 
everything before starting. This was the start” / “I would advise 
them to look at the magnitude of the problem in their country 
and study it very well before starting building... do things the 
right way from the start” 
30 Egypt 
“In a project we're working on right now in China, we were able 
to convince them that we needed inputs of disease incidence, 
population demographics, migration patterns, things like that” 
31 China 
“I find you're always more effective if you don't just walk in with 
a strong feeling, but you walk in with information to support that 
feeling” 
31 Various  
“It was very important to start with a needs assessment, just to 
understand what was going on” 
“You have to prove the need before you get it” 
32 Tanzania  
“Data on mortality and burden of disease pushed the agenda. 
Knowing that pediatric oncology is the top three reasons for 
(child) mortality in Armenia, this is why Ministry of Health 
decided to prioritize it” 
33 Armenia 
“You need to show to various Ministries the numbers and the 




Measurement of the need (pediatric oncology burden in the country) 
Respondents in Group I and III and pre-dissertation interviews (from 
oncologists, architects, facilities and construction managers, clinical operations, 
nursing, and NGO leaders) felt that sizing the problem and gaining a deeper 
understanding of the problem of pediatric oncology in the country was a key 
function. They agreed that gathering data to document and prove the need was 
integral in the planning stage because subsequent action steps (budget, space, 
staffing, etc.) depend on the actual numbers. They also stated that a situation 
analysis with concrete numbers on the burden of the disease helped frame a solid 





results and improve of clinical outcomes, such as survival rates, abandonment 
rates, etc. 
Respondents from Group I and III underscored the importance of 
incorporating predictions for demographic, policy, and market trends in the future 
such as population under 18 years old, influx of international patients, emergence 
of private insurance, enactment of universal health coverage or other new social 
insurance plan, etc.  
Elements that interviewees empirically calculated and gathered data on 
included:  
• Incidence and prevalence of the disease: ex. expected new cases of 
pediatric cancer per year 
• Types of cancer: type of cancer and percentages of patients with each type 
of cancer (leukemia, solid tumors, brain tumors, etc.) 
• Referral pathways: how and where patients are diagnosed and referred to 
a facility, level of misdiagnosis and underdiagnosis in the country 
• Level of awareness about the disease in the country 
Participants in Group I (except the KI from Egypt, discussed later) did not 
conduct a formal assessment and in none of the countries was there a dependable 
source of information to draw data such as a national, population-based registry or 
reliable longitudinal electronic medical records. However, based on their prior 
clinical experience and input from team members, participants reported that they 





burden of disease. Respondents used retrospective data from their past 
employment (previous PCU in Mexico) or current employment (National Cancer 
Institute in Egypt) or existing facilities (public hospital in Guatemala) to estimate 
the current disease burden.  
The KI from Philippines described how when she returned from her training 
in Singapore she submitted a proposal for an 8-bed unit to her hospital leadership 
where she also included data about neighboring countries (Vietnam and 
Indonesia) showing numbers on clinical outcomes, mortality, and morbidity. 
Respondents in Group II did not report having discussed the task of conducting a 
needs assessment with their team or were aware of any similar formal reports in 
their country.  
In the case of the KI from Egypt, the results showed that they were the only 
respondents that performed a formal feasibility and situation analysis before they 
embarked on detailed planning for the new PCU. The feasibility analysis was 
prepared in 1999 by a consulting firm after the leadership team solicited a formal 
request for proposals from 14 companies in Europe and USA whose teams 
included professional planners, architects, and healthcare consultants. After the 
leadership team extensively interviewed the various firms and negotiated fees, 
they selected a company that assigned 20 experts to develop a formal document 
that presented a demographic and market analysis, operational and financial 
guidelines, staffing and equipment specifications, architectural concepts, and 





and was discussed among the various stakeholders including the Foundation, 
National Cancer Institute, government, community leaders, patients, and others. 
Findings from this analysis, enabled them to move through next steps and identify 
the key elements in the process such as assessing the need, estimating the scale 
of the PCU, forecasting expenses, etc. Respondents underscored that the decision 
to spend most of the initial funds they raised to hire a consulting firm to conduct a 
feasibility analysis was a crucial element in the planning process. They explained 
that although initially several stakeholders and the general public disapproved of 
this decision and undervalued the need to perform a feasibility analysis, as there 
was no precedent in the country for a similar task, the findings from the feasibility 
report enabled them to validate their plan to establish a new hospital and helped 
them take educated, evidence-based investment decisions. For example, having 
concrete numbers on the lack of trained pediatric oncologists and healthcare 
professionals in the country, was one of the primary reasons they decided to start 
a global pediatric oncology fellowship and a health sciences academy. 
Assessment of the healthcare system in relation to pediatric oncology 
 Key informants explained that in addition to sizing the problem, they also 
mapped some elements of the current healthcare system that are relevant to 
pediatric oncology in terms of resources available to treat children with cancer and 
other PCU already treating children with cancer. They indicated that having an 
understanding of the infrastructure and development level of pediatric cancer care 





allowed them to attain a realistic appreciation of the current situation and strategic 
goals for the future. For example, knowing how few pediatric oncologists exist in 
the country, gave them the idea of recruiting pediatricians and training them on the 
job, and work with medical residents on mentoring them on a career in pediatric 
oncology, to ensure a steady flow of new specialists.  
Respondents summarize three important pieces of data in the overall 
assessment of the healthcare system, among other essential components, as 
follows: 
Human Resources: Physicians, nurses, pharmacists, technicians, administrator, 
and other healthcare professionals needed to come together to operate a PCU. 
Respondents highlighted the shortage of trained pediatric oncologists due to lack 
of formal specialization in the medical school curriculum or personal hesitation of 
medical students to become pediatric oncology specialists. For example, the pre-
dissertation KI from Ethiopia mentioned that, in 2017, there were only 3 trained 
pediatric oncologists in the country for a 100 million population. Scarcity of trained 
nurses, in general, and in pediatric oncology, in particular, was an additional 
challenge reported by respondents in all Groups.  Another constraint identified in 
the assessment of the healthcare system was the overall lack of trained individuals 
in planning and running healthcare facilities, and experts in public health.  
Support Services: Availability of supportive and related services in the country 
(psychosocial, blood banks, housing for patients, drug supply, etc.). Participants 





assisted them in the later operational steps when they planned and budgeted for 
these services.  
Other PCU: Existing facilities already providing any type or part of pediatric 
oncology services, which can be perceived as potential competitors or 
collaborators. These may include public, non-profit or private primary, secondary, 
or tertiary facility such as adult and pediatric oncology care center, private 
chemotherapy clinics, oncologists’ private practice, diagnostic laboratories, etc. 
Respondents mentioned that this information helped them predict competitive 
forces and identify potential synergies such as sharing diagnostic testing capacity 
with public hospitals.  
Facilitators 
Respondents agreed that having experience in delivering pediatric 
oncology and access to reliable past data were significant facilitators in the 
process. They added that recruiting a diverse team further facilitated their activities 
as multiple voices were incorporated and a systems-based approach was included 
in the assessment of the current situation. Participants mentioned that a culture 
that promotes data-driven planning, instead of hunches or personal opinions, 
added rigor to their analyses and set the example for other calculations in the 
future.   
Challenges 
 KI in all Groups noted that the shortage of trained healthcare professionals, 





lack of national-level, trustworthy data. They added that personal characteristics, 
such as impatience to quickly build the PCU or reluctance to resist external 
pressures (donors, politicians, etc.) who demanded immediate results, contributed 
to undervaluing the importance of conducting a situation analysis. For example, a 
KI mentioned that a donor insisted on donating an expensive, sophisticated 
diagnostic equipment while there was no provision in the construction plan to 
accommodate the special space requirements, no trained technician in the country 
to use it, and no funds allocated in the budget for maintenance. At the same time, 
the PCU first needed basic medical equipment before they could expand their 
diagnostic capacity to more elaborate labs.  
 
Advice for future planners  
ü Conduct a situation analysis early on 
ü Document and size the problem 
ü Assess the healthcare system 
ü Use baseline data to show results 
ü Frame the message to reflect situation and need 
ü Advocate based on data (not hunch or wishful thinking) 
 
A KI from Group III urged future planners to not despair, if data are not 
available.  He encouraged planners to “talk to people that have on the ground 
knowledge. It might not even be in the home country; it might be another country 
that has some similarities that you can use as an example. Don't recreate the 





is needed in terms of equipment, clinical protocols, nursing baseline standards, 
fundraising strategies, etc. Or, if a LMIC country lacks a national population-based 
cancer registry, they may use GLOBOCAN estimates that suggest 120-150 cases 
of pediatric cancer per million children under 14 years old.174 
Another KI from Group III urged planners to use this comprehensive data to 
frame the message about overall health system strengthening and show “how 
beyond the children with cancer who have the right to treatment, these investments 
will also benefit other children by strengthening pediatric services, in general.” For 
example, operating a PCU assumes that there is a functioning blood bank, solid 
infection control procedures, working intensive care unit, good pathology and lab 
infrastructure, specialized pediatricians, trained nurses to safely administer 
chemotherapy, reliable drug supply, psychosocial support, and other services 
which, in turn, may serve other pediatric or adult populations. Another participant 
added that if she had the opportunity to start a PCU in another country, she would 
“go in and do an assessment till I understand what the physical environment is 
[and] the supply resources, what the knowledge [and] workforce looks like, what 
their goals are, to really understand what are the hospital's goals in establishing a 
program, so that you could make an assessment and try to align and work on a 






Resources for future planners 
Resources  
Resources to help planners examine the Situation Analysis element in-
depth are found in Appendix 8. The Appendix includes:  
• Tools and examples on situation analysis and needs assessment 
• Frameworks, theories and approaches to conduct a situation analysis or 
needs assessment  
• Sample Health Systems Assessment Checklist 
• Sample Strength, Weaknesses, Opportunities, and Threats (SWOT) 
Analysis 
Capacity Model 
As discussed in the Study Methodology Chapter, I developed a basic 
quantitative tool to assist future planners get an approximate estimate of the size 
of pediatric oncology problem and, subsequent, size of the PCU. Part A of the tool 
(found in Appendix 3), provides scenarios to calculate the number of new 
childhood cancer cases in the country and at the PCU. The example of Armenia 
was used to pilot the tool. In the future,  efforts by the International Agency for 
Research on Cancer (IARC) and WHO to advocate for and organize the 
development of cancer registries in LMIC should enable the burden of disease in  












• What are we going to do to solve the problem? 
• How much of the problem will we solve? 
• What care services will we offer?                   - Services 
• What type of PCU do we envision?                - Status 
• How big of a PCU do we envision?                - Scale 
• Who will be involved in the delivery of the care?  
 
Table 18. Summary of Results for Key Element 6: Medical Model 
Outcome Themes 
Key Element: Medical Model of the PCU 
 
Themes: • Status model of the PCU 
• Services planned at the PCU 
• Scale of the PCU 
• Prepare scenarios 
• Assess feasibility 
• Assumptions 
• Implications for future decisions 
 
Facilitators • Past experience 
• Retrospective data 
• Data from neighboring countries 
 
Challenges: • Internal: Shortage of experienced clinicians in 
pediatric oncology, misalignment with mission 
• External: Lack of reliable data and cancer registry, 
lack of national protocols or guidelines, corruption, 
bureaucracy 
• People-related: Impatience  
 
Respondents in Group I explained that considering the overall medical 
model of the PCU was essential after situation analysis is performed (Figure 19). 





formulation, findings from the situation analysis, and decision on the planning 
principles. The KI suggested that although planners may want to offer a full-range 
of services from the start, patience and data-driven estimates are recommended 
to avoid unrealistic expectations or deciding on a PCU that does not meet the 
patients’ needs or reflect the realities of the healthcare system.    
 





Three elements were particularly 
important in strategizing how to plan for 
the medical model of the PCU, as 
depicted in the Figure on the right:  
1. Status of the PCU 
2. Services that will be offered at the 
PCU (types, range, etc.) 
3. Scale (i.e. number of beds)  
Defining and quantifying the 
assumptions behind the “three S” in the 
medical model was also underscored. 
 
Figure 21. Three S in Medical Model 
 
1. Status of the PCU  
Participants in Group I reported that they knew from the start what the status 
of the new PCU would be i.e. within an existing public general hospital (ex. 
Philippines), within an existing public children’s hospital (ex. Myanmar), or a free-
standing non-profit hospital (ex. Mexico and CCHE 57357). The a priori decision 
was based on different reasons in each case: in the cases of the PCU that were 
established within existing public hospitals, the reason was that the leaders were 
already associated with or working at these facilities and pushed the hospital 
administration to create or expand the PCU (ex. Guatemala, Myanmar, Tanzania, 








the decision was made because the planning team wanted to leave the existing 
limited and suboptimal facilities at the National Cancer Institute in Cairo and create 
a state-of-the-art, comprehensive facility. The KI from Mexico indicated that the 
driving force behind establishing a free-standing, nonprofit facility was the 
motivation and support by Teletón Foundation which was already operating free-
standing, nonprofit rehabilitation and autism facilities in other areas of Mexico and 
Latin American countries.  
Respondents in all Groups felt that bureaucracy and corruption was 
prevalent in their countries and a potential barrier to smooth planning for a PCU. 
Nevertheless, KI in Group I and III felt that a PCU needs to be embedded within 
the legislative and healthcare system, no matter the PCU legal and organizational 
status. They also observed that gaining an understanding of the overall 
infrastructure level in the country was helpful when deciding the status of the PCU 
and setting realistic expectations. They added that it is important to define how the 
new PCU will integrate within the health system and how it will synergize with the 
national healthcare priorities, so that planners guide resource allocation 
accordingly. 
KI gave arguments to support their differing views on the ideal status for the 
PCU. The KI from Tanzania explained that the PCU needs to be part of a large 
university hospital or a large government hospital where other medical disciplines, 
beyond oncology, are present. For this reason, building a stand-alone facility 





that a viable model could be a stand-alone building within a government complex. 
A KI from Armenia explained that financing and legal regulations related to 
licensing, hiring, accepting donations, access to opioids, etc. come from the 
government so a PCU would not be viable if completely outside the system. The 
KI from Guatemala stated that they decided to be part of the public hospital and 
part of the Ministry of Health very early in the process, “but outside of the traditional 
public hospital in Guatemala or Latin America”, as their organization structure and 
financing mechanisms depend greatly on the foundation/NGO which supports 
them.  A KI from Group III clarified that the new PCU “does not necessarily need 
to be part of the Ministry, or the public sector, but it needs to contribute to the health 
system generally. It's not just an island that is separate from the health system, 
benefiting a few.” 
2. Services at the PCU 
The KI from Group I and III pointed out that for financial (and later 
operational) purposes, their team had to first discuss what medical services they 
envisioned to offer at the new PCU. The lack of national guidelines, protocols or 
standards was cited as a barrier to design the medical services model. The KI 
explained that an integral part of the process which was linked to and informed by 
other elements (such as situation analysis, financial planning, international 
partnerships, etc.) was to generate an overall idea of the services they plan to 





• Types of cancer they plan to treat and clinical departments they plan to 
initially establish (ex. solid tumors, bone marrow transplant, brain tumors) 
• Medical, clinical and support services they plan to offer (ex. diagnostic labs, 
blood bank, infectious diseases) 
• Other services they plan to provide on-site and those that they plan to 
outsource or share (ex. catering, ambulance) 
The KI from Egypt and Mexico discussed that being a free-standing 
pediatric oncology hospital meant that they had to eventually estimate costs for all 
the required in-house services from laboratories, pharmacy, operating rooms, to 
catering, cleaning, and ambulance services. Respondents from Group I and III 
advised future planners to create a detailed list of these services and check the 
services that they may co-share with the main hospital if they are housed within a 
children’s hospital, or for which they may have to contract with outside hospitals 
under a fee.  
3. Scale of the PCU 
A third key consideration for KI was to calculate the approximate scale of 
the PCU i.e. overall capacity of the PCU. Respondents mentioned how having a 
rough estimate on the number of beds guided their subsequent steps on how to 
finance the PCU and implement logistical and outreach considerations 
(procurement, staffing, construction, etc.). The lack of a national, population-based 
cancer registry, valid past data or reliable electronic medical record system was 





projection may be helpful to determine the viability of the project and, if feasibility 
is confirmed, educate strategic decisions on the structure of the PCU i.e. expand 
within existing facilities or build a free-standing oncology hospital. For example, if 
the number of beds is very small it may not justify building a new facility, as it will 
not be viable or sustainable. Or, depending on the projected number of beds, 
planners may look into other viable scenarios such as decide to add a PCU in a 
new wing within a children’s hospital or house the PCU in an adult cancer center. 
The literature review and findings from in-depth interviews demonstrated that a 
systems-approach that incorporates different types of data and a sensitivity 
analysis is helpful to allow for flexibility in the calculations and explore realistic 
scenarios.  
Participants from LMIC did not mention following a certain guideline or 
systematic projection model to calculate capacity scenarios for the PCU but they 
explained how prior experience and retrospective data on number of cases, length 
of stay, readmission rates, etc. assisted them in calculating the number of beds. 
They expressed appreciation on the impact that the number of beds has on 
subsequent strategic and operations decisions, and how this number determines 
other important quantitative decisions and performance indicators, such as nurse 
to bed ratio, number of infusion beds, occupancy rates, inpatient days, etc. 
Respondents urged future leaders that when planning, it is useful to have a 
planned occupancy rate and average length of stay in mind, and underlined that 





resources needed. In summary, the decision on number of beds for KI in Group I 
was based on empirical experience, retrospective data, available budget, or 
existing space.  
In particular, the KI in Egypt (as mentioned in the Element 5 description 
earlier) based their scale decisions on the findings of the formal feasibility analysis 
which included demographic, market and demand numbers, as well as 
comparisons with HIC countries.     The report carefully examined current and 
future need in terms of childhood cancer bed capacity, and suggested 300 
inpatient beds for an expected number of 3,500 to 4,000 new childhood cancer 
cases per year, along with many assumptions about the cascade of care that go 
into this. 
The KI from Mexico indicated that they started with 22 beds and that she 
based her projections based on her previous 23-bed facility and budget allocated 
by the foundation which provided the financial support. One KI from Rwanda 
described how they started planning for a 24-bed mixed unit (adults and pediatrics) 
and nine months into the program they expanded to 40 beds. Another KI from 
Rwanda mentioned that they started by a certain calculation about how many 
patients they would be seeing and number of chairs, beds, outpatients they would 
need. The KI from Guatemala indicated that they calculated beds based on the 
limited space they had available and the allocated budget that allowed them to 
treat 100 children per year. 





vision and values of the project as they relate to capacity projections. They talked 
about a multi-disciplinary approach to PCU scaling and how the vision that the 
leadership team sets in the beginning relates to this step. They explained that 
having team members from different disciplines allowed them to raise various 
issues early on and hear the perspective of all providers involved in the treatment 
plan. In terms of vision, they illustrated that a strategic goal of being the pediatric 
oncology leader in the country or envisioning free care for all children with cancer 
may drive decisions about the status of the PCU. The KI from Tanzania said that 
their mission dictated that they never turn away any patient because of lack of 
beds. Therefore, they were willing to operate with shared beds (i.e. two patients 
may share one bed) in order to fulfil this promise to patients and the community. 
Respondents in Group III emphasized that they wanted to respect the communal 
culture of the community and allow for space for children to play which affected the 
number of beds and ways that these beds were designed later on.  
Some respondents from Group II and III who reported not being familiar with 
conducting these projections, nevertheless expressed their understanding of the 
importance of this element and welcomed advice on how to make an evidence-
driven decision based on a reliable methodology. The KI from Kenya stated that 
she is “struggling with coming up with a number of beds. I would start with existing 
data. I would need a lot of help with that trying to figure out what kind of beds, and 
it's not just for chemo. It's for supportive care, it's for ICU, it's for the surgical floors. 





oncology added that she did not have “the expertise to decide how many beds are 
needed. And then, I would want someone also to help me figure out that the 
numbers are real numbers.”  
A KI from Group III cautioned that when leaders plan for new healthcare 
facilities without first justifying that there is enough demand, they create excess 
capacity for a low patient load which does not allow physicians to become experts 
in their fields and gain in-depth specialized knowledge.  Other KI in Group III 
highlighted how bed capacity and square footage are the main drivers of budgets, 
so careful estimation, including scenario and sensitivity analysis, during the 
strategic planning process is crucial. Regarding the need to incorporate a 
sensitivity analysis in the scale projections, a KI from Group III suggested looking 
at the private industry where sales forecasting includes scenarios that give 
different sales results depending on the assumptions. He underlined that the 
assumptions made in the estimate are important and added that “You're gonna 
make a ton of assumptions. Which ones is our decision most sensitive to? In other 
words, if we change that assumption just a little bit, would it flip us from going this 
direction versus that direction?”  
Advice for future planners  
ü Define status of the PCU 
ü Decide on services offered  
ü Estimate the scale of the PCU 
ü Consider resources in the environment and healthcare system 
ü Perform sensitivity analyses and case scenarios 





Resources for future planners 
Checklist for services 
Appendix 9 includes a basic checklist that I developed to assist future 
planners start mapping their medical model, assess feasibility, and plan for next 
steps. Users may check the services they plan to offer at their PCU and, then, 
determine which they are planning to offer on-site at the PCU, or off-site at the 
existing facility (if part of a children’s or general hospital) or outsource at a different 
facility outside the PCU.  
Capacity Model  
As discussed in the Study Methodology Chapter, I developed a basic 
quantitative tool to assist future planners generate an approximate estimate of the 
number of beds they would need. The pilot exercise for a potential PCU in Armenia 
was helpful to calibrate the model and ensure users can independently input data, 
and to go over a real-life example. Appendix 3, Part B, includes the results of the 
quantitative data analysis for Armenia regarding scenarios for calculating the scale 
of the PCU (i.e. number of beds). 
Element 7. Financing  
Key Question 
 




• How much does it cost to address the problem? 
• What is the treatment cost per patient? 
• Who is currently paying to solve the problem? 
• What expenses are currently covered (type, 
percentage, etc.) and by whom? 






Table 19. Summary of Results for Key Element 7: Financing 
Outcome Themes 
Key Element: Financing 
 
Themes: • Cost of care delivery (treatment and PCU) 
• Cancer care financing system 
Facilitators • Past experience and reliable data 
• Diverse talent in the team 
• Situation analysis findings 
• Data triangulation 
 
Challenges: • Internal: Team diversity, open communication, reluctance 
• External: Lack of reliable data, lack of trained finance 
professionals, corruption, lack of fiscal accountability, lack 
of national cancer control plan 
• People-related: Impatience, ineffective leadership 
After quantifying the burden of disease and need in the country, and outlining 
the medical model, respondents in the in-depth interviews and during pre-
dissertation interviews showed that a key element in the process is to assess the 
financial mechanism for pediatric oncology in the country and subsequently, the 
financial viability of a new PCU (Figure 21).  In doing so, they examined two basic 
questions:  
1. Cost of care deliveryà How much does it cost to establish and run a PCU?  






Figure 22. Element 7: Financing 
Overall, the KI from Group I indicated that when planning the new PCU a 
formal financial plan or examination of the financing mechanisms were not 
performed but previous experience in pediatric oncology care delivery enabled 
them to make educated forecasts of cost and budget of the PCU.  Participants in 
Group II indicated that the task of examining the financing situation in the country 
was not performed and that a budget for the creation of the new PCU was not 
available at the time of the interview. The KI in Group III agreed on the need to 
incorporate this piece of information in the initial planning process to form a basic 
assessment of the financial viability of the project. Respondents highlighted the 
importance of incorporating a team and systems approach when calculating costs 





estimate from a diverse group of team members and aspects of the healthcare 
system.  
1. Cost of Pediatric Cancer Care Delivery (treatment and unit) 
Respondents in Group I, except the KI from Egypt, reported that, along with 
team members, they were personally responsible for calculating the cost of the 
new PCU and that budget templates or guidelines were not readily available. As 
mentioned in the discussion of Element 5 (Situation Analysis) earlier, the KI from 
Egypt had performed a formal feasibility plan with the assistance of a consulting 
firm and, therefore, had financial calculations handy when developing the new 
hospital. The KI from Guatemala reported that in order to come up with a high-level 
cost projection of how much the new PCU would cost to build and operate, they 
calculated the space, number of beds, number of nurses, and diagnostic capacity. 
At the time that the dissertation interviews were conducted, the KI from Egypt and 
Guatemala were in the process of planning an expansion of their existing facilities 
and reported that detailed budget plans and projections were part of the planning 
process and shared part of the documentation with me.  
The KI from Mexico said that it was a hard task to manually calculate the 
cost of treatment per patient per cancer type and that their 20-year experience as 
pediatric oncologists helped them estimate the costs. The KI from Myanmar said 
that when she started planning the dedicated PCU within Yangon Children’s 





government such as salaries of staff and part of the diagnostic services, medicines, 
and nutrition. She added that currently there are several NGO which cover 
expenses for salary supplements, travel costs, and food staples.   
The participants from Rwanda explained that some of the direct and indirect 
costs were shared among the Ministry of Health, Partners-In-Health and Dana-
Farber Cancer Institute. One KI from Rwanda described that the initial funding was 
very important and that a systems-approach in financial planning was needed 
because “even if you make all the medications free, which is already a big deal for 
chemotherapy or for anything, still, people have got gigantic barriers to care 
beyond drug delivery”. A KI from Group III underlined that “as physicians, even 
after decades of experience, it is hard to calculate the cost of care delivery for your 
patients; we are not trained for this.” 
2. Childhood Cancer Care Financing 
Respondents highlighted that it was important to know if and how much the 
government is already paying for pediatric oncology services. The literature review 
and KI summarized that in a typical country scenario there are four primary sources 
of financial support:  
a. Government through reimbursement to hospitals, covering salaries, 
overhead, or other fixed costs, a fee-for service model, social insurance 





b. Non-profit organizations or donors through monetary donations, in-kind 
donations, grants, etc.  
c.  Out-of-pocket payments that patients need to incur 
d.  Private or social insurance through reimbursement to hospitals or patients 
Respondents suggested that mapping which of these players exist in the 
local market, and calculating the percentage and amount they are currently 
covering for pediatric oncology services is a crucial step in the process.  
This element was significantly impacted by other elements in the process, 
mainly the mission and organizational platform (Foundation/NGO structure) and 
situation analysis. For example, in the case of the KI from Egypt, having made the 
decision to be a non-profit, free standing pediatric oncology hospital, provide 100% 
free care, and receive no direct financial support from the government, was a 
fundamental factor in the financial planning process. The PCU in Mexico was part 
of a network of hospitals owned by a philanthropic foundation (Teletón) and they 
decided to accept the national health insurance (“Seguro Popular”), so their model 
affected their subsequent financial projections. The KI from Myanmar explained 
that “it would not be possible to receive financial support from an international 
foundation five or ten years ago due to the restricting political situation in the 







• Past, reliable financial data 
• Diverse talent in the team  
• Sound and valid results from the situation analysis 
• Triangulation of data from various sources 
Challenges 
• Internal: 
o Team diversity 
o Open communication 
o Reluctance to engage in financial planning 
• External: 
o Lack of reliable financial data 
o Lack of national cancer control plan 
o Shortage of trained finance professional  
o Corruption, lack of fiscal accountability 
• People-related: 
o Impatience 







Advice for future planners  
ü Conduct a financial assessment early 
ü Start by developing a high-level budget 
ü Secure seed money for the planning stage 
ü Align financial goals with mission, vision, and values 
 
Experts in Group III recommended that future planners start by developing 
a “high-level budget in the beginning (while in the dream stage) and securing seed 
money upfront to sort of do the initial concept studying and then you go back for 
the whole big number.” If prior financial data is not available, a KI from Group III 
encouraged future planners to “start by asking your neighbors and then, translate 
that to what it would be like in the home country. Make best guesses.” Another KI 
from Group III indicated that “financial projections are important even though reality 
never holds to the projections, but just having a vision of how the performance 
could look from a quantitative point of view and dollars and cents point of view.” 
Participants underscored the importance of having a clear mission and 
goals for the project, and defining the measurable outcomes that the PCU is trying 
to achieve. They highlighted that these strategic elements are vital in the financial 
planning phase and will have a huge impact on the budget. For example, being 
committed to providing free care to all children with cancer without any direct 
treatment-related out-of-pocket costs for patients, determined the financial 





Resources for future planners 
Development of a financial projection or plan for a new PCU was beyond 
the scope of this study and would vary in each setting depending on the financial 
system in the country. However, various resources exist that provide guidance on 
how to develop a budget and estimate start-up costs for a new healthcare facility. 
The Washington State Department of Health offers detailed budgets of more than 
30 hospitals in Excel format which are available for free.177 Appendix 10 includes 
resources on financial planning. 
Financial Planning Tool  
During my doctorate studies at Boston University School of Public Health in 
summer 2015, I attended a course on Health Facilities & Planning where we 
developed budgets for new hospitals. Moreover, as part of a group project for the 
Strategic Planning for Healthcare Organizations course during spring 2016 
semester, I worked with four other classmates on a service area competitor 
analysis for UNOP in Guatemala and compiled a comprehensive budget for 
UNOP’s expansion, using quantitative data provided by UNOP and AYUVI.  
Finally, during a work-related global health research project from 
September 2016 to May 2017, I collaborated with Nitin Shrivastava (MD candidate 
at UMass Medical School, MPH candidate at Harvard T. H. Chan School of Public 
Health) as part of his practicum project to develop a financial planning tool using a 
Lean/Six Sigma methodology. Lean/Six Sigma is a method which allows 





process.178,179  Experts from Boston Children’s Hospital Project Management 
Office and a Lean/Six Sigma Black-Belt consultant (Lorraine Daniels, PhD, MA) 
contributed their insight and later awarded a Lean/Six-Sigma Green Belt 
certification to the project in August 2017. Other experts in financial planning and 
pediatric oncology cost analysis were also consulted and offered their input in the 
project. For this project, we applied the DMADV Framework which included the 
following steps as depicted by the acronym: Define, Measure, Analyze, Design, 
and Verify.  
Furthermore, I integrated budget worksheets that engineers, project 
managers, and facility planners at Dana-Farber/Boston Children’s shared with me 
during 2013-2017.  
I combined all these data to create a quantitative, hands-on financial tool in 
Excel located in Appendix 11. The tool includes four separate spreadsheets: 
1. Capital (Construction) Budget 
2. Equipment and Supplies (Start-up) Budget 
3. Operating Budget 
4. Financing Mechanisms 
In Spreadsheets 1-3, users may input rough amounts of estimated costs 
and get subtotals; in Spreadsheet 4, they may enter amounts and percentages of 
financial support they expect to receive from each funding source. 
The spreadsheets may be used independently or combined depending on 





example, if the land is donated, there will not be a purchasing or rental cost for this 
expense category (Spreadsheet 1). If a new PCU is built within an existing 
children’s hospital, there may be cost-shared expenses with the existing Intensive 
Care Unit and Emergency Department (Spreadsheet 2). If the hospital planners 
decide to hire a project manager to coordinate the planning process of the new 
PCU, their salary and fringe benefits must be added in the budget (Spreadsheet 
3). If the PCU does not expect or accept any financial support from the government 
(as in the case of CCHE 57357), the projected reimbursement from the 
government will be zero (Spreadsheet 4). If the PCU expects to offer their 
diagnostic services for a fee to adult patients, they will have an additional income 
source in Spreadsheet 4. Inputting amounts or quantities in the tool assumes that 
other steps and financial calculations in the process have already been completed 
such as number of new cases per year, number of beds, staff ratios, cost per 
treatment, square feet/meters per area, average cost per square feet/meter, and 
so forth.  
The tool is rudimentary and it serves as a means to give a preliminary idea 
of the cost of the PCU, financing mechanisms, and, subsequently, to assess the 
financial feasibility and implications of this project. The tool also serves as a 
platform for the planning team to appreciate the multidimensional aspect of 
establishing a PCU, exchange ideas on their vision, discuss realistic issues, and 
incorporate a systems-level approach to planning. It is evident that assumptions 





impact the financial projections and planning process. 
 
Element 8. Stakeholders  
Key Question 
 




• Who else is needed to solve the problem? 
• Who are the stakeholders involved? 
• Why stakeholders do not want to solve the problem? 
• Who do we need to engage and convince? 
• Who is likely to help or impede our efforts? 
 
Table 20. Summary of Results for Key Element 8: Stakeholders 
Outcome Themes 
Key Element: Stakeholders  
 
Themes: • Need for identification and analysis of stakeholders  
• Common stakeholders 
• Stakeholder engagement strategies 
• Resistance  
 
Facilitators • Transparency, trust 
• Strong leadership, inclusive team 
• Common mission 
 
Challenges: • Internal: Culture 
• External: Corruption, political agendas 
• People-related: Ineffective leadership style, impatience 
  
Respondents discussed that identifying individuals or organizations 
(stakeholders) that can help them early on and developing strategies to engage 
them was a key element in the process (Figure 22). Although the KI did not report 
conducting a systematic and formal stakeholder analysis, they had a clear idea of 





manage relationships with stakeholders to leverage support from those in-favor of 
the project, minimize resistance from those against the project, reduce pressure 
from stakeholders, and keep engaged those already involved.  
 
Figure 23. Element 8: Stakeholders 
 
Examples/Quotes: Stakeholders KI#, Country 
“One of the biggest learnings has been that we… in every 
program is a local project committee made up of different 
stakeholders. If you don’t, it can cause conflict because then 
not everybody is on board with what you're doing or somebody 
might be running off doing activities without taking them through 
the process” 
6 Various 
“Involve community and parent advisory board” 8, 9 USA 
“If you don't engage your stakeholders to understand what they 
want out of this, you can spend as much money as you want 
and try to push our agenda but if you don't have the same 
agenda, you won't get anywhere.” 
10 Rwanda, 
Haiti 
“It's really we have to be in contact to everybody. With people 
with money, with people with power, and with people who are 






“You have to talk with so many different constituents. It's not 
only your patients and the parents and your staff. It's everybody 
else that make this happen. 
15 Myanmar 
“People can help with ideas, with this. Not with money, but with 
ideas. With support” 
20 Bulgaria 
“When starting a new project, useful to know who the various 
players in the community are” 
22 Liberia 
“First Lady’s campaign about awareness helped” 23 Kenya  
“The input from the companies has been immensely useful” 29 Guatemala 




The KI in Guatemala indicated that the first stakeholders his team tried to 
engage were the Minister of Health and President of the country. Convincing 
people from the Foundation (AYUVI) and collaborating with colleagues from St. 
Jude and University of California San Francisco was also instrumental in their first 
steps. The KI from Myanmar felt that stakeholders came from different sectors and 
she mentioned that she had the support of local NGOs, various government 
entities (Ministry of Health, Ministry of Home Affairs, Ministry of Education), as well 
as non-medical professionals, such as teachers in the community. A KI from Group 
III also underlined the importance of involving other Ministries besides the Ministry 
of Health such as Ministries of Finance, Development, and Education. 
Respondents from Group III underlined that endorsement from hospital 
leaders is essential and described experiences where this posed a major challenge 
because it delayed progress, stopped implementation of action steps, and 
diminished morale and team confidence. Participants highlighted the need to 
engage the hospital leadership and get their buy-in when planning a PCU within 





specifically referred to the hospital administrator as the number one individual who 
had the power to prioritize the issue locally.  
Many KI advised to include parents from the start to make sure that their 
voice is represented but also because they can contribute to advocacy efforts and 
potentially affect health policy. Inviting the community, especially the people and 
businesses physically close to the planned PCU, was essential because 
constituents may be worried about how the new PCU may affect their everyday life 
and neighborhood. The KI from Bulgaria emphasized the role of creating a sense 
of community and uniting stakeholders for the benefit that the PCU brings to the 
entire community.  
Several KI underscored the need to engage corporations and the vital role 
that corporate social responsibility (CSR) played in the development and 
sustainability of their PCU. The KI from Guatemala emphasized that local 
corporations in the fast food, soda, cement manufacturing, banking, and 
telecommunications industries were instrumental in the beginning for their 
monetary and in-kind donations, and also for building trust in the community.  The 
KI from Egypt illustrated that it was a few local businessmen from Cairo who 
donated the first million Egyptian pounds and catalyzed the beginning of the 
project. Another KI from Egypt stressed the role of the religious leaders, celebrities 
from the sports, arts, and other areas, students from all levels of education, and 
volunteers as primary stakeholders. 





identified was the expatriate community in the US, Canada and EU. The KI 
recognized the power of these stakeholders and that engaging them early on can 
help not only with donations from abroad but also with credibility, technical 
expertise, and power to persuade others.  
Resistance 
 Many respondents (Egypt, Guatemala, Armenia, and other countries) 
indicated that strong resistance came from their medical colleagues at other 
healthcare institutions. External, existing pediatric oncologists not only did not 
believe in the mission of the project but were actively against it because they were 
afraid that they would lose income or recognition when a new PCU is established. 
The KI from Egypt said that “we had too many people who were attacking and 
opposing the decisions of our organization, but when the dream came true, when 
we opened the hospital, everything changed.” A KI from Group III explained that 
resistance comes from not understanding the full stakeholder relationship and 
understanding what's in it for the different stakeholders. He added that “sometimes 
you get blindsided because you just don't know enough about the internal politics” 
so learning as much as possible from the beginning about each stakeholder is vital 
for the success of the project. For example, the KI mentioned a case when 
understanding that the number one priority of the hospital leader was to promote 
a positive personal public image in the media, helped the team create media 
opportunities for him and keep him engaged in their fundraising events that 






Participants indicated that in order to properly identify stakeholders and 
actively engage them, they needed to provide measurable results, exhibit 
transparency in all their interactions, be inclusive and open during the dialogue to 
allow for free flow of ideas, and have strong leadership. They highlighted the 
importance of being aligned under the common mission and how their founding 
values and principles enabled them to gain the trust of stakeholders and slowly 
win over skeptical or risk-averse stakeholders.  
Challenges 
Respondents discussed that impatience, naiveté, and undervaluing the 
need for data-driven planning has resulted in underestimating the power of 
stakeholders who are against the project or missing opportunities to engage 
stakeholders who had the potential to significantly assist their mission. An internal 
or external culture that does not welcome open communication and exchange of 
opinions was cited as an additional barrier to realistic identification of stakeholders 
and the development of effective engagement strategies. Corruption and political 
agendas were the reason that individuals or organizations were assigned an active 
role in the process without actually having a stake or interest in the PCU, which 
was not beneficial for the project. For example, a KI from Group II mentioned that 
a physician was appointed director of the national hematology center without being 
a hematologist. This resulted in poor planning and unsafe care delivery. Another 





quickly through the process and difficulties that planners face in managing those 
stakeholders who demanded quick results. Leadership teams that did not exhibit 
transparent and inclusive management styles were another reason why a 
stakeholder analysis was not performed effectively.  
Identifying the Stakeholders 
Findings from the literature review, pre-dissertation interviews, and data 
analysis indicated that common stakeholders involved in similar projects include: 
Table 21. Summary of Stakeholders 
Stakeholders within the country (internal) 
• Foundation/NGO affiliated with the 
PCU 
• Foundations/NGOs  
• Patients 
• Board of Directors of the 
Foundation/NGO affiliated with 
the PCU 
• Parents 
• Ministry of Health • Ministries of Finance, Education, 
Interior, Planning, Foreign Affairs, 
etc.  
• Governmental and regulating 
organizations issuing licenses, 
accreditations, etc. 
• Religious institutions based on 
the country’s predominant 
denominations 
• Corporations with corporate social 
responsibility programs 
 
• Healthcare staff: physicians, 
nurses, psychologists, social 
workers, etc. 
• Academic institutions (medical 
school, nursing school, etc.) 
• Country offices of international 
organizations (USAID, UNICEF, 
WHO, etc.) 
• Embassies based in the country • Celebrities (individuals, cancer 
survivors, parents of children with 
cancer) 
• Private, public and non-profit 
oncology centers in the country 
• Surrounding neighborhood / 
community 
• Private insurance companies • Politicians leading health policy  
• First Lady 
• Social insurance programs 
• Media (print, online, television, 
radio, etc.) 






Stakeholders outside the country (external) 
• Expatriate community • International foundations 
supporting children with cancer 
(e.g. Sanofi-Espoir, World Child 
Cancer Foundation) 
• Grant-giving organizations • Academic medical centers, PCU, 
and other collaborators in HIC 
• Multinational companies with 




Advice for future planners  
ü Identify and include stakeholders early 
ü Plan engagement strategies to keep stakeholders involved 
ü Prepare a strategic communications plan for stakeholders 
ü Prioritize transparency and open communication in all stakeholder 
engagement efforts 
ü Perform periodic stakeholder analyses to monitor stakeholder 
engagement and identify new stakeholders 
 
Resources for future planners 
Information on resources on stakeholders and steps on how to perform a 
stakeholder analysis are found in Appendix 12. 
Element 9. International Partners 
Key Question 
 




• Who else is needed to solve the problem? 
• Why are international partnerships important? 
• What makes a strong collaboration? 
• How do we transfer best practices? 





Table 22. Summary of Results for Key Element 9: International Partners 
Outcome Themes 
Key Element: International Partners 
 
Themes: • Need to form international partnerships 
• Access to resources and knowledge 
• Two-way learning 
• Confidence 
• Credibility 
• Benefits of forming international collaborations 
 
Facilitators: • Willingness to learn and change 
• Mission-alignment 
• Transparent and open communication 
• Mutual respect and cultural sensitivity 
• Long-term horizon 
 
Challenges: • Internal: Culture, academic integrity, brand abuse, 
communication, lack of accountability 
• External: Political instability, unsafety, corruption 
• People-related: Dishonesty, ineffective leadership 
 
The establishment of international partnerships within LMIC or HIC is a key 
element in the process of planning a new PCU (Figure 23). Respondents 
discussed that forming strong collaborations with other PCU regionally (such as 
within Central America or South-East Asia) or internationally (for example with St. 
Jude Children’s Research Hospital or Dana-Farber/Boston Children’s) was a 







Figure 24. Element 9: International Partners 
 
Examples/Quotes: International Partnerships KI#, Country 
“Goal-alignment and transparency needs to be in place” 5 Various 
“What was the key thing for us was having partnerships. 
Partnerships is very important because you need expertise. 
You need clinical expertise, you need programmatic expertise, 
you need community resources. And you need training” 
7 Rwanda 
“Allowed us to gain the respect and trust of the government and 
community” 
10 Rwanda 
“I would advise future planners to form a collaboration with 
other countries” 
11 Georgia 
“For a good partnership, you need a good team. People very 
committed, interested” 
“An ideal international partner is one that wants to learn and is 
a ‘like-minded partner’ from a mission standpoint” 
14 China, 
Saudi Arabia 
“Our biggest strength is international collaboration” 15 Myanmar 
“This is one of the advantages of having a collaboration: 
technical and moral support, especially when we feel desperate 
or have difficult cases” 
16 Myanmar 
“Our connections with abroad makes us stronger. Builds trust 
in patients, helps us become more confident and receive 






“It is important for me to create international connections and 
get advice” 
20 Bulgaria 
“You can see tangible change through international 
collaborations” 
23 Kenya 
“That's mutually beneficial. Going with a lot of humility. We don't 
know everything. These are some things that we do know that 
might work here and might not work here. Let's work on it 
together, so that there's local ownership. If there's not local 
ownership, it's just not going to happen” 
25 Various 
“Longitudinal, shared mission and goals, both parties bringing 
something to the table…and then trust” 
27 Various 
“It’s two-way learning because they have treated us as equals 
from the professional standpoint of view. They have been 
respectful of the cultures and of the politics in each country. 
Which I think is very important. I think that's the recipe for 
success” 
29 Guatemala 
“The turning point was our relationship with Dana-
Farber/Boston Children’s. We moved from just treating patients 
to doing research and our oncologists the same way, with the 
same standards as in Boston” 
30 Egypt 
  
A KI from Group III emphasized the importance of investing time in forming 
a relationship and said that “the groundwork of building the relationships, and 
figuring out what's going on and who's in charge, takes a year or two, it takes a 
long time.” A few respondents raised the issue of the complicating dynamics when 
the partner is also the initial funder and how this donor/recipient relationship may 
require thoughtful and open communication. Furthermore, KI addressed the issue 
of local ownership and making sure that even when a solid collaboration existed, 
it was useful to hire people locally to ensure buy-in and fit with the local culture and 
context.  
Benefits 





technical advice, sharing insights from their past experience, and transferring their 
knowledge from the beginning significantly facilitated the planning process of the 
new PCU. In addition to technical knowledge and personal anecdotes, 
international partners have shared with KI in Group I other types of resources such 
as human resources, funding, equipment, written policies, prepared operating 
standards, access to research infrastructure, and other usable and practical 
knowledge. Moreover, having a trustworthy international partner added credibility 
and trust to the planning elements of KI in Group I within their local community and 
stakeholders.  
Participants in Group III underlined the mutually benefiting nature of 
international partnerships. A KI who was a practicing pediatrician in USA and then 
led the planning of the PCU in Rwanda said:  
“In America and in medical school, you don't learn how to battle the system 
and how to solve quality issues and how to go to an empty building and 
make a hospital out of it. And I think I had to learn that and it is a very, very 
important skill that I think I can now use in lots of settings to help other 
people. How to create health systems, or how to just function in a really, 
really bad health system and still provide good care even when things are 
so much less than ideal.”  
 
Others agreed that reciprocal relationships were valuable to both parties and that 
the two-way exchange of ideas was helpful in the planning process of the PCU.  
A KI from Group III talked about reverse innovation and stated that “There 
are examples of, call it reverse innovation, that from places that are resource-





better ways to do things, and even [when religious matters are involved].” For 
example, he mentioned that when he was developing a training curriculum for a 
Muslim healthcare audience, he had to adjust the materials to respect religious 
beliefs and think of innovative ways to present the learning modules. This later 
helped him when he used the same materials with healthcare providers in Boston 
and offered a creative learning platform for other learners.  
Facilitators 
• Willingness to learn and change 
• Mission- and goal-alignment 
• Transparent and open communication 
• Being equal partners 
• Mutual respect, cultural sensitivity, and humility 
• Long-term horizon 
• Strong leadership  
Challenges 
 Respondents from all three Groups explained that challenges hindering the 
fruitful development and maintenance of international partnerships happen when 
there is lack of transparency, misuse of funds, breaches of integrity, misalignment 
of goals, lack of respect for culture, and miscommunication. Participants in Group 
III mentioned that factors in the environment may create delays or end partnerships 





other conditions that may make a visit to the country unsafe. Respondents talked 
about how lack of communication between the partners hindered the progress of 
the project and implied lack of commitment or common interest in the project. They 
added instances when funds were not used properly or brand abuse cases 
happened, which led to the termination of partnership.  Regarding brand abuse, KI 
referred to cases of (intentional or unintentional) unauthorized use or misuse of 
partner’s logo, misappropriation of branded content, unsubstantiated reference to 
partnership, inaccurate publication of affiliation, and other breaches of name use 
and intellectual property rights. KI discussed how lack of cultural understanding 
from both sides created misunderstandings and raised concerns about trust and 
motives. 
Examples/Quotes: Challenges & Deal-breakers    KI#, Country 
“A mismatch in your aims and your needs is always a 
challenge” 
6 Various 
“Deal-breakers are not having same mission, financial 
looseness, breach of academic integrity” 
27 Various 




“A deal breaker is one that the leader really won't step up” 25 Various 
 
A summary of challenges is listed below: 
• Internal  
o Lack of communication or miscommunication 
o Destructive organizational culture (distrustful, closed, etc.) 
o Politics 





o Misalignment of mission and goals 
o Academic and scientific integrity breaches, brand abuse 
• External: 
o Culture, lack of cultural understanding 
o Corruption, misuse of funds 
o Political instability, safety and security concerns 
o Inadequate adherence to standards and principles 
• People-related:  
o Lack of effective communication  
o Inefficient leadership  
o Dishonesty 
Advice for future planners  
ü Identify international collaborators early 
ü Maintain ongoing communication  
ü Develop an exit strategy and sustainability plan 
ü Define and agree on shared assumptions and expectations from the 
start 




Three overarching concepts include future planners, believing in the dream, 
and building arguments with data. These are discussed below:  





a. Future Planners 
Applying the concept of “voice of the customer” found in Lean/Six Sigma 
methodology, the findings of the study reflected not only the experiences of leaders 
who have already established a new PCU in a LMIC (Group I) and those involved 
in the process (Group III), but also the perspective of future users (Group II) who 
are currently in the process of planning a new PCU or exploring strategic 
considerations related to the PCU. The “voice of the customer” principle urges 
Lean/Six Sigma practitioners to incorporate the voice, expectations, comments, 
preferences, questions, and needs of internal and external customers when 
designing or improving a process, as they are the receivers of the output of the 
process.178,180,181 Incorporating the study results into the development of a 
stakeholder-driven planning framework that reflects real-life experiences and 
needs enhances the credibility of the planning model and serves as a practical tool 
for future planners. 
A summary of the questions that KI in Group II and pre-dissertation 
interviews wanted to ask to leaders in Group I and III who had experience with 
planning a new PCU are listed below. Respondents talked about needing a 
roadmap (KI from Kenya), not being familiar with how to do financial and bed 
capacity calculations (informal KI from Ethiopia), needing to know how to start 
thinking about the key elements (KI from Bulgaria), and inquiring about first steps 
(KI from Armenia).  





• What is key for me to know in the beginning?  
• Who needs to be involved in the beginning? 
• How do I prioritize activities? 
• How do I start? how do you operationalize it?  
• How do I know how big of a place I should start with? 
• What players I should look for? Who the players should be?  
• How much will it cost? 
• How do I know how big of a PCU I need? 
• What data do I need to start planning? What data do I need to convince 
others? 
b. Believing in the “dream” 
 Respondents in Group I and II consistently talked about their “dream” to 
improve the care of children with cancer in their countries. The KI emphasized that 
leaders, team members, and stakeholders need to believe in the dream and that it 
is possible for their country to change the status-quo. The KI from Guatemala said 
that he started with “some believers who convinced other believers.” He added that 
believing in the dream is essential before starting “because if you think something 
is impossible in the beginning, then it's not possible. But if you think it's possible, 
then you fight to make it happen.”  The KI from Egypt underlined that their dream 
was to create high-quality, free care for children with cancer, not to have a building.  
c. Building an argument with data  





project moves was instrumental in its implementation but also for program 
evaluation purposes. They highlighted how having a measurable baseline helped 
them show tangible results of outcomes and overall impact for patients and society. 
Respondents in Group I explained how being able to quantify the value that their 
PCU created in the lives of children, health system, and country enabled them to 
build trust among stakeholders, receive more donations from funders, increase 
political support, and maintain morale. Experts in the USA from Group III stated 
that when they were planning a new PCU or expansion of existing PCU, they built 
out for the predicted need they would have years ahead and this served them as 
leverage to gain buy-in from leadership about space and convince stakeholders 
for funding. A KI from Guatemala interviewed during the pre-dissertation phase 
highlighted that being able to show valid data also helps when applying for loans 
from banks and companies that will perform due-diligence before contracting with 
the new PCU and its leadership team.  
Examples / Quotes: Data KI#, Country 
“If we show results, society will start noticing this difference and 
the medical community will really believe in this, things will 
change”   
2 Mexico 
“To gain buy-in, you need to show data, not a claim or feeling” 4 USA 
“Having a report with reliable data helps us get support from 
hospital administration and show magnitude of problem” 
15 Myanmar 
“It takes a lot of work but you have to show results” 29 Guatemala 
“I think this is the thing that gives the trust to the people to 
continue to donate, and to help to sustain the project, and it's 
not only the number. The quality of service” 
30 Egypt 
“Data is important to document and show results. Go back and 
ask for more money” 
21 Laos 






CHAPTER 6. DISCUSSION & RECOMMENDATIONS 
  
Strengthening local PCU planning in LMIC and establishing sustainable 
PCU enhances access to childhood cancer care. This contributes to the 
improvement of outcomes for children with cancer globally and bridges the survival 
gap between LMIC and HIC. Yet, few studies have explored the experiences of 
planners who have successfully worked to create a PCU in a LMIC and assessed 
the key considerations in the planning process. There is also little guidance on 
identifying challenges in the process and limited opportunity for those involved in 
the process to share their lessons learned with future planners and assist them in 
the process.  
 Previous research has focused on narrower medical, technical, or 
construction aspects of planning for a PCU, looked at creating a national cancer 
control plan from the government perspective, or highlighted how twinning 
programs may assist in the improvement of clinical outcomes at a new PCU. There 
is little documentation on the elements that need to be in place early on in the 
process when planners are still struggling to materialize their vision.  
The dissertation starts to fill the gap by documenting the experiences of 
planners, incorporating questions of those currently in the process, and integrating 
knowledge from individuals who assisted planners in the process. It uses a 
qualitative research case study approach with multiple context studies. The 
research took place between August 2016 and January 2017, and combined work 





conducted during directed study courses and independent research. The findings 
are structured using a modification of Porter’s Value Chain Model which describes 
how important strategic elements are involved in a process and linked in order to 
bring value or benefit to the customer or recipient of the process.  
The primary questions of the study were as follows: 
Research Question #1: What are the key initial strategic elements that need to 
be identified for the effective planning of a new pediatric oncology unit in a low-
resource setting? 
Research Question #2: What are the key barriers and facilitators that need to be 
considered during the planning of a new pediatric oncology unit in a low-resource 
setting? 
Key Findings & Porter’s Value Chain Model Adaptation 
Findings from the in-depth interviews allowed for the development of a 
modified Porter’s Value Chain Model for the establishment of PCU in LMIC. The 
adapted conceptual framework is a step-wise model and suggests that nine key 
elements need to be present in order to effectively plan a PCU in a low-resource 
setting (listed in Figure 24 below). The nine elements are grouped into structure 
elements (essential elements for the internal foundation of the organization) and 
execution elements (operational elements for the implementation of the plan). 
These elements are presented in the modified Porter’s Value Model below and 





in the planning process of a new PCU. Although none of the respondents in Group 
I or II had a formal strategic plan laid out at the beginning or followed a clearly 
outlined roadmap in the planning process, they all agreed on the necessity to 
systematically incorporate these key elements early on.  
 
Figure 25. Modified Porter's Value Model (Research Question #1) 
 
Key findings from the qualitative data addressing Research Question #2 
are summarized below: 
Research Question #2: Summary of Perceived Challenges 
Internal: • Rigid institutional hierarchy 
• Communication: lack of or non-transparent  
• Organizational politics 
• Culture: distrust, suspicion, resistance to change, 
unwillingness to learn 
• Lack of experts in pediatric oncology 
• Lack of team diversity and teamwork 
• Lack of transparency and fiscal accountability 





External: • Corruption 
• Culture: stigma, misconceptions about cancer, 
dishonest communication 
• Lack of national regulations, protocols, guidelines 
• Bureaucracy 
• Rigid institutional hierarchy 
• Brain-drain 
• Government instability and turnover 
• Unstable financial environment 
• Natural disasters 
• Security and safety concerns 
• Political and power games 
• Donor and political pressure  
• Political impetus to just build a building 
• Distrust and suspicion among competitors 
• Shortage of trained professionals 
• Lack of systematic planning mentality 




• Ineffective leadership: dishonest, micromanaging, lack 
of communication skills, unfocused   
• Inability to convince stakeholders and donors, and 
ensure buy-in 
• Impatience 
• Resistance to change  
• Lack of humility 
• Self-serving agendas  
 
Research Question #2: Summary of Perceived Facilitators 
Internal: • Deep knowledge in pediatric oncology  
• Clear mission, vision, and values; mission-alignment 
• Organizational culture: open, transparent, blame-free 
• Transparency 
• Strong teamwork and Board of Directors 
• Leadership buy-in 
• Communication: open, transparent, culturally sensitive 
• Team diversity 
• Respect for data-driven and long-term planning 
• Willingness to change and learn 
• Being the main referral center 





External: • Culture: open to change and innovation 
• Stable political, economic, social environment 
• Transparency  
• Political support  
• Supportive and progressive Minister of Health  
• Stakeholder buy-in 
• International collaborations 
• Strong philanthropic culture  
• Appreciation for systematic planning 




• Effective leadership: open, trustworthy, empowering, 
mission-aligned, visionary, change agent 
• Communication skills: clear, open, consistent 
• Passion and perseverance  
• Patience  
• Trustworthiness  
 
Theoretical Implications 
The modified Porter’s Value Chain Model is proposed as a conceptual 
framework for future research and implementation of efforts related to planning a 
new PCU in a low-resource setting. The adapted model expands the current 
understanding of Porter’s Model and builds upon its principles regarding hierarchy, 
linkages, and dynamic nature of the elements.   
Hierarchy: The modified model aligns with the hierarchical nature of 
Porter’s Model as it groups the nine elements in two sets of elements, one 
depending on the other and, thus, needing to happen after the other:  
a) Four Structure Elements: leadership, mission, planning guidelines, and 
organizational structure, and  
b) Five Execution Elements: situation analysis, medical model, financing, 





Data showed that the nine elements need to be defined and coordinated as 
two groups in two phases, as execution elements depend on structure elements. 
The four elements in the structure elements group need to be defined first as they 
will dictate how the five elements in the executive elements group are developed 
later. For example, the leadership team needs to be assembled and the 
organizational structure needs to be defined before international partnerships are 
formed and stakeholders are engaged. There needs to be a team first to lead 
efforts in order to reach out to international partners and explore potential 
collaborations. In addition, the leadership style will affect the types of stakeholders 
who are approached and the engagement strategies that will be developed.  
Linkages: The results illustrated that all nine elements need to be in place 
and that they are linked with each other and dependent on each other. In adapting 
Porter’s Model and identifying elements, linkages were also illustrated. 
Participants demonstrated how linkages were created among the elements and 
highlighted the importance of elements working synergistically, not independently, 
to create a sustainable and effective plan for the PCU.   
For example, effective leadership contributed to active stakeholder 
engagement and strong international collaborations. The scale of the PCU (i.e. 
number of beds) was linked to the Situation Analysis Element as participants had 
first to think of data in the macroenvironment (incidence of the disease, population, 
etc.) in order to estimate how many new pediatric oncology cases they would 





mechanism and based on the mission and vision. Respondents emphasized that 
omitting one of these key elements or underestimating the element’s role in the 
process or guiding the planning process only on one of the nine elements will likely 
lead to plans not being materialized, waste of resources, or a PCU that is not 
sustainable in the future and does not bring value to patients.  
Dynamic Nature: The modified model reflects the complex process of 
establishing a new PCU, for the first time in a country in many cases. The elements 
are not static or isolated, but dynamic in nature and interactive. Elements may 
change in the future or be different depending on the context. For example, if a 
new insurance system is created or tax-exemption for donations is enacted in the 
country, financing considerations will change. Or, a stakeholder who is considered 
an opponent may turn into an ally in the future, implying different engagement 
strategies.   
 
It is unlikely that a PCU can be established in a LMIC without taking into 
consideration these nine essential components that will impact the planning 
process and the subsequent operations and sustainability of the PCU. Future 
planners are advised to consider these findings when planning a new PCU and 
benefit from the lessons learned that past planners have shared. Results from the 
dissertation enabled the development of a stakeholder-driven, systems-based 
planning framework. Leaders are urged to consider the theoretical implications of 





the modified model which underline the hierarchical, dynamic, and interactive 
nature of the nine elements and allow for time to develop these elements and 
implement them.  
Practice Implications 
Planning for the establishment of a PCU in a low-resource setting is a 
complex and time-consuming effort. Experiences from planners who have 
successfully established a PCU may provide important lessons that future leaders 
may use to facilitate the process while adapting to local context and infrastructure 
level of the PCU.  
Findings from the study may be reframed as concrete, practical guidelines 
which are embedded in the elements of the modified model as follows: 
Ø Recruit effective leadership team 
Ø Clearly define your mission, vision, and values 
Ø Establish planning principles based on best-practices 
Ø Develop your organizational platform as a Foundation/NGO 
Ø Analyze the current situation and assess the need 
Ø Define your medical model 
Ø Estimate costs 
Ø Analyze and engage stakeholders 
Ø Partner with international collaborators  
Moreover, once the key elements are identified and feasibility for the new 





strategic/business plan and possibly start preliminary fundraising efforts to assist 
during the initial phase of the planning. Laying out a written strategic plan could 
serve as a good opportunity to outline concrete details about the budget, clinical 
operations, integration of PCU in the existing healthcare system, relationship with 
a foundation/NGO, PCU status, medical model, communications plan, monitoring 
and evaluation plan, and such. Given that all respondents from Group I highlighted 
the importance of forming or partnering with a non-profit organization that supports 
the development and sustainability of the PCU, an additional next step would be 
for the planners to consider creating an NGO or NGO affiliation, and recruiting their 
first Board of Directors to jointly develop a strategic and business plan. Resources 
on strategic planning and business plan development are found in Appendix 13.  
  
This study provides a basis for further research in strategic planning for new 
PCU in a low-resource setting. It demonstrates the importance of documenting 
past experiences and incorporating the voice of future planners to reflect the areas 
where they need guidance.  
In addition to observing a lack of formal and evidence-based strategic plans 
in the process of planning PCU in LMIC, the dissertation revealed a gap in the 
following three research areas:  
1. Documentation and dissemination of planning and implementation 
strategies from PCU which have successfully established a PCU in a LMIC 





2. Systematic, data-driven planning public health interventions such as the 
establishment of a PCU in a LMIC 
3. Monitoring and evaluation in designing and implementing a plan to establish 
a PCU 
Although a randomized study cannot be implemented due to ethical 
considerations, it may be possible to identify a natural experiment to see if the 
model is predictive and test the hypothesis that the nine elements in the modified 
Porter’s Value Chain Model are key drivers of performance and efficiency of the 
PCU. The hypothesis can be tested to argue that when all nine elements are 
applied, the PCU is more likely to be successfully in its establishment and efficient. 
Metrics may include performance indicators for the hospital, in general, (such 
occupancy rate, turnover rate, profit margin, percentage of need met, etc.) and 
clinical indicators for the PCU (such as 5-year survival, treatment adherence, 
documented evidence of multidisciplinary team, use of standardized patient safety 
protocols, etc.).182,183,184,185,186 
In addition, further study is needed to explore the importance and role of the 
macroenvironment and local context in the process of planning, and to develop a 
tool to conduct a context analysis pertinent to pediatric oncology. The tool could 
help document how social culture (e.g. stigma), organizational culture (e.g. 
resistance to change), economic factors (e.g. openness to innovation), political 
history (e.g. norms towards authority), existing country and healthcare 





external environment facilitate or impede the strategic planning process. A 
hypothesis could be developed to test which factors in the macroenvironment are 
the most likely to lead to a successful and sustainable PCU and what specific 
contextual conditions are more conducive or discouraging establishing a new PCU. 
For example, how would the planning for the PCU be different in a post-Soviet 
country or within a newly established open market? Perceptions towards risk-
taking and receptiveness to entrepreneurship were areas discussed in the in-depth 
interviews and can be examined in future studies to see how they are related to 
success.  
A major theme mentioned by key informants was the role of philanthropy in 
the planning process of the PCU. Additional research may be conducted to explore 
past experiences in changing the perceptions and norms around philanthropy and 
investigate best practices and successful giving models as a fundraising and 
financing mechanism for a new PCU.  
 Furthermore, a comprehensive review of leadership styles and 
organizational behavior at existing PCU can be conducted to examine the role of 
the leader and the dynamics of the leadership teams on effective planning and 
PCU performance. Studies have been conducted in other organizations or 
contexts on the dynamics of leadership teams and have examined the relation 
between leadership style and organization performance or project 
success.187,188,189,190 It would be helpful to replicate these studies in a PCU setting 





Useful topics that may provide additional insight include a detailed assessment of 
the qualities of leadership that led to successful establishment of a PCU, available 
training resources for leaders and type of training needed for leaders, and a 
systematic approach on interactions among individuals within the PCU and within 
other organizations.  
 Additionally, researchers may wish to create an online toolbox with 
resources and guidelines on the topics included in the Appendices (e.g. financial 
resources, strategic planning, etc.). The resources listed in the Appendices are 
limited to the purpose of this dissertation but a wealth of resources is available for 
free and accessible online.  
 To further assist future planners to effectively map the key elements in the 
process, hands-on tools or educational modules may be developed that are 
adjusted to each country’s context. For examples, research is needed to describe 
the logistical steps involved in formulating the mission, vision and values during 
the early stages of the planning and study how these elements later impacted the 
operation of the PCU in the long-run and specific decisions. Studies have 
discussed the strategic planning process of organizations and how teams have 
moved through the process of finalizing their mission, vision, and values, but future 
planners may benefit from having a step-by-step guide on how to engage in this 
strategic planning exercise.191,192,193,194,195 This might include how to develop their 
mission, what discussion points to raise within their teams, who can help them 





debate among team members, how to know if their mission statement is powerful, 
etc.  
Finally, research can be conducted to expand on the recurring theme from 
the in-depth interviews which emphasized the human rights approach when 
planning a new PCU. Respondents felt the main impetus for change and personal 
motivation was derived from a commitment to equal access to care for all children 
with cancer and the belief that health is a basic human right. Further research may 
examine the definition of a human rights based approach, evaluate the impact of 
this approach, and examine whether different outcomes (clinical or performance) 
are achieved depending on the type of approach or impetus that led to the 
establishment of the PCU (human rights approach as opposed to a clinical- or 
profit- or market-based or other approach).  Examining cases when a human rights 
approach is applied is necessary to address the inequities in childhood cancer and 
integrate them in the broader public health agenda to bridge inequities globally.   
 
 
Next steps for the dissemination of the findings of this study include: 
1. Development of a guidebook. The purpose of this guidebook would be to 
promote a common understanding of the key strategic elements that are 
needed when planning a new PCU in a low-resource setting. I will share this 
manual with my colleagues at Dana-Farber Cancer Institute and Boston 
Children’s Hospital, international partners, and any leadership team that 





may be in the process of planning a new PCU.  
2. Publication of results in a peer-reviewed journal. I am planning to write 
a manuscript to summarize the results of the study and submit for 
publication to a peer-reviewed journal such as the Journal of Global 
Oncology (JGO) or Health Policy and Planning. Moreover, I will explore the 
possibility of preparing a second manuscript on stakeholders and submitting 
it to the American Journal of Public Health (AJPH) or Strategic Management 
Journal (SMJ).  
3. Publication of results during a major conference. I am planning to 
prepare a poster to submit at a major international conference, such as 
International Society for Pediatric Oncology (SIOP) or World Cancer 
Congress (WCC), on the challenges and facilitators.   
4. Preparation of an editorial: I am planning to draft an editorial to submit to 
the American Journal of Public Health (AJPH) or Lancet Global Health 
highlighting the gap in existing studies and resources about planning for 
PCU in LMIC and calling for closer, cross-sector collaboration between 
public health practitioners, clinicians, and strategic planners. 
5. Production of a communications toolkit: I am planning to collaborate 
with Persistent Productions to create a short video and PowerPoint 
presentation summarizing the findings of the study which would be publicly 












CHAPTER 7. CONCLUSION  
Data-driven, systematic strategic planning is essential in the process of 
establishing pediatric oncology units in low-resource settings. Identifying and 
applying the key elements in the strategic planning process is critical in the 
effective development of new PCU and contributes to improving pediatric oncology 
care. The lack of documentation of successful past experiences and limited 
understanding of important elements in the process hinders the knowledge transfer 
and poses additional barriers for leaders currently planning a new PCU. An 
evidence-based framework that summarizes the key elements in the process may 
fill a missing piece in the existing global pediatric oncology capacity-building area. 
Documenting the expertise of leaders from their past experiences and presenting 
guidance for future planners offers tangible advice for public health practitioners. 
Future planners are strongly urged to review the modified Porter’s Value 
Chain Model and apply the elements in their strategic planning process. Users of 
this study may choose to focus on individual key elements or all nine elements as 
a comprehensive, data-driven planning framework depending on their current 
planning stage or resources available. For example, a leader with a planning team 
already at their side and an NGO supporting the cause, may start by formalizing 
their mission and vision and, then, move forward with conducting a needs 
assessment. A leader in the very early, conceptual phase may use the findings in 
the dissertation to gain a preliminary understanding of the steps, timeline, and 





Gaining an understanding of the key elements in the planning process may 
serve as a practical, hands-on toolkit for planners, increase confidence within the 
leadership team, and guide the next operational steps of the PCU development 
such as budget, construction, staffing, etc.  
Bridging business concepts with public health principles promotes 
interdisciplinary collaboration and maximizes the expertise of managers and 
clinicians to create sustainable and efficient PCU, as explained in Figure 1 in the 
beginning of the dissertation.  The adapted Porter’s Value Chain Model illustrates 
how synergies between sciences may contribute to innovative ways to improve 
outcomes in pediatric oncology and enhance healthcare management capacity in 
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Interview Guide – Group I  
 
Strategic Planning/Leadership/Vision and Mission Formulation 
1. Can you tell me the story of your hospital? 
2. How did you formulate the decision for the new hospital? 
Probes:  
3. When was the first moment when you ... 
4. What was your vision and mission for the hospital back then? 
5. What compelled you to start thinking about building a new facility? 
6. What was the driving force behind the new facility?  
7. Would you say that there was one single person driving the plans / leading 
the process? 
8. What were the barriers in the beginning? What kept you going? 
9. How did you develop your mission, vision, and values? 
10. What were the first five steps you took to get your closest colleagues 
involved?  
11. What were the most important milestones in the history of the organization? 
12. What kept you going? 
13. How did you keep others/your team committed and excited throughout the 
process? 





14. How did you measure success? 
15. If you had unlimited money, what would you have done differently? 
16. If you have the opportunity to start again, what would you change? 
17. Detailed questions: 
18. Did you develop a business plan? 
19. Who was responsible for managing the project / assuming the role of project 
manager? 
20. Who was involved in the initial planning phase? 
21. Did you work with external consultants? 
22. Was there a project manager assigned? 
23. Who was the ultimate decision maker? 
24. Was there a person that was working close to you helping you in the process 
(a business colleague – your “number two”)?  
25. How did you know where to start and what were the specific steps involved 
(i.e. develop a budget, hire a consultant, etc.)? 
26. How did you choose your team? What qualities were most important for 
your team members while you were planning the new facility? 
Needs Assessment/Determination of Need/Rationale 
1. Can you tell me how you estimated the size of the new facility? 
Probes: 
2. How did you gather data about the country’s demographic, epidemiology 





a. What were the sources of the data?  
b. Was a local, regional or national cancer registry? 
3. How did you estimate how many new cases or beds do you need? 
4. How did you calculate inpatient and outpatient volumes? 
5. How did you decide which diseases you will treat and which clinical 
programs you will include? 
6. How did you decide which diseases to treat first and how many patients to 
gradually start admitting? 
7. How did you know what equipment is needed? 
8. Did you have to follow national or international standards or licensing 
requirements?  
9. How were the standard treatment plans developed? 
10. What would you advise hospital leaders in other countries who are in the 
process of planning a new facility regarding estimating the size of the new 
facility, especially when there is no cancer registry or national records? 
Financial Planning/Cost Estimate 
1. How did you estimate the cost of the new facility? 
Probes: 
2. Did you have a budget (construction, start-up, operating)? 
3. Have you had developed a budget before? 
4. How was the initial budget planned?  





6. What were the barriers in calculating the cost of the new facility? 
7. If you have the opportunity to start again, what would you have included in 
the initial budget from the beginning? What steps in the financial planning 
process would you change? 
8. What would you advise hospital leaders in other countries who are in the 
process of planning a new facility regarding estimating the cost of the new 
facility early on? 
Financing & Fundraising 
1. How did you finance the new facility? 
Probes: 
2. What were your sources of funding ex government, donations, grants, etc.? 
3. Did you develop a fundraising strategy/campaign? If yes: 
a. How was the fundraising campaign originally organized? 
b. Who developed the campaign? 
c. Who participated in the campaign? 
d. What were the short term and long-term fundraising goals? 
e. How did you come up with a fundraising goal? 
4. What barriers did you encounter in the process? 
5. If you have the opportunity to start again, what would you have changed in 
terms of financing and fundraising? 
Hospital Facilities Planning & Design 






2. How did you decide about the location of the new facility? 
3. What steps were undertaken? 
4. Did you hire an architect/engineer firm? 
5. Who was involved in the process? 
6. How did you calculate how big (square feet/meters) you need? 
7. Who helped you with floor plans? 
8. What barriers did you encounter in the process? 
9. If you have the opportunity to design the facility again, what would you 
change?  
Human Resources 
1. Can you tell me how you estimated your staffing needs? 
Probes: 
2. How did you develop the staffing categories (medical, nursing, 
administrative, etc.)? 
3. How did you estimate how many full-time employees you need per staff 
category? 
4. When did you start hiring your first full-time employees (at which point in the 
process)? 
5. At which point did you develop an organizational chart?  
6. How did you develop job descriptions? 





8. How did you train new employees?  
9. How did you interview and select new employees?  
10. Who was involved in this process? 
11. What barriers did you encounter in the process? 
12. If you have the opportunity to start again, what would you change?  
13. What would you advise hospital leaders in other countries who are in the 
process of planning a new facility regarding estimating staffing needs early 
on? 
Board & Nonprofit Governance 
1. Can you tell me how the nonprofit organization was involved? 
Probes:  
2. How did you develop a Board of Directors? How did you choose the 
members to join the Board? 
3. How did you assign roles? 
4. How did you ensure engagement and retention? 
5. Did you have an External Scientific Advisory Board as well? If yes, how did 
you choose the members to invite to serve on the Board? 
6. Can you tell me more about the role of the Foundation in the development 
of the facility? 
7. Can you tell me more about the specific role of the Foundation in the 
everyday decision-making process, for example to hire a new person? 





9. What barriers did you encounter in the process? 
10. If you have the opportunity to start again, what would you change?  
11. What would you advise hospital leaders in other countries who are in the 
process of planning a new facility regarding forming a Board of Directors 
and their relationship? 
Partnerships & Affiliations 
1. Could you tell me more about your international partnerships with other 
oncology hospitals or foundations (ex St. Jude, Dana-Farber, World Cancer 
Foundation, etc.)?   
2. Could you tell me more about your affiliation with the local medical school 
or school of public health? 
3. Could you tell me more about the relationship with the Ministry of Health? 
Other Considerations 
Probes: 
1. Did you have an electronic medical records system from the beginning?  
2. Have you had experience in conducting clinical research before?  
3. How did you create the infrastructure for research capacity? How were the 
standard treatment plans developed?  
4. Were there any security or political instability issues in the country while the 
new facility was being planned?  
5. In what ways did you engage the local community, for example through 





6. Can you tell me more about procurement and drug supply? 
7. Can you tell me about the local accreditation and licensing requirements, 
and how they influenced your plans? 
8. Is there anything else that I didn’t ask you but you think is important to know 
or helpful to others who are currently planning a new facility? 
 
Interview Guide – Group II  
1. Can you tell me more about your plan for the new facility?  
2. If somebody could give you a roadmap, what would be in the first chapter? 
What would you want to know first? 
3. What do you worry the most? 
4. What keeps you up at night? 
Probes: 
5. Why is this project important?  
6. What problems is the project expected to solve? What needs will this new 
facility cover?  
7. What are the real issues at the core of the project?  
8. [if not a public entity] Why hasn’t the government developed a similar 
facility?  
9. What are your specific goals and objectives?  
10. Do you have a timeframe for this project?  





12. Who is involved in this project?  
13. Who are the main decision-makers? 
14. Is there a Project Manager (i.e. dedicated person to lead all planning 
activities)?  
a. If yes, can you please tell me about their responsibilities?  
b. If not, can you please tell me if a discussion about hiring a Project 
Manager was part of the planning process? 
15. What are your available resources?  
16. How are you going to measure success?  
17. What haven’t I asked you that you would like to share? 
18. What would be the 3 most important things that would you ask a PCU 
leader regarding developing a new facility? 
19. If you had unlimited budget, who would you hire first to help you with the 
planning phase? 
Stakeholders 
1. Who are the main stakeholders?  
2. How do various stakeholders’ goals differ?  
3. What deliverables do stakeholders expect from this project?  
 
Interview Guide – Group III  
Project Managers 






2. Can you please briefly tell me about your role here at [organization]? 
3. How would you describe a successful project? 
4. What was the most frustrating project? 
5. What was the most rewarding project? 
6. Have you been involved in renovation or expansion projects?  
7. What would you say are the critical elements of success? 
8. If you had to hire a PM to help you, what traits would you look for? 
9. Do you use a PM software or other tools to monitor progress? 
10. Were there instances that there were conflicting demands between you and 
the project sponsor/client? 
11. Were there cases that the scope changed significantly and why? 
12. With what other departments at the hospital do you work closely with? 
13. What advice would you give to somebody who is in the process of 
expanding their pediatric oncology unit or building a new one? 
14. What are the main drivers of cost? 
15. What type of information do you need before you start a project? 
16. What are the main phases of a project? 
17. What are the main reasons when a project is off in terms of budget or time? 
18. How do you assess risk when planning a new project? 
Architect Firms 






2. What documents or pieces of information do you request from your client to 
consider working with them? 
3. Do you have minimum requirements or criteria for clients? 
4. Do you always conduct a site-visit? 
5. What are the steps when you first meet with a potential client? 
6. What is the most useful piece of information to know from the beginning? 
7. Describe the ideal partnership 
8. What are the main drivers of cost? 
9. What are the most frequent initial questions you get and how do you 
respond? 
10. Was there a time when you didn’t do things according to the schedule? 
11. How do you assess risk when working with an international partner? 
12. How do you assess security or political turmoil issues when working with an 
international partner? 
13. How did you find that communication work best? 
14. What are the barriers and challenges when working with a hospital in a 
LMIC? 
Global Health Programs at teaching and academic hospitals 
1. Can you tell me about your last experience? What activities were involved? 
Probes: 





3. What is the most useful piece of information to know from the beginning? 
4. Was there a time when you didn’t do things according to the schedule? 
5. Describe the ideal partnership 
6. What was the most frustrating partnership? 
7. What was the most rewarding partnership? 
8. What is the most frequent request from a partner who is planning a new 
facility? 
9. How did you find that communication work best? 
10. What were the benefits for your academic institution? What were the 
reasons people benefited? 
11. How do you assess risk when working with an international partner? 
12. How do you assess security or political turmoil issues when working with an 
international partner? 
13. What are the barriers and challenges when working with a hospital in a 
LMIC? 
Consulting Firms 
1. Can you tell me about your last experience? What activities were involved? 
Probes:  
2. What was your Scope of Work and how did it evolve over time? 
3. What documents or pieces of information do you request from your client? 
4. Do you have minimum requirements or criteria for clients? 





6. What are the steps when you first meet with a potential client? 
7. What is the most useful piece of information to know from the beginning? 
8. Describe the ideal partnership 
9. Was there a time when you didn’t do things according to the schedule? 
10. What are the main drivers of cost? 
11. What is the professional background of your Consultants who work with 
similar projects? 
12. How do you assess risk when working with an international partner? 
13. How do you assess security or political turmoil issues when working with an 
international partner? 
14. How did you find that communication work best? 
15. What are the barriers and challenges when working with a hospital in a 
LMIC 
Foundations involved in global pediatric oncology 
1. Can you tell me about your last experience? What activities were involved? 
Probes: 
2. How do you choose a partner – what are the criteria and the steps? 
3. What is the most useful piece of information to know from the beginning? 
4. Was there a time when you didn’t do things according to the schedule? 
5. Describe the ideal partnership 
6. What was the most frustrating partnership? 





8. What is the most frequent request from a partner who is planning a new 
facility? 
9. How did you find that communication work best? 
10. What were the benefits for your academic institution? What were the 
reasons people benefited? 
11. How do you assess risk when working with an international partner? 
12. How do you assess security or political turmoil issues when working with an 
international partner? 
13. What are the barriers and challenges when working with a hospital in a 
LMIC? 
14. If a hospital in Zambia with no current pediatric oncology services came to 
you and asked for advice on how to start a new program, what would your 
first questions to them be? 
15. When you are providing funding to partners, what are the main drivers of 









Capacity Model for Pediatric Oncology Units in LMIC 
Introduction 
Rationale 
Projecting the number of new pediatric oncology cases in the country and the 
subsequent number of beds needed at a new pediatric oncology unit is one of the 
starting points in the strategic planning process. These figures will determine the 
major components of the business plan such as staffing levels, budget, operations, 
procurement, fundraising, etc. An evidence-based, data-driven analysis of current 
and future market situation will assist hospital planners align planning activities 
with expected patient volumes and PCU utilization patterns. 
 
In LMIC, a number of gaps exist in the healthcare, economic, political and business 
context that underline the need for a capacity project model. Decisions on the 
establishment of new unit and number of beds are frequently not based on data-
driven scenario analysis, and business and public health experts are often not 
included in the decision-making process until late, if at all. 
 
Realizing the need to, first, systematically assess the size of the new unit and, 
then, concretely calculate the projected number of inpatient and outpatient visits 
will help hospital planners avoid long-term consequences of developing a facility 





that exceeds or does not meet demand. In addition, filling the gap in the current 
healthcare system with a facility that adequately and efficiently covers the needs 
of the population, improves the system’s performance and strengthens its various 
components such as financing, leadership, workforce, etc. 
 
Developing a model to estimate capacity for a new PCU in an underdeveloped or 
developed country will, therefore, assist decision-makers to determine whether a 
new facility is feasible and, if yes, quantify the number of inpatient beds needed at 
the new facility.  
 
Who May Use the Model 
The model can be useful to hospital leaders (administrators, planners, managers), 
international and local foundations which provide funding for hospital development, 
government officials who are planning a national oncology facility, and academic 
or healthcare institutions which develop capacity-building programs in low-
resource countries.   
 
Background 
Considerations/Trends that may influence capacity calculations 
• Increase of childhood cancer awareness, decrease of stigma 






• Introduction of universal health coverage 
• Changes in percent of people having private insurance or private insurance 
coverage 
• Changes in epidemiologic trends (ex. comorbidity factors, increase in risk 
factor) 
• Changes in demographic trends (ex. increase in live births per year) or 
population pyramid (ex. younger population) 
• Changes in treatment outcomes (ex. survival rate, abandonment rate) 
• Increase in early and accurate diagnosis due to improved knowledge, better 
diagnostic equipment, etc. 
• Establishment of or high-quality national, population-based cancer registry 
• High-quality national surveillance and vital registration systems 
• Market forces  
• Government laws regulating licensing or operation standards for private and 
public oncology facilities 
• Changes in nonprofit industry supporting pediatric oncology patients and 
families (ex. providing additional support for transportation, housing, food). 
• Improved transportation access to oncology facilities (ex. new road system, 
more affordable train tickets) 
• Changes in PCU structure and capacity (ex. renovation of existing unit, 
creating of new ward) 





• Increased number of trained pediatric oncologists and nurses 
• Currency rate fluctuations impacting taxes and prices of imported drugs, 
supplies and equipment 
• Migration trends and brain drain (ex. physicians, nurses and skilled 
personnel leaving the country to work abroad) 
• Change in the strategic or operations goals of the PCU (ex. target 
occupancy rates decrease or target market share increases) 
 
Challenges in Data Sources 
Low-quality, inaccurate, or non-existent data sources contribute to the challenges 
in gathering data on population and demographics, and cancer epidemiology in 
LMIC. The International Agency for Research on Cancer (IARC) notes that the 
international incidence of childhood cancer may be significantly higher than 
estimated numbers and that there are significant differences in disease patterns176. 
Incidence and prevalence data reported by GLOBOCAN tends to be lower than 
actual numbers in low-resources countries174.  
 
In addition to incomplete or inaccurate incidence and prevalence data, data 
sources in LMIC may lack information on survivorship, lifetime admissions, long-
term remission and relapse patterns. It is therefore difficult to calculate how much 
care needs to be delivered at the new unit after the first couple of years of treatment 





How to Use the Model 
 
Structure of the Model 
I have constructed a simple Excel-based computer model that includes a two-part 
calculation scheme. The two parts may be used independently depending on the 
needs of future planners and data already available.  
• Part A: the projected number of new pediatric oncology cases per year in 
the country and at the PCU  
• Part B: the subsequent number of beds required to treat these new cases   
The model combines data from four different sources: 
1. Population Science and Demographics  
2. Epidemiology of Pediatric Oncology 
3. Hospital Utilization 
4. Market/Demand 
It is recommended that calculations take into consideration the strategic goals of 
the organization and align with the mission that drives hospital operations.  
 
Model Parameters 
Some parameters mentioned below are necessary to be able to process the Model 
i.e. the eleven data points mentioned in the previous section. Additional 
parameters are included in order to educate the Model and provide a more 














The number of people actually living 
in the country.  This includes all 
residents of the country or all persons 
present in the country at the time of 
the census197. This number may be 
lower than the de jure population 
(citizens with a right to live in the 
country). International and national 
sources are used for best 
comparison.  
Millions  World Bank; and 
country’s National 
Statistical Service  
Population 
0-14 
The number of children and 
adolescents between the ages of 0 
and 14 living in the country.  
International and national sources 
are used for best comparison. 
Thousands 
or millions  
World Bank; and 
country’s National 




The percent of children and 
adolescents between the ages of 0 
and 14 over total population in the 
country.  International and national 
sources are used for best 
comparison. 
Percentage World Bank; and 
country’s National 
Statistical Service  
Population 
under 5 
The number of infants and children 







Birth rate The crude birth rate of an area is the 
number of births actually occurring in 
that area is a given time period, 
divided by the population of the area 
as estimated at the middle of the 









The number of live births taking place 












Total number of children that would 
be born to each woman if she were to 
live to the end of her child-bearing 
years and give birth to children in 
alignment with the prevailing age-












by totaling the age-specific fertility 
rates as defined over five-year 
intervals199.  
2. Epidemiology Data 
Incidence 
Rate 
The number of new cancers of 
pediatric oncology occurring in 
children under 18 or 21 years old 
during a year, usually expressed as 
the number of cancers per 100,000 
population at risk200,201. 
Incidence rate = (New cancers / 













The number or percent of children 
under 18 or 21 years old alive on a 
certain date in a population who 
previously had a diagnosis of the 
disease. It includes new (incidence) 
and pre-existing cases and is a 
function of both past incidence and 
survival.  
Percentage GLOBOCAN; 
MOH; or National, 
population-based 
cancer registry 
# of New 
Pediatric 
Cases 
The crude number of new pediatric 
oncology cases diagnosed in 
individuals under 18 or 21 years old 





cancer registry; or 
hospital-based 
cancer registry; or 
estimate 




The crude number of pediatric 
oncology cases in individuals under 
18 or 21 years old who were not 




3. Hospital Utilization Data 
# of New 
Pediatric 
Cases 
The number of new, single pediatric 
oncology cases diagnosed at the 











The total number of days admitted at 
the facility per pediatric oncology 










The total number of pediatric 
oncology patients admitted at the 













The average number of nights the 
patient remained in the hospital per 
admission202.  
Days Facility records 





The percentage of beds occupied by 
patients in a defined period of time, 
usually a year. It is a measure of 
utilization of the available bed 
capacity203,204. 
Percentage Facility records 
(electronic or hard 
copy) 
4. Market/Demand Data 
Market size The total number of new pediatric 





The proportion of the market (total 
number of pediatric oncology cases) 
seen at the facility per year. 
Percentage Industry records, 






The proportion of the market (total 
number of pediatric oncology cases) 
seen at the primary competitor’s 
facility per year. The competitor may 
be a private or public facility. 
Percentage Industry records, 






The proportion of all population in the 
country having access to 
public/social insurance.  









The proportion of all population in the 
country owning private insurance. 










The proportion of new pediatric 
oncology cases seeking treatment 
abroad per year. Patients mainly go 
to Russia, Israel, Iran, Germany, 
Netherlands, Austria, Belgium, 
France, Italy, Canada and the United 
States. 










How to Input Data  
Hospital planners will need to be able to answer the following questions and 
provide essential input on eleven data points, as indicated in the Excel in the end 
of this Appendix. If valid and reliable data does not exist, planners are encouraged 
to enter best guess estimates. The following table lists the types of data, questions 
to facilitate answering them, and input number where planners may enter their data 














What is your country’s population according to World Bank? 1 
What is your country’s population according to your national 
source (statistical service, Ministry of Health, etc.)? 
2 
What is your country’s population under 14 years old 
according to World Bank? 
3 
What is your country’s population under 14 years old 
according to your national source (statistical service, 
Ministry of Health, etc.)? 
4 




















What is the number of new cases per year (0-14 years old) 
in the country based on: 
 
- Existing data (national, population-based cancer registry, 
medical records, personal estimate, etc.) 
5 
- GLOBOCAN 6 
- Incidence in HIC 7 
- International standards 8 

















What is the number of new cases per year (0-14 years old) 
at the existing/projected PCU? 
 
- Existing data (national, population-based cancer registry, 
medical records, personal estimate, etc.) 
9 
- GLOBOCAN 10 
- Incidence in HIC 11 
- International standards 12 























What is the number of inpatient admissions per year? 13 
What is the average length of stay per patient per year 
(ALOS)? 
14 
What is the number of inpatient days per patient per year 
based on 5 admissions/year? 
15 
What is the number of inpatient days per patient per year 
based on 8 admissions/year? 
16 
What is the number of inpatient days per patient per year 
based on 10 admissions/year? 
17 
What is the expected average occupancy rate per year? 18 












What percent of all new cases per year (0-14 years old) in 
the country, does your facility treat (i.e. current market 
share)? 
19 
What percent of all new cases per year (0-14 years old) in 
the country, does your new facility would like to treat (i.e. 
target market share)? 
20 
What is the market share of the major competitors? 21 
What proportion of the patients have private insurance? 22 
What proportion of the patients go abroad for care? 23 















Are there any strategic factors that need to be taken into 
consideration, such as strategic goal to be the market leader 
and capture 50% of the market share; or goal to offer 











(% market share * number of new cases in the country) * number 
of inpatient days per year / 365 days = Average Daily Census 





Results from the pilot test (Armenia)  
For the purposes of this dissertation, I examined the case of Armenia and the plans 
to examine the feasibility of establishing a new PCU.  For fiscal year 2018, Armenia 
was considered a lower middle-income country according to the World Bank 
country classification system205. The following assumptions were considered in the 
simulation exercise: 
a) A typical pediatric oncology case will be admitted 5 times a year 
b) A typical pediatric oncology case will stay 8 days per admission (ALOS) 
resulting in 5 * 8 = 40 inpatient days per patient per year 
c) The planned PCU will treat 40% of all pediatric oncology cases in Armenia 
d) All other external factors and considerations (discussed below) stay the 
same (such as fertility rates, mortality rates, survival rate, access to care, road 
system, etc.). 
Users of the Model are encouraged to use their own assumptions.  
 
Scenario 1: Low-demand (baseline):  
In the low-demand scenario, two scenarios were examined:  a. numbers of total 
new cases per year from GLOBOCAN (i.e. 60); and b. the low estimate in the 
international standard annual incidence (i.e. 69). 
a. GLOBOCAN Data: Number of cases calculated as reported by GLOBOCAN, 






Incidence: 60 new pediatric oncology cases/year total in the 
country 
Current market share: 40% --> 60 new cases* 40% market share = 24 
new cases at the unit 
 
Utilization: 40 inpatient days per patient per year at the unit 
 
Formula: 40*24 new cases = 960 / 365 days = 2.63 Average 
Daily Census --> 3 beds needed 
# of Beds needed: 3 
 
 
b. International Standards: Low international standard annual incidence, typical 
inpatient utilization and current market share was assumed as follows: 
Incidence: 69 new pediatric oncology cases/year total in the 
country 
(low estimate* population) <14/million children; 
(120*573,420)/million 
Current market share: 40% --> 69 new cases* 40% market share = 27.6 
new cases at the unit 
 
Utilization: 40 inpatient days per patient per year at the unit 
 
Formula: 40*27.6 new cases = 1,104 / 365 days = 3.02 
Average Daily Census --> 3 beds needed 




The baseline scenario is the conservative, current setting of pediatric oncology in 
Armenia. Provided that present conditions continue, there will be a need of 3 beds 






Scenario 2: Medium-demand (intermediate):  
In the intermediate-demand scenario, two scenarios were examined:  a. number 
of total new cases per year based on past data and key informant interview findings 
(i.e. 80 cases); and b. the intermediate estimate in the international standard 
annual incidence (i.e. 77 cases). 
a. Existing data/KII: Medium-demand based on past data at existing facilities 
and findings from conducting key informant interviews, typical inpatient 
utilization and current market share was assumed as follows: 
Incidence: 80 new pediatric oncology cases/year total in the 
country.   
Current market 
share: 
40% --> 80 new cases* 40% market share = 32 new 
cases at the unit 
Utilization: 40 inpatient days per patient per year at the unit 
Formula: 40*32 new cases = 1,280 / 365 days = 3.50 Average 
Daily Census --> 3-4 beds needed 
# of Beds needed: 3 - 4 
 
b. International Standards: Incidence, market share and utilization levels 
were assumed as follows: 
Incidence: 77 new pediatric oncology cases/year total in the 
country.  This is the midpoint between low-demand 
scenario (69 new cases per year) and high-demand 
scenario (86 new cases per year). 
Current market 
share: 
40% --> 77 new cases* 40% market share = 30.8 new 
cases at the unit 
Utilization: 40 inpatient days per patient per year at the unit 
Formula: 40*30.8 new cases = 1,232 / 365 days = 3.37 
Average Daily Census --> 3-4 beds needed 






It was observed that even with an increase of approximately 15% in the number of 
new cases per year (from 69 per year to 80 per year), the average daily census 
would still not justify more than 4 beds needed. 
 
Scenario 3. High-demand (maximum): 
In the high-demand scenario, two scenarios were explored: a. incidence in a high-
income country such as the United States (17 per 100,000, i.e. 97 cases) and; b. 
numbers of total new cases per year according to high-estimates in international 
standards (i.e. 86 cases). 
a. Incidence as reported in HIC: The incidence in the United States was used 
as an example: 
Incidence: 97 new pediatric oncology cases/year total in the 
country 
 
Current market share: 40% --> 97 new cases* 40% market share = 38.8 
new cases at the unit 
 
Utilization: 40 inpatient days per patient per year at the unit 
 
Formula: 40* 38.8 new cases = 1,552 / 365 days = 4.27 
Average Daily Census --> 4 beds needed 
# of Beds needed: 4 
 
 
This scenario used local numbers (i.e. population under 14 years old) and 
prevalence in HIC countries.  For the purposes of the Model, the incidence in the 





Given Armenia’s population <14 (573,420 according to GLOBOCAN), the highest 
number of new cases would be around 97. Formula used as follows:  
Incidence rate = (New cancers / Population) × 100,000 
 
b. International Standards: Incidence, market share and utilization levels were 
assumed as follows: 
Incidence: 86 new pediatric oncology cases/year total in the 
country 
 
Current market share: 40% --> 86 new cases* 40% market share = 34.4 
new cases at the unit 
 
Utilization: 40 inpatient days per patient per year at the unit 
 
Formula: 40*34.4 new cases = 1,376 / 365 days = 3.77 
Average Daily Census --> 4 beds needed 
# of Beds needed: 4 
 
 
This scenario explored what happens if the country optimizes early and accurate 
diagnosis, strengthens its health system, quality population-based cancer 
registries exist, and the PCU implements a solid public awareness campaign.  
 
Discussion 
Assuming the high-estimate according to international incidence or an incidence 







In summary, the pilot test of the Model on Armenia with multiple case scenarios 
and sensitivity analysis, indicated that the range of beds ranged from a minimum 
of 2.63 to a maximum of 10.68. Hospital planners in Armenia may use this exercise 
to modify assumptions and proceed to future decisions based on the Model 
calculations. Other planners may use this Model to calculate their own scenarios 
and facilitate the planning process of the new PCU. 
 
Recommendations for next steps 
 
One of the first implications of this model is the understanding that estimating the 
size of a PCU depends on tracing and measuring a series information pieces from 
a diverse set of data sources from population data, epidemiology, market trends 
and hospital utilization data. Analyzing three scenarios allows hospital planners to 
realize whether a new facility is indeed needed and feasible and, if yes, at which 
capacity level.  
 
As countries in LMIC develop national, population-based cancer registries, 
national surveillance systems, electronic medical record systems and capability to 
triangulate data sources, this model will be enhanced with more reliable and valid 









































































Element 1. Leadership  
• Who is the champion? 
• Who is leading this effort? 
• Who are the leadership members? 
• Who needs to be involved? 
• What makes a good leadership team? 
• What qualities characterize a good leader? 
• What qualities are attributed to a strong leadership team? 
• Why is effective leadership important? 
 
Element 2. Mission, Vision & Goals 
• Why are we doing this? 
• Why is this PCU needed? 
• What goal will this new PCU serve? 
• Where do we want to be in 5, 10, 20 years from now? 
• On what values will be build our project? 
• Why is this PCU needed? 
• What are we trying to achieve? 
 
Element 3. Planning Principles 
• How are we going to plan for this effort? 
• How do I start? 
• Where will we base our decisions? 
• What is the risk of starting without a plan? 
• Why is a plan important? 
• Why are planning principles important? 
 
Element 4. Organizational Platform  
• What is the organizational platform needed? 
• Why is it important to form or work closely with a Foundation/NGO? 
• What is important when forming or working closely with a 
Foundation/NGO 




Element 5. Situation Analysis Data  





• What is the problem? 
• How big is the problem (prevalence, incidence, etc.)? 
• Why is it a public health problem? 
• Who is currently solving the problem and how (competition, patients going 
abroad for treatment)? 
• What is the current pediatric oncology situation in the country? 
• Is there problem big enough to justify the establishment of a PCU? 
• What resources exist in the environment to help solve the problem? 
(technology, road system, internet, etc.) 
• What are the characteristics of our population? (demographics, socio-
economic status, comorbidities, education level, access, etc.) 
• How many new pediatric oncology cases do we expect per year? 
• Of all the new pediatric oncology cases per year in the country, what 
percent do we expect to receive at our PCU? 
 
Element 6. Medical Model 
• What are we going to do to solve the problem? 
• How much of the problem will we solve? 
• Services: What care services will we offer (medical, diagnostic, etc.)?                    
• Status: What type of PCU do we envision?                 
• Scale: How big of a PCU do we envision? How many beds do we plan 
for? 
• What are our assumptions? 
 
Element 7. Financing 
• How much does it cost to address the problem?  
• How is childhood care currently being paid for? 
• How much does it cost to treat a child with cancer? 
• What is the treatment cost per patient? 
• What costs do we need to consider in this phase? 
• Who is currently paying to solve the problem? 
• What expenses are currently covered (type, percentage, etc.) and by 
whom? 
• Is this project financially feasible? 
 
Element 8. Stakeholders 
• Who else is needed to solve the problem? 
• Who are the stakeholders involved? 
• Why stakeholders do not want to solve the problem? 
• Who do we need to engage and convince? 
• Who is likely to help or impede our efforts?  






Element 9. International Partners 
• Who else is needed to solve the problem? 
• Why are international partnerships important? 
• What makes a strong collaboration? 
• How do we transfer best practices? 









Note: Mission statements are publicly available at each organization’s website. 
Organization Country Mission Statement 
Amelia Project  Myanmar Help change lives by offering free 
transportation to adults and children in need 






To offer medical care to all children with 
cancer207  
AYUVI Guatemala To continue being a competitive team 
dedicated to the creation of income 
generating proposals, and through them 






USA Provide the highest quality health care. Be the 
leading source of research and discovery. 
Educate the next generation of leaders in 
child health. Enhance the health and well-




Armenia Act as a link connecting pediatric cancer 
patients in Armenia with the life-saving 
medical advances and resources available in 
the United States211 
CCHE 57357 Egypt Building a sustainable foundation to prevent 
and combat cancer through evidence-based 
research, smart education and free quality 
healthcare provided with passion and justice 
to alleviate the suffering of children with 




USA To provide expert, compassionate care to 
children and adults with cancer while 
advancing the understanding, diagnosis, 






To provide resources to Egyptian hospitals 
and non-profit organizations focused on 
cancer in the areas of patient care, scientific 
advancement and education214 











HITO Mexico Serve our girls, boys and adolescents with 
disability and cancer, promoting our human 
values through actions that promote and 









Promote amicable and cooperative relations 
and mutual exchange by rendering support for 




USA To provide a preferential option for the poor in 
health care. By establishing long-term 
relationships with sister organizations based in 
settings of poverty, Partners In Health strives 
to achieve two overarching goals: to bring the 
benefits of modern medical science to those 
most in need of them and to serve as an 







Philippines We are a community of committed volunteers 
generating resources in support of the health 
and welfare of the Filipino people through the 
various projects of the Philippine General 
Hospital as the national university hospital in 





USA To advance cures, and means of prevention, 
for pediatric catastrophic diseases through 
research and treatment. Consistent with the 
vision of our founder Danny Thomas, no child 
is denied treatment based on race, religion or 





To raise critical funds and awareness, inspiring 
a more inclusive, accepting world for children 
with disabilities and their families while 





USA To create a healthier future for children and 
women throughout our global community by 
leading in patient care, education and 
research222 















Tanzania Working within the National health frame work 
in Tanzania, provide continuing medical 
education for local professionals, implement 
programmes to deliver top quality care, both 
medical and psychosocial, and extending out-
reach until all children with cancer in Tanzania 
have been reached223 
UNOP Guatemala Offer quality services and treatment to 





To improve diagnosis, treatment and support 
for children with cancer, and their families, in 








Organization/Topic Resource Title and Source 
American Academy of 
Pediatrics (AAP) 
Guidelines for Pediatric Cancer Centers226 
 
Association of Pediatric 
Hematology/Oncology 
Nurses (APHON) 
Evidence Based Practice Guidelines227 
Children's Oncology 
Group (COG) 
COG Supportive Care Guidelines228 
Facilities Guidelines 
Institute 
Guidelines for Design and Construction of 
Hospitals and Outpatient Facilities36 
Joint Commission Planning, Design, and Construction of Health Care 
Facilities229 
Guiding Principles for the Development of the 
Hospital of the Future230 
National Cancer Institute Psychosocial Guidelines in Pediatric 
Oncology231  
SIOP  SIOP Nursing Group Baseline Standards232,233,234 
SIOP SIOP Working Committee on Psychosocial Issues 
in Pediatric Oncology235,235 
Psychosocial Standards  Standards for the Psychosocial Care of Children 
With Cancer and Their Families236 
Pediatric Psycho-oncology Care: Standards, 
Guidelines and Consensus Reports237 
Implementing the psychosocial standards in 
pediatric cancer238 
WHO Essential Medicines for Cancer239,240 









Examples & Tools 
Organization Resource Title and Source 
 
Examples 
Columbia University, USA Health Needs Assessment for Louga City, 
Senegal242 
 
Health Resources and 
Services Administration, 
USA 
Promising Practices in MCH Needs 
Assessment: A Guide Based on a 
National Study243 
 
Maine Medical Center Assessment of Surgical Services at Hôpital 
Universitaire Justini en (HUJ), Cap Haitien, Haiti244 
 
UN Millennium Development Goals Needs 
Assessments. Country Case Studies of 





Millennium Development Goals (MDGs) Needs 
Assessment for Nepal 2010246 
 
Various Gambia RBM Needs Assessment247  
 
Tools 
American Society of 
Clinical Oncology 
Determining the Best Model for You: Conducting a 
Needs Assessment248 
 
Maternal and Child Health 
Bureau 
Assessment of Health Status Problems. Self-
Instruction Manual249 
 
National Institute for 
Health and Clinical 
Excellence, UK 
 
Health Needs Assessment Guide250 
Royal College of 
Obstetricians & 
Gynaecologists, UK 
Health and Training Needs Assessment. Global 
Health Toolkit251 
 





HealthCompass How to conduct a situation analysis252 
 
UN Needs Assessment Coordination Tools253 
 






Capacity Assessment Methodology255 
 
University of San 
Francisco  
 
TOWS Matrix Tool for Situation Analysis256 
USAID The Health System Assessment Approach:  A 
How-To Manual257 
 
WHO Tool for Situational Analysis to Assess Emergency 
and Essential Surgical Care258 
 
WHO Community health needs assessment an 
introductory guide for the family health nurse in 
Europe259 
 
WHO Everybody's business: strengthening health 
systems to improve health outcomes : WHO's 
framework for action 260 
 
WHO & Alliance for Health 
Policy and Systems 
Research 












Frameworks, Theories and Approaches  
• WHO Health Systems Framework262,263 
 
Figure 26. WHO Health Systems Framework 
Figure reprinted from WHO Health Systems Framework website262. 
 
• Social Ecological Model264,265,266,267
 
Figure 27. Social Ecological Model 





• Health System Context Analysis Framework269,270,271 
 
Figure 28. Health System Context Analysis Framework 





• Precede-Proceed Model272,273,274 
 
Figure 29. Precede-Proceed Model 






Health Systems Assessment Checklist for PCU in LMIC 
I consulted resources on health systems strengthening and created a sample 
dashboard to assist users assess the healthcare system based on the health 
systems strengthening building blocks framework261. I used the illustration 
reprinted in Figure 19 and 20 which, in addition to the six building blocks, they 
highlight the role of “people” as well. This way, patients and families are at the 
center of the process and relate to Porter’s Value Chain Model where the goal is 
to create value for the patients. Figure 19 depicts the dynamic architecture and 
interconnectedness of the building blocks within the healthcare system and Figure 
20 includes concepts such as participation and transparency.  
 
The basic checklist serves as an example of how planners can brainstorm on this 
element with their team members and includes the following component: 
- Name of each building block 
- Data Type: 2-3 examples for each building block to demonstrate which 
types of information can be considered when assessing each building block. 
Users are encouraged to conduct an exercise with their teams to add more 
components 
- Country or PCU data: Users may input numbers, percentages, yes/no 
answers, ratios, or other data for each building block, if available 
- Tier-levels: A three-tier level option for each component of the building block 





the PCU; green for positive or helpful or the fact that data is available for 
this item; yellow for neutral; red for negative or restricting or lack of data 
available for this item. 
For example, there may be no national, population-based cancer registry in the 
country (C =     ) but the PCU may intent to create a hospital-based one (PCU 
=    ); or there may be trained pediatric oncology surgeons available in the 




Figure 30. Health Systems Building Blocks 







Figure 31. Assessing governance across the health system 







Health Systems Assessment Checklist for PCU in LMIC 
 Data Type C PCU    
People 
 Patients and families      
 Cancer-related NGO & donors      
 Awareness/stigma      
Service Delivery 
 # of new cases/year      
 # of other PCUs (competitors)      
 Tier / Infrastructure level      
Financing 
 Universal Health Coverage      
 % of treatment cost paid by government      
 Private insurance       
 User fees      
Human Resources 
 # of trained physicians      
 # of trained nurses      
 # trained public health practitioners      
Information 
 Cancer registry      
 Internet      
 Electronic Medical Records       
Governance 
 Definition of “child” (<years old)      
 National treatment protocols by Ministry      
 Tax exemption for donations      
 Licensing for PCU      
Medicines & Technologies 
 Access to opioids      
 Blood bank      
 Road system, transportation      








SWOT Analysis for the Strategic Planning for the Establishment of PCU in 
LMIC 
SWOT Analysis (Strengths, Weaknesses, Opportunities, Threats)276,277,278 
I prepared the following sample SWOT Analysis template to assist planners 
assess their strengths and weaknesses (internal environment), and opportunities 
and threats (external environment). The SWOT Analysis refers to the initial 
planning stage when leaders are considering the development of a new PCU. 
Once the PCU is established, a similar analysis may be performed to assess the 
SWOT after the first year of operation or if an expansion is being planned. The 
SWOT Analysis reflects findings from the in-depth interviews, literature review, and 







Figure 32. SWOT Analysis for the Strategic Planning for the Establishment of 







-Solid ties with stakeholders
-Collaborative culture
-Commitment to clearly defined 
mission and goals
-Committed and effective NGO and 
Board
-Openness to change and learning
-International collaborations
Weaknesses





-Lack of standardized guidelines
-Dishonest and ambiguous practices
-Lack of past or access to data
-Lack of planning culture or strategy
-Unclear or weak message/argument
Opportunities
-Unsaturated market










-Increase in global awareness of 
NCD
Threats
-Political and economic instability
-Low awareness or stigma
-Limited coverage
-Decreasing or inconsistent 
government reimbursement
-Corruption and nepotism
-Shortage of trained staff or lack of 
specialized university training
-New competitors
-Lack of national registry or 
statistical database









Medical Model Services planned to offer 








Types of Cancer 
   
• Solid Tumors 
• Hematologic Malignancies 
• Brain Tumors 
• Bone Marrow Transplant 

















Medical & Support Services 
   
• Infusion Area (Outpatient)  
• Pharmacy 
• Procedure Area (Outpatient) 
• Pathology Labs (Chemistry, 
Microbiology, Pathology, Coagulation, 
etc.) 
• Blood Bank 
• Diagnostic Labs (CT Scan, MRI, 
Ultrasound, Radiology, Nuclear 
Medicine, Radiation Therapy, etc.) 
• Operating Rooms  
• Surgical specialties (general, 
ophthalmology, orthopedics, etc.) 
• Anesthesiology  
• Emergency Department 
• Intensive Care Unit 
• Psychosocial Services 
• Child-Life Services 
• Pastoral Care Services 
• Palliative Care 
• Nutrition 
• Data Management 
• Quality Control 
• Infectious Control 
• Infectious Diseases 
• Other medical specialties (cardiology, 
ophthalmology, etc.) 

























































































    





Medical Model Services planned to offer 







Other Services    
• Catering 
• Waste Management 
• Custodial / Cleaning 

















Organization Type of Resource Website 
Advisory 
Board 







































































































































SPREADSHEET 1.  








Land (purchase, rent, lease, donation, etc.)     $ 
Construction (including guaranteed maximum 
price (GMP), mockup, etc.)     $ 
Project Complexity and Risk Assessment (PCRA)     $ 
Architectural & Engineering fees (A&E)     $ 
Construction Contingency %     $ 
Capitalized Financing Cost     $ 
Permits and Licenses     $ 
Furniture & Furnishings     $ 
Other: Abatement, artwork, audiovisual, air 
balancing, moving, security systems, 
housekeeping, commissioning, signage, 
telecom/data, infrastructure deficiencies 
allowance, staff salary & fringe, etc. 
  
  $ 
Taxes     $ 
Incidental     $ 
Project Contingency %     $ 
TOTAL (1)     $0.00 
SPREADSHEET 2  









Intensive Care Unit     $ 
Emergency Department       
Diagnostics (CT Scanner, MRI, Ultrasound, 
Nuclear Medicine, etc.)     $ 
Angiography     $ 
Blood Bank      $ 
Pharmacy      $ 
Laboratories (Microbiology, biochemistry, 
pathology, etc.)     $ 
Chemotherapy Clinic     $ 





Procedure Room     $ 
Medication Room     $ 
Nourishment Room     $ 
Surgical and Operating Room     $ 
Electronic Medical Records System     $ 
Information Technology System     $ 
Patient Room (beds, cribs, bedside tables, CV 
monitor, etc.)     $ 
Other (wheelchairs, stretchers, CV monitors, etc.)     $ 
TOTAL (2)     $0.00 
SPREADSHEET 3  








Salaries & Fringe       
Pediatrician     $ 
Pediatric Oncologist     $ 
Nurse & Nurse Aids     $ 
Nurse Educator     $ 
Social Worker     $ 
Psychologist     $ 
Palliative Care Specialist     $ 
Intensivist     $ 
Emergency Department Specialist     $ 
Data Manager     $ 
Administrative Assistant     $ 
Project Manager     $ 
Administrator     $ 
Finance Manager     $ 
Office Manager     $ 
Pharmacist     $ 
Nutritionist     $ 
Maintenance Staff     $ 
Laboratory Staff     $ 
Diagnostics Lab Staff     $ 
Surgery & Anesthesiology Staff     $ 
Information Technology Staff     $ 





Medications     $ 
Medical Supplies     $ 
Office Supplies     $ 
Storage Facilities      $ 
Other Supplies      $ 
Other Costs     $ 
Water     $ 
Telephone & Internet      $ 
Electricity & Energy     $ 
Waste Management & Toxic Waste Disposal     $ 
Laundry & Linens     $ 
Food Service/Catering     $ 
Insurance     $ 
Training     $ 
Ambulance Service     $ 
Total (3)     $0.00 
SPREADSHEET 4  
4. FINANCING MECHANISMS  
Government     $ 
Donations (private donors, NGO, fundraising 
events, etc.)     $ 
Foundation/NGO Support     $ 
Private Insurance     $ 
Patient Self-Pay/Out-of-pocket     $ 
Research Grants     $ 
Income-Generating Activities (lab rental, 
international patients, investment, etc.)     $ 









Steps in Stakeholders Analysis 
 
Workshop format  
a) Facilitator: The facilitator may be a community member, NGO leader, public 
health professional, communications professional or other individual 
experienced in facilitating discussions, building consensus, eliciting 
responses, and fostering productive dialogue. A second individual should 
be assigned to be the note taker and observer of the process, and help 
during the break compile results.  
b)  Participants: 
a. Leadership Team 










• Determine current and required commitment level of stakeholders
Step 
4




• Determine strategies to engage stakeholders
Step  
6
• Implement strategies to engage stakeholders
Step
7
• Measure, evaluate, and modify strategies to engage stakeholders





c. Members of the planning team 
d. Parent(s) 
e. Community member(s) 
c) Site: A conducive conference room ideally in a U shape. 
d) Materials and Supplies: Flip charts with markers, projector, computer. It is 
recommended that the session is both recorded and video-taped, if the 
possibility exists, for record keeping and retrieving purposes. Snacks and 
beverages may be offered to participants. 
Instructions for the Facilitator 
Ø Briefly explain the purpose of the workshop. Estimated duration is 10 
minutes. 
Ø Hang 2-3 self-stick wall pads (Post-It) on the walls.  
Ø Start by asking participants questions to identify stakeholders (Step 1) 
Ø List all stakeholders on the wall pads as they are mentioned. Estimated 
duration is 20 minutes. 
Ø Confirm that there are no other stakeholders that participants have in mind. 
Use the template list and stakeholders from preliminary research to ask if 
additional stakeholders are relevant to this population. 
Ø Ask participants to identify stakeholders’ interest/power on a 5-point Likert 
Scale. Points 1 and 2 will be grouped together as Low; Point 3 will be 
considered Average (not Low or High); Points 4 and 5 will be grouped 





who are not relevant in this population.  (Step 2). Estimated duration is 20 
minutes. 
Ø Mark interest and power levels next to each stakeholder (four options: HI, 
LI, HP, LP) 
Ø Ask participants to classify each stakeholder on one of the six Stages of 
Change. (Step 3). Estimated duration is 20 minutes. 
Ø Ask participants to indicate what needs, benefits and resistance they expect 
from each stakeholder. (Step 4). Estimated duration is 20 minutes. 
Ø Ask participants to think about strategies to engage stakeholders (Step 5). 
Estimated duration is 20 minutes. 
Stakeholders Analysis – Overview of Steps 
Step Activity Duration 
Introduction Briefly explain the purpose of the workshop 10 minutes 
 Hang 2-3 self-stick wall pads (Post-It) on the walls  
Step 1 Ask participants to identify stakeholders 20 minutes 
 Write all stakeholders on the wall pads as they are mentioned in no particular order  
 
Confirm that there are no other stakeholders that 
participants have in mind. Use the template list and 
stakeholders from preliminary research to ask if 
additional stakeholders are relevant to this population 
 
Step 2 Ask participants to identify stakeholders’ interest/power on a 5-point Likert Scale (see below) 20 minutes 
 
Mark interest and power levels next to each 
stakeholder (four options: HI, LI, HP, LP) 
 
 
Step 3 Ask participants to classify each stakeholder on one of the six Stages of Change 20 minutes 
Step 4 Ask participants to indicate what needs, benefits and resistance they expect from each stakeholder 20 minutes 





Likert Scale:  
1=Very Low 2=Low 3=Average (not Low or High) 4=High 5=Very High 
N/A= May be listed for stakeholders or institutions who are not relevant in this 
population 
Coding: Points 1 and 2 will be grouped together as Low; Points 4 and 5 will be 
grouped together as High; 
Questions to Facilitate the Stakeholder Analysis Workshop 
Questions to identify stakeholders (Step 1): 
• Who is affected/impacted by our project?  
• Who benefits from the project? 
• Who has a direct interest in our project? 
• Who else is providing pediatric oncology services in the country? 
• Who controls resources needed for our project (financial, educational, legal, 
etc.)? 
• Who can help us move the project forward? 
• Who can affect the public opinion regarding our project? 
• Who may object against our project? 
• Who influences the opinions of each stakeholder, in general? 
• Who influences the opinions of each stakeholders about our project? 
• Is there a celebrity who is a cancer survivor, parent of a child with cancer or 
motivated for social causes? 





• What international organizations operate in our country (such as USAID, 
UNICEF, etc.?) 
• Who else is involved in pediatric oncology or in our project? 
Questions to assess Stakeholders’ Interest/Power Level (Step 2): 
• How much is this stakeholder interested in our project (High, Low)? 
• How much power does this stakeholder have on affecting our project in a 
positive or negative way (High, Low)?  
Questions to assess Stakeholders’ Commitment and Stage of Change (Step 
3): 
• Is this stakeholder uninformed or underinformed about the project? 
[Precontemplation Stage] 
• Is this stakeholder currently neutral about our project? [Precontemplation 
Stage] 
• Do we expect that this stakeholder will allow the project to happen? 
[Precontemplation Stage] 
• Does this stakeholder intend to take action in the foreseeable future, i.e. 
one year? [Precontemplation Stage] 
• Does this stakeholder intend to start engaging in the project in the 
foreseeable future, i.e. one year? [Contemplation Stage] 






• Is this stakeholder starting to take small steps in the project? [Preparation 
Stage] 
• Does this stakeholder actively believe in this project? [Preparation Stage] 
• Is this stakeholder already involved in the project in the last 6 or 12 months? 
[Action stage] 
• Is this stakeholder currently actively helping our project to happen? [Action 
stage] 
• Has this stakeholder been engaged in actions related to the project in the 
last 6 or 12 months? [Action stage] 
• Has this stakeholder sustained involvement in the project for more than 6 
months? [Maintenance Stage] 
• Does this stakeholder intent to maintain the involvement in the project in the 
future? [Maintenance Stage] 
• Does this stakeholder have no desire to actively get involved in the project? 
[Termination Stage] 
 
Ask for all stakeholders: 
• What is the required level of commitment for this stakeholder? (indicate a 
“C” for their current stage) 
• What is the required position of the stakeholder? (indicate an “R” for the 





Questions to assess Stakeholders’ perceived Needs, Benefits and 
Resistance (Step 4):  
• What is important to the stakeholder? What motivates each stakeholder? 
(Needs) 
• What specific interest (financial, programmatic, emotional, etc.) do 
stakeholders have in this project? 
• How can stakeholders contribute to the project? (Benefits) 
• How can we maximize the contributions of stakeholders? 
• How can the stakeholder block the project? (Resistance) 
• How can we minimize the barriers that stakeholders put? 
• How can we manage stakeholders’ opposition? 
Questions to plan engagement strategies (Step 5): 
• How can we increase awareness about the project? 
• What type of information do stakeholders want from us? 
• Where are stakeholders currently getting their information on our project? 
Is this a reliable source? 
• How do stakeholders want to receive information from us? 
• How can we provide feedback on the project progress to stakeholders? 
• What media outlets work best for each stakeholder? 
• What can win stakeholders around to support our project? 
• How can we maintain the stakeholders engaged? 





• What type of reminders (email, social media, letters, etc.) would work better 
for each stakeholder? 










Title and Source 
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